WO2011153516A2 - Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose - Google Patents
Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose Download PDFInfo
- Publication number
- WO2011153516A2 WO2011153516A2 PCT/US2011/039192 US2011039192W WO2011153516A2 WO 2011153516 A2 WO2011153516 A2 WO 2011153516A2 US 2011039192 W US2011039192 W US 2011039192W WO 2011153516 A2 WO2011153516 A2 WO 2011153516A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beta
- endo
- seq
- glucanase
- host cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2445—Beta-glucosidase (3.2.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
- C12N9/2482—Endo-1,4-beta-xylanase (3.2.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01021—Beta-glucosidase (3.2.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01091—Cellulose 1,4-beta-cellobiosidase (3.2.1.91)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- Biomass is biological material from living, or recently living organisms, such as wood, waste, (hydrogen) gas, and alcohol fuels. Biomass is carbon, hydrogen and oxygen based. Nitrogen and small quantities of other atoms, including alkali, alkaline earth and heavy metals can be found as well. Metals are often found in functional molecules such as the porphyrins which include chlorophyll which contains magnesium. Plants in particular combine water and carbon dioxide to sugar building blocks. The required energy is produced from light via photosynthesis based on chlorophyll. On average, between 0.1 and 1 % of the available light is stored as chemical energy in plants. The sugar building blocks are the starting point for all of the major fractions found in terrestrial plants, lignin, hemicellulose and cellulose.
- Biomass is widely recognized as a promising source of raw material for production of renewable fuels and chemicals.
- the primary obstacle impeding the more widespread production of energy from biomass feedstocks is the general absence of low-cost technology for overcoming the recalcitrance of these materials to conversion into useful fuels.
- Biomass contains carbohydrate fractions ⁇ e.g., starch, cellulose, and hemicellulose) that can be converted into ethanol.
- starch, cellulose, and, hemicellulose In order to convert these fractions, the starch, cellulose, and, hemicellulose must ultimately be converted or hydrolyzed into monosaccharides; it is the hydrolysis that has historically proven to be problematic.
- Biomass processing schemes involving enzymatic or microbial hydrolysis commonly involve four biologically mediated transformations: (1) the production of saccharolytic enzymes (amylases, cellulases and hemicellulases); (2) the hydrolysis of carbohydrate components present in pretreated biomass to sugars; (3) the fermentation of hexose sugars ⁇ e.g., glucose, mannose, and galactose); and (4) the fermentation of pentose sugars (e.g., xylose and arabinose).
- saccharolytic enzymes as amylases, cellulases and hemicellulases
- carbohydrate components present in pretreated biomass to sugars
- hexose sugars ⁇ e.g., glucose, mannose, and galactose
- pentose sugars e.g., xylose and arabinose
- CBP consolidated bioprocessing
- CBP offers the potential for lower cost and higher efficiency than processes featuring dedicated saccharolytic enzyme production.
- the benefits result in part from avoided capital costs, substrate and other raw materials, and utilities associated with saccharolytic enzyme production.
- several factors support the realization of higher rates of hydrolysis, and hence reduced reactor volume and capital investment using CBP, including enzyme-microbe synergy and the use of thermophilic organisms and/or complexed saccharolytic systems.
- cellulose-adherent cellulolytic microorganisms are likely to compete successfully for products of cellulose hydrolysis with non-adhered microbes, e.g., contaminants, which could increase the stability of industrial processes based on microbial cellulose utilization.
- Amylase is an example of an amylolytic enzyme that is present in human saliva, where it begins the chemical process of digestion.
- the pancreas also makes amylase (alpha amylase) to hydrolyze dietary starch into disaccharides and trisaccharides which are converted by other enzymes to glucose to supply the body with energy.
- Plants and some bacteria also produce amylases.
- Amylases are glycoside hydrolases and act on a-l,4-glycosidic bonds.
- alpha-amylase (alternate names: 1 ,4-a-D-glucan glucanohydrolase; glycogenase) are calcium metalloenzymes, i.e., completely unable to function in the absence of calcium.
- alpha-amylase breaks down long- chain carbohydrates, ultimately yielding maltotriose and maltose from amylose, or maltose, glucose and "limit dextrin" from amylopectin. Because it can act anywhere on the substrate, alpha-amylase tends to be faster-acting than beta-amylase.
- beta-amylase (EC 3.2.1.2) (alternate names: 1,4-a-D-glucan maltohydrolase; glycogenase; saccharogen amylase) catalyzes the hydrolysis of the second a- 1,4 glycosidic bond, cleaving off two glucose units (maltose) at a time.
- the third amylase is gamma-amylase (EC 3.2.1.3) (alternate names: Glucan 1 ,4-a-glucosidase; amyloglucosidase; Exo-l,4-a-glucosidase; glucoamylase; lysosomal a-glucosidase; 1 ,4-oc- D-glucan glucohydrolase).
- Glucan 1 ,4-a-glucosidase amyloglucosidase
- Exo-l,4-a-glucosidase glucoamylase
- glucoamylase lysosomal a-glucosidase
- 1 ,4-oc- D-glucan glucohydrolase In addition to cleaving the last a(l-4)glycosidic linkages at the nonreducing end of amylose and amylopectin, yielding glucose, gamma-
- alpha-glucosidase acts on maltose and other short malto- oligosaccharides produced by alpha-, beta-, and gamma-amylases, converting them to glucose.
- the first type are endoglucanases (1,4-P-D-glucan 4-glucanohydrolases; EC 3.2.1.4). Endoglucanases cut at random in the cellulose polysaccharide chain of amorphous cellulose, generating oligosaccharides of varying lengths and consequently new chain ends.
- the second type are exoglucanases, including cellodextrinases (1,4-P-D- glucan glucanohydrolases; EC 3.2.1.74) and cellobiohydrolases (l ,4- -D-glucan cellobiohydrolases; EC 3.2.1.91).
- Exoglucanases act in a processive manner on the reducing or non-reducing ends of cellulose polysaccharide chains, liberating either glucose (glucanohydrolases) or cellobiose (cellobiohydrolase) as major products. Exoglucanases can also act on microcrystalline cellulose, presumably peeling cellulose chains from the microcrystalline structure.
- the third type are ⁇ -glucosidases ( ⁇ -glucoside glucohydrolases; EC 3.2.1.21). ⁇ -Glucosidases hydrolyze soluble cellodextrins and cellobiose to glucose units.
- a variety of plant biomass resources are available as starch and lignocellulosics for the production of biofuels, notably bioethanol.
- the major sources are (i) wood residues from paper mills, sawmills and furniture manufacturing, (ii) municipal solid wastes, (iii) agricultural residues and (iv) energy crops such as com.
- Pre-conversion of particularly the cellulosic fraction in these biomass resources using either physical, chemical or enzymatic processes) to fermentable sugars (glucose, cellobiose, maltose, alpha- and cellodextrins) would enable their fermentation to bioethanol, provided the necessary fermentative micro-organism with the ability to utilize these sugars is used.
- Plant biomass consists of about 40-55% cellulose, 25-50% hemicellulose and 10-40% lignin, depending whether the source is hardwood, softwood, or grasses (Sun, Y. and Cheng, J., Bioresource Technol. 83, 1-1 1 (2002)).
- the major polysaccharide present is water-insoluble, cellulose that contains the major fraction of fermentable sugars (glucose, cellobiose or cellodextrins).
- Bakers' yeast ⁇ Saccharomyces cerevisiae remains the preferred micro-organism for the production of ethanol (Hahn-Hagerdal, B., et ah, Adv. Biochem. Eng. Biotechnol. 73, 53-84 (2001)). Attributes in favor of this microbe are (i) high productivity at close to theoretical yields (0.51 g ethanol produced/g glucose used), (ii) high osmo- and ethanol tolerance, (iii) natural robustness in industrial processes, (iv) being generally regarded as safe (GRAS) due to its long association with wine and bread making, and beer brewing. Furthermore, S.
- cerevisiae exhibits tolerance to inhibitors commonly found in hydrolyzaties resulting from biomass pretreatment.
- the major shortcoming of S. cerevisiae is its inability to utilize complex polysaccharides such as starch and cellulose, or its break-down products, such as cellobiose and cellodextrins.
- CBHA and CBHB and P. chrysosporium
- CBHl -4 P. chrysosporium
- the proteins encoded by these genes are all modular enzymes containing a catalytic domain linked via a flexible liner sequence to a cellulose-binding molecule.
- CBH2 and CBHB are family 6 glycosyl hydrolases.
- CBHl and CBHl-4 are family 7 glycosyl hydrolases.
- Glycosyl hydrolases are a widespread group of enzymes that hydrolyze the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety.
- Glycoside hydrolase family 7 comprises enzymes with several known activities including endoglucanase and cellobiohydrolase. These enzymes were formerly known as cellulase family C.
- Cellobiohydrolases play a role in the conversion of cellulose to glucose by cutting the dissaccharide cellobiose from the reducing (CBHl ; GHF7) or nonreducing (CBH2; GHF6) end of the cellulose polymer chain.
- CBHl reducing
- CBH2 nonreducing
- cellulases and xylanases generally consist of a catalytic domain joined to a cellulose-binding domain (CBD) via a linker region that is rich in proline and/or hydroxy-amino acids.
- CBD domain is found at the C-terminal extremity of these enzyme (this short domain forms a hairpin loop structure stabilised by 2 disulphide bridges).
- Some cellulases have only the catalytic domain.
- Glycosyl hydrolase family 7 enzymes have a 67% homology at the amino acid level, but the homology between any of these enzymes and the glycosyl hydrolase family 6 CBH2 is less than 15%.
- ethanol producing yeast such as S. cerevisiae require addition of external cellulases when cultivated on cellulosic substrates such as pre-treated wood because this yeast does not produce endogenous cellulases.
- Functional expression of fungal cellulases such as T. reesei CBH1 and CBH2 in yeast S. cerevisiae have been demonstrated (Den Haan R et al., Metab Eng., 9, 87-94 (2007)).
- current levels of expression and specific activity of cellulases heterologously expressed in yeast are still not maximally efficient with respect to the lignocellulosic substrate.
- CBP consolidated bioprocessing
- the secretome of Trichoderma reesei consists of 22 unique identifiable protein species (Herpoel-Gimbert I, Margeot A, Dolla A, et al, Comparative secretome analyses of two Trichoderma reesei RUT-C30 and CL847 hypersecretory strains, Biotechnol Biofuels. 2008 Dec 23; 1 (1): 18), identified by 2D gel electrophoresis and MALDI-TOF mass spectrometry.
- the present invention is drawn to identifying cellulolytic enzymes from a variety of organisms and subsequently identifying enzymes that work in maximally efficient combinations to digest lignocellolosic material. Given the diversity of cellulolytic bacteria, classification of these organisms based on several parameters (Lynd et al, 2002) may inform the choice of gene donors. The following are possible distinguishing characteristics: A) aerobic vs. anaerobic, B) mesophiles vs. thermophiles; and, C) noncomplexed, cell free enzymes vs. complexed, cell bound enzymes.
- FIG. 1 provides an overview of the carbohydrate structures present in plant material given in Van Zyl WH et al., Consolidated bioprocessing for bioethanol production using Saccharomyces cerevisiae, Adv Biochem Eng Biotechnol., 108, 205-235 (2007).
- Hardwoods contain 2-5% of a glucomannan composed of beta-D-glucopyranose and beta- D-mannopyranose units linked 1-4— somewhat similar to structure (C) from Figure 1 ; and hardwoods contain small amounts of pectins, starch and proteins.
- Panel F from Figure 1 gives the structure for a type of xylan- ⁇ -lignin linkage, as well as the 4-O-methylglucuronic acid linkage to xylan that are associated with hardwoods. This figure was taken from Spanikova S and Biely P, FEBS Lett., 580, 4597- 4601 (2006). The authors of this paper identified an enzyme, glucuronoyl esterase, which acts on these linkages. They identified the T ⁇ reesei Cip2 as a homologue of this enzyme.
- the present invention provides for the identification of novel saccharolytic enzymes that are capable of facilitating efficient cellulase digestion and fermentation product production in host cells.
- the present invention is directed to the isolation of novel genes for saccarolytic enzymes from cellulolytic organisms.
- the present invention provides novel genes that are capable of being heterologously expressed in yeast systems and facilitate the digestion of starch, pentose sugars, and lignocellulosic components.
- the present invention provides in one embodiment for novel genes for saccharolytic enzymes from a variety of bacterial, fungal, non-conventional yeast, and plant organisms which can be expressed in yeast.
- the present invention also describes industrial yeast strains that express enzymes for the production of fuel ethanol from corn starch.
- yeast strains expressing enzymes for the production of fuel ethanol from whole grain or starch have been previously disclosed, the application has not been commercialized in the grain-based fuel ethanol industry, due to the relatively poor ability of the resulting strains to produce/tolerate high levels of ethanol.
- US Pat. No. 7,226,776 discloses that a polysaccharase enzyme expressing ethanologen can make ethanol directly from carbohydrate polymers, but the maximal ethanol titer demonstrated is 3.9 g/1.
- US Pat. No. 5,422,267 discloses the use of a glucoamylase in yeast for production of alcoholic beverages; however, no commercially relevant titers of ethanol are disclosed.
- yeast cells are known to naturally utilize sugars such as glucose and mannose, they lack the ability to efficiently utilize pentose sugars such as xylose and arabinose.
- the present invention describes industrial yeast strains that are engineered to express a broad spectrum of various saccharolytic enzymes as well as pentose utilization pathways for production of various compounds from biomass feedstock containing mix of hexose and pentose mono- and poly- saccharides.
- biomass feedstock could include several different polymeric compounds such as: cellulose, hemicellulose, starch, pectin, inulin, levan and others.
- biomass feedstock could contain the mix of pentose and hexose carbohydrates. Therefore, complex substrates derived from plants such as wood, corn, agave, switch grass and others that contain combination of different carbohydrates and carbohydrate polymers could be utilized in a bioprocess without prior separation of different substrates.
- substrates derived from different sources could be combined in the same bioprocess. The substrates could be derived directly from plants or from any kind of waste or byproducts containing carbohydrates.
- the present invention represents the first demonstration of a full CBP effect at commercial ethanol production level, wherein yeast produced enzymes completely replace exogenous enzyme added in standard commercial process.
- yeast CBP strain was able to produce over 125g/l ethanol from liquefied corn mash in 72 hrs without any exogenous enzymes added. This was achieved due to engineering selected set of enzymes into an industrial robust background strain.
- the resulting strains may also be used to produce ethanol directly from granular starch without liquefaction.
- the invention comprising a yeast strain, or strains, secreting a full suite, or a subset of that full suite, of enzymes to hydrolyze lignocellulose, including enzymes that hydrolyze chemical linkages in cellulose, hemicellulose, and between lignin and carbohydrates.
- the invention is also a set of proteins that are well-expressed in yeast for each category of necessary enzymatic activity in order to efficiently utilize a particular lignocellulosic material.
- This full suite of enzymes contains activities beyond those identified previously for expression in yeast: CBH1 , CBH2, EG, and BGL (as disclosed e.g. in PCT Application No. PCT/US2009/065571).
- the present invention relates to a yeast cell that expresses one or more gene products of the genes: Aspergillus fumigatus Endoglucanase (Accession No. XPJ747897); Neosartorya fischeri Endoglucanase (Accession No. XP_001257357); Aspergillus clavatus Endoglucanase (Accession No. XP_001270378); Aspergillus terreus Endoglucanase (Accession No. XP_001217291); Penicillium marneffei Endoglucanase (Accession No.
- XP 002152969 Chaetomium globosum Endoglucanase (Accession No. XP 001229968); Neurospora crassa Endoglucanase (Accession No. XP_956431); Aspergillus oryzae Endoglucanase (Accession No. BAA22589); Thielavia heterothallica Endoglucanase (Accession No. AAE25067); Fusarium oxysporum Endoglucanase (Accession No. AAG09047); Humicola insolens Endoglucanase (Accession No.
- Phanerochaete chrysosporium Endoglucanase (Accession No. AAU 12276); Stachybotrys echinata Endoglucanase (Accession No. AAM77710); Neosartorya fischeri Endoglucanase (Accession No. XP_001261563); Chaetomium brasiliense Endoglucanase (Accession No. AAM77701); Chaetomium globosum Endoglucanase (Accession No. EAQ86340); Aspergillus fumigatus Endoglucanase (Accession No.
- CAB42307 Thielavia terrestris Endoglucanase (Accession No. CAH03187); Chrysosporium lucknowense Endoglucanase (Accession No. AAQ38151); Magnaporthe grisea Endoglucanase (Accession No. EDJ97375); Chaetomium globosum Endoglucanase (Accession No. EAQ84577); Humicola insolens Endoglucanase 1DYS B; Neurospera crassa Endoglucanase (Accession No. XP_957415); Trichoderma reesei Xyloglucanase (Accession No.
- AAQ38147 Aureobasidium pullulans Endoxylanase (Accession No. BAE71410); Aspergillus nidulans beta-xylosidase (Accession No. CAA73902; Cochliobolus carbonum beta-xylosidase (Accession No. AAC67554); Penicillium herquei beta-xylosidase (Accession No. BAC75546); Pyrenophora tritici-repentis beta- xylosidase (Accession No. XP_001940956); Aspergillus niger beta-mannosidase (Accession No.
- Trichoderma reesei acetylxylanesterase (Accession No. Q99034); Neosartorya fischeri acetylxylanesterase (Accession No. XP_001262186); Trichoderma reesei arabinofuranosidase, 1,4-beta-D-arabinoxylan arabinofuranohydrolase (Accession No. AAP57750); Chaetomium globosum arabinofuranosidase, 1,4-beta-D-arabinoxylan arabinofuranohydrolase (Accession No.
- XP_001223478 Aspergillus niger arabinofuranosidase, 1,4-beta-D-arabinoxylan arabinofuranohydrolase (Accession No. XP 001389998); Penicillium decumbens Swollenin (Accession No. ACH57439); Neosartorya fischeri Swollenin (Accession No. XP_001257521); Talaromyces stipitatus Swollenin (Accession No EED19018); Trichoderma reesei (Accession No. AAP57751); Chaetomium globosum (Accession No.
- XP 001228455 Magnaporthe grisea (Accession No. XP 365869); Trichoderma reesei glucuronyl esterase (Accession No. AAP57749); Chaetomium globosum glucuronyl esterase (Accession No. XP_001226041); Aspergillus fumigatus giucuronyl esterase (Accession No. XP_75 313); Popidus alba aipha-expansin (Accession No. BAB39482); Vitis lubrusca a!pha-expansin (Accession No.
- Triticum aestivwn beta- expansin (Accession No. AAS48881); Eucalyptus globulus beta-expansin (Accession No. AAZ08315); Aspergillus niger Feruoyl esterase (Accession No. XP GO 1393337); Aspergillus terreus Feruoyl esterase (Accession No.
- XP 00121 1092 Talaromyces stipitatus Feruoyl esterase (Accession No, EED17739); Chaetomium globosum Feruoyl esterase (Accession No, XP 001228412) Streptomyces avermitilis 1 ,4-beta-ceiiobiosidase guxAl (Accession No. P_821732.1); Streptomyces avermitilis 1 ,4-beta-cellobiosidase guxA2 (Accession No.
- NP_823029.I Streptomyces avermitilis 1 ,4-beta-cellobiosidase guxA3 (Accession No. NP 823031.1); Streptomyces avermitilis ⁇ - 1 ,4-beta-glucanase celAl (Accession No. NP_821730.1): Streptomyces avermitilis Endo- 1 ,4-beta-glucanase ce!A2 (Accession No. NP___823030.1); Streptomyces avermitilis Endo- 1 ,4-beta-glucanase ceIA3 (Accession No.
- NP_823032.1 Streptomyces avermitilis Endo-l,4-beta-glucanase celA4 (Accession No, NP_823744.1); Streptomyces avermitilis Endo- 1 ,4-beta-giucanase (Accession No. NP 826394.1); Streptomyces avermitilis Endo- 1 ,4-beta-glucanase celA5 (Accession No. NP _828072.1); Streptomyces avermitilis Beta-l,4-xyianase (Accession No.
- NP_823272.1 Streptomyces avermitilis Beta-l,4-xylanase (Accession No. NP_826161.1); Streptomyces avermitilis Xylanase (Accession No. NP_827548.1); Streptomyces avermitilis Endo-l,4-beta-xylanase xynD (Accession No. NP_827557.1); Streptomyces avermitilis 1,4-beta-xylosidase xynBl (Accession No.
- NP_822628.1 Streptomyces avermitilis Beta-xylosidase (Accession No. NP_823285.1); Streptomyces avermitilis 1,4-beta-xylosidase xynB2 (Accession No. NP 826159.1); Streptomyces avermitilis 1,4-beta-xylosidase xynB3 (Accession No. NP_827745.1); Streptomyces avermitilis Beta-glucosidase bglCl (Accession No.
- NP_822977.1 Streptomyces avermitilis Beta-glucosidase bglC2 (Accession No. NP_826430.1); Streptomyces avermitilis Beta-glucosidase bglC3 (Accession No. NP_826775.1); Streptomyces avermitilis AXE1 (Accession No. NP 822477.1); Streptomyces avermitilis AXEl (Accession No. NP_822632.1); Streptomyces avermitilis abfA (Accession No. NP_822218.1); Streptomyces avermitilis abfB (Accession No.
- NP_822290.1 Streptomyces avermitilis abfA (Accession No. NP 826920.1); Streptomyces avermitilis abfB (Accession No. BAC74043.1); Streptomyces avermitilis SAV_6756 (Accession No. BAC74467.1); Streptomyces avermitilis agaAl (Accession No. BAC68338.1); Streptomyces avermitilis agaA3 (Accession No. BAC68787.1); Streptomyces avermitilis agaB2 (Accession No. BAC69185.1); Saccharophagus degradans 2-40 Sde_2993 (Accession No.
- Saccharophagus degradans 2-40 Sde_2996 (Accession No. YP_528465.1); Saccharophagus degradans 2-40 Sde_3023 (Accession No. YP_528492.1); Saccharophagus degradans 2-40 cel5A (Accession No. ABD82260.1); Saccharophagus degradans 2-40 cel5E (Accession No. ABD82186.1); Saccharophagus degradans 2-40 cel5F (Accession No. ABD80834.1); Saccharophagus degradans 2-40 cel5J (Accession No. ABD81754.1; Saccharophagus degradans 2-40 cel9A (Accession No.
- Saccharophagus degradans 2-40 ced3A Accession No. ABD81757.1
- Saccharophagus degradans 2-40 ced3B Accession No. ABD79509.1
- Saccharophagus degradans 2-40 bgllA Accession No. ABD82858.1
- Saccharophagus degradans 2-40 bgllB Accession No. ABD80656.1
- Saccharophagus degradans 2-40 Cep94A accesion No. ABD80580.1
- Saccharophagus degradans 2-40 Cep94B accesion No. ABD80168.1
- Saccharophagus degradans 2-40 Sde_0509 accesion No.
- YP_525985.1 Saccharophagus degradans 2-40 Sde 0169 (Accession No. YP_525645.1); Bacillus subtilis Expansin exlX (Accession No. CAB13755.1); Bacillus subtilis Endo-l,4-beta-glucanase eglS (Accession No. CABl 3696.2); Bacillus subtilis Endo-xylanase xynC (Accession No. CAB13698.1); Bacillus subtilis Endo-l,4-beta- xylanase xynD (Accession No.
- Clostridium phytofermentans Cphy_3368 (Accession No.
- Clostridium phytofermentans Cphy_2058 (Accession No.
- Clostridium phytofermentans Cphy_ 3202 cellulase B (Accession No.
- Clostridium phytofermentans Cphy_1163 (Accession No.
- Clostridium phytofermentans Cphy_3329 (Accession No.
- Clostridium phytofermentans Cphy_1125 (Accession No.
- Clostridium phytofermentans Cphy_1510 (Accession No.
- Clostridium phytofermentans Cphy_0624 (Accession No.
- Clostridium phytofermentans Cphy_2105 XynA (Accession No.
- Clostridium phytofermentans Cphy_2108 (Accession No. YPJ)01559213.1) Clostridium phytofermentans Cphy_3207 Y (Accession YP_001560300.1) Clostridium phytofermentans Cphy_0191 (Accession No. YP_001557317.1) Clostridium phytofermentans Cphy_0875 (Accession No. YP , 001558000.1) Clostridium phytofermentans Cphy_1 169 (Accession No. YP_001558286.1) Clostridium phytofermentans Cphy 1071 (Accession No.
- Clostridium phytofermentans Cphy_2128 (Accession No. YP 001559233.1) Clostridium phytofermentans Cphy_2276 (Accession No. YP . , 001559376.1) Clostridium phytofermentans Cphy_1936 (Accession No. YP_001559043.1) Clostridium cellulolyticum cel5I (Accession No. AAL79562.1); Clostridium cellulolyticum CelCCF (dockerin) Cel48F-yeast CO template pMU914 (Accession No. AAB41452.1); Clostridium cellulolyticum Ccel_1259 (Accession No.
- Clostridium cellulolyticum Ccel_2226 (Accession No. YP_002506548.1); Clostridium cellulolyticum Ccel_0732 (dockerin) Cel9E-yeast CO template pMU913 (Accession No. YP_002505091.1); Clostridium cellulolyticum Ccel 1099 (dockerin) Cel5A-yeast CO template pMU967 (Accession No. YP_002505438.1); Clostridium cellulolyticum Ccel_2392 (dockerin) (Accession No.
- YP_002506705.1 Clostridium cellulolyticum Ccel_0731 (dockerin) Cel9G-yeast CO template pMU892 (Accession No. YP 002505090.1); Clostridium cellulolyticum Ccel_0840 (dockerin) Cel5D-yeast CO template pMU891 (Accession No. YP_ 002505196.1); Clostridium cellulolyticum CelCCC (dockerin) Cel8C-yeast CO template pMU969 (Accession No. AAA73867.1); Thermobifida fusca endo-l ,4-beta xylanase (Accession No.
- Thermobifida fusca endo-l,4-beta-D-xylanase (xyll l) (Accession No. AAV64879.1); Thermobifida fusca Endoglucanase (Accession No. AAZ55112.1); Thermobifida fusca cellulase (Accession No. AAZ56745.1); Thermobifida fusca exo-l,4-beta-glucosidase (Accession No. AAZ55642.1); Thermobifida fusca beta-glucosidase (Accession No.
- Thermobifida fusca cellulose 1,4-beta-cellobiosidase (Accession No. YP 290015.1); Thermobifida fusca CBD E8 (Accession No. AAZ55700.1); Thermobifida fusca celC (E3) (Accession No. YP_288681.1); Thermobifida fusca celE (E5) (Accession No. YP_288962.1); Thermobifida fusca cel5B (Endoglucanase) (Accession No. AAP56348.1); Thermobifida fusca celA (El) (Accession No.
- Thermobifida fusca celB (E2) (Accession No. YP_289135.1); Thermobifida fusca Tfu_1627 (1,4-beta-cellobiosidase) (Accession No. YP 289685.1); Clostridium thermocellum celA (dockerin) (Accession No. YP_001036701.1); Clostridium thermocellum celY (cel48Y) (Accession No. CAI06105.1); Clostridium thermocellum Cthe_0625 (dockerin) (Accession No. YP_001037053.1); Clostridium thermocellum celC (Accession No.
- Clostridium thermocellum (Accession No. YP_001037893.1); Clostridium thermocellum (Accession No. YP 001038519.1); Clostridium thermocellum bglA (Accession No. CAA42814.1); Clostridium thermocellum bglB (Accession No. CAA33665.1); Clostridium thermocellum Cthe_2548 (Accession No. YP_001038942.1); Clostridium thermocellum Cthe_1273 (Accession No. YP_001037698.1); Clostridium thermocellum Cthe_0040 (Cel9I) (Accession No.
- YP_001036474.1 Clostridium thermocellum Cthe_0412 (dockerin) (Accession No. YP 001036843.1); Clostridium thermocellum Cthe_0825 (dockerin) (Accession No. YP_001037253.1); Clostridium stercorarium xynA (Accession No. CAD48307); Clostridium stercorarium xynB (CelW - celloxylanase) (Accession No. CAD48313); Clostridium stercorarium xynC (CelX - celloxylanase) (Accession No.
- Clostridium stercorarium bxlB (b-Xylosidase B) (Accession No. AJ508405); Clostridium stercorarium bxlA (b-Xylosidase A) (Accession No. AJ508404) ; Clostridium stercorarium bglZ (beta-glucosidase) (Accession No. CAB08072); Clostridium stercorarium arfA (alpha-arabinofuranosidaseA) (Accession No. AJ508406); Clostridium stercorarium arfB (alpha-arabinofuranosidaseB) (Accession No.
- Clostridium stercorarium celZ (Cs-Cel9Z - Avicellase I) (Accession No CAA39010); Clostridium stercorarium celY (Cs-Cel48Y - Avicellase II) (Accession No. CAA93280); Anaerocellum thermophilum celA (1,4-beta-glucanase) (Accession No. CAB06786); Anaerocellum thermophilum celD (EG) (Accession No. CAB01405); Anaerocellum thermophilum xynA (1,4-beta-D-xylan xylanhydrolase) (Accession No.
- Anaerocellum thermophilum celB (EG5) (Accession No. Z86104); Anaerocellum thermophilum Athe_1866 (endo-l,4-beta-mannosidase) (Accession No. YP_002573059); Anaerocellum thermophilum Athe_0594 ("cellulase”) (Accession No. YP_002572493).
- the cells of the invention can express pairs of enzymes that have synergistic activity with respect to their action on a given Ugnocellulosic substrate.
- pairs include, but are not limited to (Slreptomyces avermitilis endo- 1,4-beta- glucanase ce!A2 (Accession No. NP 823030.1) and Streptomyces avermitilis endo-1 ,4- beta-glucanase celA5 (Accession No. NP__828072.1)); ⁇ Streptomyces avermitilis endo- 1 ,4-beta-glucanase celA2 (Accession No.
- NP 823030.1 Bacillus subtilis endo-1,4- beta-glucanase (Accession No CAB 13696.2)); ⁇ Streptomyces avermitilis endo-l,4-beta- glucanase celA3 (Accession No. NP_823032.1) and Streptomyces avermitilis endo-1,4- beta-glucanase (Accession No. NP_826394.1)); ⁇ Streptomyces avermitilis endo-l,4-beta- glucanase celA4 (Accession No.
- NP_823744.1 and Streptomyces avermitilis xylanase accesion No. NP_827548.1
- ⁇ Bacillus subtilis endo-l,4-beta-glucanase accesion No CAB 13696.2
- Streptomyces avermitilis endo-l,4-beta-glucanase accesion No. NP_826394.1
- ⁇ Streptomyces avermitilis endo-l,4-beta-glucanase celA4 accesion No.
- NP_823744.1 and Bacillus subtilis endo-l,4-beta-glucanase (Accession No CAB13696.2)); ⁇ Streptomyces avermitilis endo-l,4-beta-glucanase celA5 (Accession No. NP_828072.1) and Streptomyces avermitilis endo-l,4-beta-glucanase celA4 (Accession No. NP_823744.1)); ⁇ Streptomyces avermitilis endo-l,4-beta-glucanase celA5 (Accession No.
- NP_828072.1 and Clostridium phytofermentans xylanase (Accession No. YP_001557750.1)); ⁇ Saccharophagus degradans 2-40 mannanase (Accession No. YP_525985.1) and Streptomyces avermitilis endo-l,4-beta-glucanase (Accession No. NP 826394.1)); ⁇ Streptomyces avermitilis xylanase (Accession No. NP_827548.1) and Saccharophagus degradans 2-40 mannanase (Accession No.
- YP_525985.1 ⁇ Clostridium phytofermentans xylanase (Accession No. YP_001557750.1) and Streptomyces avermitilis xylanase (Accession No. NP 827548.1)); ⁇ Clostridium phytofermentans xylanase (Accession No. YP_001557750.1) and Streptomyces avermitilis xylanase (Accession No. NP_827548.1)); ⁇ Streptomyces avermitilis endo-1,4- beta-glucanase celA5 (Accession No.
- NP 828072.1 and Streptomyces avermitilis xylanase (Accession No. NP_827548.1)); ⁇ Streptomyces avermitilis endo-l,4-beta- glucanase (Accession No. NP_823744.1) and Saccharophagus degradans 2-40 mannanase (Accession No. YP_525985.1)); ⁇ Streptomyces avermitilis endo-l,4-beta- glucanase celA2 (Accession No. NP_823030.1) and Saccharophagus degradans 2-40 mannanase (Accession No.
- YP_525985.1 ⁇ Streptomyces avermitilis endo-l,4-beta- glucanase (Accession No. NP__823744.1) and Streptomyces avermitilis endo-l,4-beta- glucanase celA3 (Accession No. NP_823032.1)); ⁇ Streptomyces avermitilis endo-1,4- beta-glucanase (Accession No. NP_823744.1) and Clostridium phytofermentans xylanase (Accession No.
- host cells of the invention can express three enzymes that have synergistic activity with respect to their action on a given lignocellulosic substrate.
- triplets of enzymes can be, for example (Streptomyces avermitilis endo-l,4-beta- glucanase celA4 NP 823744.1 , Streptomyces avermitilis endo-l ,4-beta-glucanase celA5 NP 828072.1, and Streptomyces avermitilis endo-l ,4-beta-glucanase celA2 NP_823030.1); ⁇ Streptomyces avermitilis xylanase NP 827548.1, Streptomyces avermitilis endo-l,4-beta-glucanase celA5 NP_828072.1, and Streptomyces avermitilis endo-l,4
- host cells of the invention can express four enzymes that have synergistic activity with respect to their action on a given lignocellulosic substrate.
- quadruplets of enzymes can be, for example (Streptomyces avermitilis endo-1,4- beta-glucanase celA4 NP_823744.1 , Streptomyces avermitilis xylanase NP_827548.1, Streptomyces avermitilis endo-l,4-beta-glucanase celA5 NP_828072.1, and Streptomyces avermitilis endo-l,4-beta-glucanase celA2 NP_823030.1); (Clostridium phytofermentans xylanase YP_001557750.1, Streptomyces avermitilis xylanase NP_827548.1, Streptomyces avermitil
- the yeast cell expresses any one or more of the above- named genes in conjunction with one or more CBH1, CBH2, EG, or BGL.
- the cells of the invention can be used to reduce the amount of external enzyme needed to hydro lyze Hgnocellulose during an SSF or CBP process, or to increase the yield of a fermentation product during SSF or CBP at a given cellulase loading.
- the invention provides polynucleotide and amino acid sequences of endoglucanases, xylanases, xylosidases, esterases, other hydrolases, and other accessory enzymes that are active and well-expressed by S. cerevisiae and other yeast species.
- these well-expressed enzymes provide an increased ability of cellulase cocktails to hydrolyze Hgnocellulose.
- combinations of the enzymes of the present invention are useful for increasing the activity of yeast expressed "core" cellulases, CBH1, CBH2, EG, and BGL.
- the host yeast cell expresses, in addition to the "core" cellulases, xylanase, xylosidase, glucoamylase, and acetixy!an esterase.
- the invention provides technology for expressing multiple genes in multiple copies using yeast high- expression vectors, centromeric vectors and by genomic integration.
- the present invention relates to processes of producing fermentation products by contacting cells of the invention with lignocellulosic material and then recoving the fermentation material.
- the invention relates to the products produced by the fermentation of lignocellulosic materials.
- the saccharolytic enzymes (amylases, cellulases, hemicellulases, cellulolytic and amylolytic accessory enzymes, inulinases, levanases, and others) and pentose utilizing enzymes are combined in a single yeast strain.
- the hydrolytic and pentose hydrolyzing enzymes are expressed in different yeast strains used in the same technological process.
- yeast strains, each expressing a different enzyme, or a different combination of enzymes are co-cultured in the same volume.
- yeast strains, each expressing a different enzyme, or a different combination of enzymes are cultured in separate tanks.
- yeast strains of the present invention are constructed to express different saccharolytic enzymes at different levels.
- a yeast strain expresses one or more cellulolytie enzymes at a higher level than one or more amylolytic enzymes and one or more pentose sugar utilizing enzymes.
- the yeast strain expresses one or more amylolytic enzymes at a higher level than one or more cellulolytie enzymes and one or more pentose sugar utilizing enzymes.
- the yeast strain expresses one or more pentose sugar utilizing enzymes at a higher level than one or more cellulolytie enzymes and one or more amylolytic enzymes.
- the present invention relates to a recombinant yeast host cell comprising a heterologous polynucleotide encoding a polypeptide comprising an amino acid sequence at least 90% identical to any one of the amino acid sequences of SEQ ID NOs: 442-446.
- the present invention relates to a recombinant yeast host cell comprising one or more heterologous polynucleotides encoding a polypeptide of Table 19.
- the present invention relates to a recombinant yeast host cell comprising: (a) at least one heterologous polynucleotide comprising a nucleic acid which encodes a glucoamylase; (b) at least one heterologous polynucleotide comprising a nucleic acid which encodes an alpha-glucosidase; (c) at least one heterologous polynucleotide comprising a nucleic acid which encodes an enzyme that utilizes pentose sugar; and (d) further comprising at least one heterologous polynucleotide encoding a polypeptide comprising an amino acid sequence according to SEQ ID NOs: 442-446.
- the yeast host cell further comprises an alpha-amylase, a pullulanse, and /or an isopullulanse.
- the cells of the invention can express pairs of amylolytic enzymes that have synergistic activity with respect to their action on a given biomass substrate.
- pairs include, but are not limited to (SEQ ID NO: 443 and SEQ ID NO: 444); (SEQ ID NO: 443 and SEQ ID NO: 445); (SEQ ID NO: 445 and SEQ ID NO: 446); (SEQ ID NO: 443 and SEQ ID NO: 445); (SEQ ID NO: 442 and SEQ ID NO: 445); (SEQ ID NO: 444 and Bacillus subtilis arabinoxylanase (Accession No.
- host cells of the invention can express three enzymes that have synergistic activity with respect to their action on a given biomass substrate.
- triplets of enzymes can be, for example (SEQ ID NO: 442, SEQ ID NO: 445 and SEQ ID NO: 446); (SEQ ID NO: 444, SEQ ID NO: 445 and SEQ ID NO: 446); (SEQ ID NO: 442, SEQ ID NO: 445 and SEQ ID NO: 446).
- host cells of the invention can express four enzymes that have synergistic activity with respect to their action on a given biomass substrate.
- Such quadruplets of enzymes can be, for example (SEQ ID NO: 442, SEQ ID NO: 444, SEQ ID NO: 445 and SEQ ID NO: 446); (SEQ ID NO: 443, SEQ ID NO: 444, SEQ ID NO: 445 and SEQ ID NO: 446).
- the present invention relates to a method of producing a fermentation product comprising: (a) combining a yeast cell of any one of claims 1-34 with grain feedstock; (b) allowing the yeast cell to ferment the grain feedstock; and (c) recovering one or more products of the fermentation.
- the present invention relates to a recombinant yeast host cell comprising two or more heterologous polynucleotides encoding a polypeptide comprising: (a) at least one amino acid sequences at least 90% identical to one or more of the amino acid sequences of SEQ ID NOs: 219-436; and (b) at least one amino acid sequences at least 90% identical to one or more of the amino acid sequences of SEQ ID NOs: 442-446.
- the present invention relates to a recombinant yeast host cell comprising: (a) at least one heterologous polynucleotide encoding a polypeptide of Table 1 1 ; and (b) at least one heterologous polynucleotide encoding a polypeptide of Table 19.
- Figure 1 depicts the complexity of cellulose and hemicellulose and the enzymes involved in their degradation.
- Hexoses are distinguished from pentoses by the presence of a protruding line from the cyclic hexagon (pyranose ring), depicting the CI3 ⁇ 4OH group.
- Hydrolase enzymes and the bonds targeted for cleavage in the four polysaccharide structures are indicated by arrow.
- Figure 2 depicts a basic cloning and expression vector for testing cellulases
- This vector is an episomal 2- ⁇ yeast expression vector used for expression of genes in yeast. ENOl promoter- S.cerevisiae ENOl promoter; S.cer ENOl ter - S. cerevisiae ENOl terminator; S.cer. URA3 - S. cerevisiae URA3 auxotrophic marker; 2 mu ori ⁇ - 2 ⁇ S.
- Figure 3 depicts CMC (top panel) and avicel (bottom panel) assay results for EGl candidates expressed in M0509. All EGl constructs were tested under the control of the ENOl promoter and terminator. Strain Ml 322 is expressing an EG from the termite C. formosanus. T. reesei EGl and T. reesei EG2 were included as controls.
- Figure 4 depicts results from a pretreated hardwood (PHW) assay for the top 6
- EGl candidates mixed with yeast made, purified, TeCBHlw/TrCBD, and C1CBH2, and Novozyme 188.
- Figure 5 depicts results of a PHW assay for EGl candidates in the presence of
- Figure 6 depicts results of a SDS-PAGE analysis of the supernatants of (A) the
- EG2 and B the EG3 producing strains.
- a strain containing a plasmid with no foreign gene was used as reference strain (REF).
- Figure 7 depicts results of a CMC and a barley- ⁇ -glucan assay. Cultures were spotted on SC "URA plates containing 0.2% of either CMC (A and B) or barley- -glucan (C). Numbers indicate the plasmid contained by each strain. pRDH180 contained the T. reesii eg2 and served as positive control. Plates were incubated for 3 (A) or 24 (B & C) hours at 30°C, after which colonies were washed of and the plates were stained with 0.1% congo red and de-stained with 1% NaCl.
- Figure 8 depicts results from an assay measuring activity of YPD and SC cultured strains expressing EGs on avicel (24 hours) and CMC (3 hours).
- a strain containing a plasmid with no foreign gene was used as reference strain (REF) and the strain expressing T.r.eg2 (pRDH180) was included as positive control.
- Figure 9 depicts results of a CMC plate assay of EG4, EG5, and EG6 clones to verify activity expression of the genes.
- Figure 10 depicts PHW assay results for candidate EG4s, EG5s, and EG6s.
- Figure 1 1 depicts results from experiments with EG4, EG5, EG6, and xyloglucanase candidates by PHW assay. Cultures were grown in 15mls of YPD for 2 days at 35 degrees in 50ml tubes. Cultures were spun down and 2mls of each supernatent was added to 2ra!s of PHW components (Negative control is M0544, and Ml 179 expresses CBH1, CBH2, EG2, and BGL). 4mg/g of purified enzymes was used as a screening partner in a ratio of 40:40: 15:5 of CBH1 :CBH2:EG2:BGL1.
- Figure 12 depicts results of a SDS-PAGE analysis of the supernatants of (A) xylanase and (B) xylosidase producing strains.
- a strain containing a piasmid with no foreign gene was used as reference strain (REF).
- the strain containing the piasmid pRDH182 (expressing T.r.xynl) or containing the piasmid pRDH l.81 (expressing A.n.xlnD) was also included.
- Figure 13 depicts the results of a RBB-xylan assay. Cultures were spotted on SC " URA plates containing 0.2% RBB-xylan. Numbers indicate the piasmid contained by each strain. Plates were incubated for 24 hours at 30°C.
- Figure 14 depicts results of an assay measuring activity of YPD and SC cultured strains expressing xylanases arid xylosidases on 1 % birchwood glucuronoxyian (A) and pNPX (B).
- a strain containing a piasmid with no foreign gene was used as reference strain ( R EF).
- Figure 15 depicts results from an assay measuring hydrolytic activity as measured by reducing sugar released by mixtures of yeast supernatants from 5 % xylan.
- Figure .16 depicts results of a TLC assay measuring sugars released by yeast supernatants from birchwood glucuronoxy an.
- Stdl contained xylotetrose, xylotriose, xylobiose and xylose;
- Std2 contained, xylotriose, xylobiose and xylose. 5pL of reactions 1 to 6 were loaded.
- Figure 17 depicts results of an arabinofuranosidase activity assay with pNPA as substrate.
- Figure 18 depicts results of an esterase activity of candidate enzymes on pNP- acetate.
- Figure 19 depicts results in a PHW assay on unwashed MS630 for various accessory enzymes. Cultures were grown for 3 days at 35 degrees in lOmls YPD with 20ug/ml zeocin in 50ml conical tubes. 1ml of supernatant was added for each candidate, 0.5ml each of M1457 (BC60 xylanase) and M1381 (P.t.r. GH43 xylosidase) plus 2mls of PHW core mix. Core enzymes added were lmg/g of purified CBH1/CBH2/EG2 and 0.2mg/g of BGLl .
- Figure 20 depicts results of a PHW assay using combinations of accessory enzymes on unwashed MS630 (hardwood substrait).
- So called "Big 6" enzymes were: 1 mg/g of purified CBHl and CBH2, 0.4 mg/g purified EG2, and 0.2 mg/g purified BGL, 0.5 mL of each of Ml 457 (GH10 xylanase from C. phytofermentens, or BC60— see bacterial enzyme screening below) and Ml 381 ⁇ P.t.r. GH43 xylosidase). These were combined with PHW and buffer in a total volume of 2 mL and 2mL of additional enzymes were added as tests, split evenly between the enzymes ⁇ i.e. 1 mL each of 2 enzymes, or 0.67 mL each of 3 enzymes, etc). Results for glucose and xylose liberated are depicted in panels A and B respectively.
- Figure 21 depicts results from a xylanase assay of yeast strains expressing bacterial (top) and fungal (bottom) enzymes. On the top graph the numbers mean BC numbers described in Table 7.
- Figure 22 depicts results from an assay evaluating the secreted activity on CMC of bacterial endoglucanases expressed in yeast. Strains were patched on YPD+Zeo plates (Zeo 250mg/L) for 2 days and inoculated in 600 uL YPD in 96 wp, and grown for 3 days at 35°C at 900 rpm. The standard CMC assay was performed on supernatants. All strains have M0749 background. The negative control is M0749 transformed with empty expression vector pMU1575. T. reesei EG2 in pMU1575 was used as positive control construct.
- Figure 23 depicts results from a PHW assay with yeast-made bacterial endoglucanases (see Table 7) in the presence of yeast made purified CBHl and CBH2. All wells were supplemented with 3.5 mg/g TS BGL (Novozyme-188) and 2mg/g TS yeast made purified CBH1+CBH2 (ratiol :1). Supernatant of the strain expressing empty vector was used as negative control.
- Figure 24 depicts results from an assay measuring glucose release from PHW provided by different combinations of bacterial GH9 EG ( ⁇ . fusca Cel9A) and fungal GH5 EG (T. reesei EG2).
- the negative control empty vector
- the negative control was added in amount of 2 ml. Compositions of all other samples are shown on the figure.
- Left side bars depict results from samples that were supplemented by purified yeast made enzymes (1 mg/g CBHl, 1 mg/g CBH2, 0.2 mg/g BGL) plus not purified yeast made xylanase (BC60, 100 ul/well) and xylosidase (Ml 381 , 100 ul/well).
- Right side bars depict results from samples that were supplemented with the same amount of purified CBHs plus 1 mg/g AB BGL.
- Figure 25 depicts results of an assay of secreted activity on birchwood xylan for bacterial xylanases expressed in yeast. Strains were patched on YPD+Zeo plates (Zeo 250mg/L) for 2 days and inoculated in 600 ⁇ , YPD in 96 well plate. Plates were then grown for 3 days at 35 °C at 900 rpm. Standard xylose assay (DNS based) was performed on supernatants. All strains have M0749 background. The negative control is M0749 transformed with empty expression vector pMU1575. T. ree ' sei Xyn2 in pMU1575 was used as positive control construct.
- Figure 26 depicts the results of an assay measuring the effect of yeast made xylanases on glucose release from PHW by yeast made cellulases measured by PHW assay.
- Left-side bars depict results from an assay that was supplemented with yeast made purified cellulases (CBH1 - 1 mg/g TS; CBH2 - 1 mg/g TS; EG2 - 0.4 mg/g TS, BGL - 0.2 mg/g TS) and yeast made unpurified Pyrenophora tritici-repentis ⁇ -xylosidase (GH43, M1381) - 50 ul sup/4 ml reaction.
- yeast made purified cellulases CBH1 - 1 mg/g TS
- CBH2 - 1 mg/g TS CBH2 - 1 mg/g TS
- EG2 - 0.4 mg/g TS BGL - 0.2 mg/g TS
- M1381 strain expressing xylosidase was grown in YPD in shake flask for 3 days.
- Right side bars depict results from an assay that was supplemented with the same amount of yeast made purified CBH1, CBH2 and EG2 plus 1 mg/g TS AB BGL (ME057).
- the glucose was measured by a glucose hexokinase kit (Sigma). Each experiment was performed in triplicates.
- Supernatant from a strain expressing empty vector was used as negative control ( egCon).
- Supernatant expressing fungal T. reesei Xyn2 was used as positive control.
- Figure 27 depicts results from a xylanase assay in which yeast strains expressing
- T. saccharolyticum xylanase genes were evaluated.
- Figure 28 depicts results from an assay measuring glucose release from PHW provided by bacterial accessory enzymes in the presence of yeast made enzymes.
- a standard PHW assay was performed.
- Glucose was measured by HPLC.
- the sample numbers mean BC numbers (see Table 7). All samples were added in amount of 2 ml. All samples including NC (negative control) were supplemented with purified lmg/gCBHl, lmg/gCBH2, 0.4mg/g£G2, 0.2mg/g BGL; not purified 2.5% (v/v) xylanase (M1457) and 2.5% (v/v).
- Figure 29 depicts results from an assay measuring glucose release from PHW provided by different combinations (pairs) of EGs that belong to different GH families.
- Glucose was measured by glucose hexokinase kit. The samples were taken at 27 hrs and 48 hrs. The sample numbers are the GHF numbers (see Tables below).
- NegCon NC - empty vector supernantant was added in amount of 2 ml. The first bar in each colored block is 2ml of single EG. All other bars in each colored block represent a combination of two different EGs (1ml each). All samples including NC were supplemented with lmg/g CBHl+lmg/gCBH2+4mg/g EE.
- EE - External Enzymes was composed of 3.25 mg/g ME50-2 (cellulase Novozyme22C, batch# CZP00004, Novozymes); 0.25 mg/g ME54-2 (xylnase XYN30, batch# EL2007020L, EB Enzymes; 0.25 mg/g ME57 ( ⁇ - glucosidase ABK, batch# EL2008044L, EB Enzymes; and 0.25 mg/g ME64 (Pectinase FE, batch# 1660 05x lm 401-083-3580, Genencor). MS630 (a pretreated hardwood) was used as substrate. All experiments were performed in triplicate. The missing bars or the bars without error bars had all or most of the repeats fail.
- Figure 30 depicts results from an assay measuring glucose release from PHW provided by different combinations (triplets) of EGs that belong to different GH families.
- Glucose was measured by GHK kit. The samples were taken at 48 hrs. The sample numbers are GHF numbers (see Tables below).
- the negative control (NC - empty vector) and other single EGs supernatants were added in amount of 2 ml. In samples with two EGs, 1 ml of each supernatant was added. In samples with three EGs 0.666 ml of each supernatant was added. All samples including NC were supplemented with lmg/g CBHl+lmg/gCBH2+4mg/g EE. MS630 was used as substrate (a pretreated hardwood). All experiments were performed in triplicate. The bar without error bars had two repeats fail.
- Figure 31 depicts results from an assay measuring glucose release from PHW provided by different combinations of EGs that belong to different GH families.
- Glucose was measured by a glucohexokinase kit. The samples were taken at 24 (A), 48 (B), 72 (C) and 96 (D) hrs. The sample numbers are GHF numbers (see Tables).
- the negative control (NC - empty vector) and other single EGs supernatants were added in amount of 2 ml. In samples with two EGs 1 ml of each supeiiiantant was added. In samples with three EGs 0.666 ml of each supernatant was added.
- FIG. 32 depicts a time course of glucose release from PHW provided by selected samples from Figure 31.
- Figure 33 depicts a CEN vector with a Gal promoter upstream of the centromere and an ARS replication origin (another 2 ⁇ origin is also present to fire replication at multiple points for large vectors).
- the four endoglucanases have unique promoters driving them.
- the promoter/ EG/ terminator cassettes were PCR amplified from existing vectors and incorporated into Notl digested pMU1943.
- the right hand panel shows the activity of 6 separate colonies picked from the YML transformation plate, which all demonstrated EG activity.
- Figure 34 depicts CEN vectors built for testing the ability to assemble large constructs.
- Ml 634 contains the CEN with 7 genes (23 kB), and Ml 635 contains the CEN with 11 genes (Ml 635).
- Figure 35 depicts results from an assay measuring CMC activity for colonies picked from selective and non-selective plates after growth of the starting culture in YPD or YP-Galactose. Activity is comparable before and after galactose treatment in colonies from high antibiotic resistance plates. Colonies treated with galactose and plated on YPD without hygromycin show a large variation as seen from the error bars indicating that the CEN vector is functioning as expected during galactose growth.
- Figure 36 depicts results from a CMC assay on strains expressing CEN6 vector passaged twice (about 10 generations) in YPD without antibiotic.
- the CMC activity is comparable after passaging for about 10 generations in YPD without antibiotic.
- Figure 35 shows the CMC assay data after only an hour, whereas the CMC assay before passaging the strains is for a 1.5 hour time point.
- Figure 37 depicts an assay which is a comparison between the top-performing colonies from YPD/ zeocin (100) and YPD/ zeocin (50) plates at various dilutions.
- Figure 38 depicts results from a PHW assay with yeast produced enzymes alone.
- Ml 179 (Strain with core cellulases CBHl/ CBH2/ EG2/ BGLl) was used along with CEN strain expressing 4 EGs (EG1, 4, 5 and 6) strain M1377 (EG3) and M1050 (cel9A).
- Figure 39 depicts conversion of xylan to ethanol by several strains of S. cerevisiae expressing xylanase alone, xylosidase alone, or a combination of the two enzymes.
- Figure 40 depicts a genetic construct used to co-express xylanase and xylosidase via integration at the rDNA loci.
- Figure 41 depicts a map of the episomal 2- ⁇ yeast expression vector used for expression of genes from Tables 15-17.
- S.cer ENOl pr- S.cerevisiae ENOl promoter S.cer Invertase SP - S. cerevisiae Invertase signal peptide
- pBR322 is a map of the episomal 2- ⁇ yeast expression vector used for expression of genes from Tables 15-17.
- Figure 42 depicts secreted activity of strains expressing new synthetic genes measured by Starch-DNS (top), Starch-GHK (middle), and Maltose (bottom) assays. All genes are described in Tables 15 and 16. All genes were inserted between PacI/AscI of pMU1575 2 ⁇ expression vector and transformed into M1744 strain. Transformants were grown in YPD for 3 days and supematants were analyzed for activity. "CO" - codon optimized for yeast synthetic genes; others - PCRed from genomic DNA or cDNA.
- Figure 43 depicts starch activity of yeast made amylolytic enzymes in combination with yeast made AE8. Supematants of strains grown for 3 days in YPD were mixed with supernatant of AE8 expressing strain at 50:50 ratio. In the first sample AE8 supernatant was 100%. Supernatant of M0509 was used as negative control. "CO"
- Figure 44 depicts a com mash assay for new secreted genes individually and in combination with AE8. Supematants of strains grown for 3 days in YPD were mixed with supe of AE8 expressing strain at 50:50 ratio. Supernatant of M0509 was used as negative control.
- Figure 45 depicts the effect of arabinases (top) and xylanases (bottom) added to
- amylases AE3, AE8, and AE49 were evaluated by activity of supernatants on maltose. All genes were subcloned into pMU1575 2u expression vector by yeast mediated ligation and transformed into one of three strains. Transformants were grown in YPD for 3 days and supernatants were analyzed for activity by Maltose assay. Four transformants were analyzed for each transformation.
- Figure 47 depicts expression constructs used for random integration strain construction (top). P - S.cerevisiae promoter; t - S.cerevisiae terminator; URA3 - S.cerevisiae URA3 marker; D - delta integration sites; "CO” - codon optimized synthetic genes. Combinations of genes used for random integration (bottom). Genes used in each combination are marked gray.
- Figure 48 depicts the secreted activity on starch of strains built by random integration.
- Supernatants of strains grown for 3 days in YPD were used in starch-DNS assay.
- Ura - transformants were selected from SD-URA plates;
- Starch - transformants were selected from YM-Starch plates (lxYNB plus 0.5% starch);
- Controls - strains do not express amylases.
- CBP strain-M1973 was used as a positive control. The same experiment was repeated twice in duplicates: 1 st experiment - top; 2 nd experiment - bottom.
- Figure 49 depicts a scheme of directed integration strain construction approach with negative selection marker FCYl used as integration site.
- Amylolytic strains Ml 973 and M2016 expressing glucoamylases AE8 and/or AE9 were used as examples.
- the expression cassettes flanking regions of FCY were integrated into FCYl locus (position ⁇ 677162 on chromosome 16) of industrial strain M0139 as PCRed DNA fragments with overlapping ends.
- the host M0139 is a diploid, therefore each expression cassette was integrated in two copies.
- the 2- ⁇ plasmid with Hyg marker was co-transformed with PCR products.
- the transformants were first cultivated in liquid YPD+Hyg media overnight and then plated on media with FCY knock-out selective compound 5- fluorocytosine. Precultivation on media with antibiotic increases efficiency of double FCYl knock-out.
- Figure 50 depicts integration of additional copies of glucoamylase into a genomic site such as an Adenine-phosphoribosyltransferase 2 (APT2) locus.
- Figure 51 depicts a scheme of directed integration strain construction approach with universal integration site. Amylolytic strain M2022 expressing multiple copies of glucoamylases AE8 and AE9 was used as an example.
- Figure 52 depicts ethanol produced by amylolytic yeast without exogenous glucoamylase from liquefied corn mash. The numbers are average of triplicate runs and error bars are 1 std. Inoculum of O.lg/L was used. Fermentations were performed in 250 mL sealed shake flasks with a total fermentation mass of 50 g on corn mash obtained from Valero bio-refinery at 30% solids (TS) at a fermentation temperature of 32° C at a shaking speed of 125 rpm. The fermentations were performed using 500 ppm urea as the only nutrient source.
- TS solids
- Standard dose (0.45 AGU/g TS) of commercial glucoamylase (Spirizyme Ultra, Novozymes) was added to the control strain M0139. All other strains were fermented without any exogenous enzymes added. The ethanol produced after 60 h is shown.
- Standard dose (0.45 AGU/g TS) of commercial glucoamylase (Spezme, Genencor Inc.) was added to the control strain MO 139. All other strains were fermented without any exogenous enzymes added
- Figure 54 depicts the adaptation of amylolytic Ml 973 strain by serial transfer.
- FIG. 55 depicts an example of a process flow sheet with CBP yeast strains.
- Ground corn mash is used as a substrate.
- Two yeast CBP strains are used in the process and cultured separately, SI and S2.
- Liquefied corn pre-treated with alpha-amylases is fermented by yeast strain SI .
- SI has an optimal set of amylases and accessory enzymes engineered to efficiently convert starch into glucose without any exogenous enzymes added. After distillation the stillage is being pre-treated and fermented by strain S2.
- S2 has a cellulolytic set of enzymes engineered and optimized for corn fiber conversion as well as xylose and arabinose pathways.
- Figure 56 depicts PCR genotyping of industrial yeast strains genomic DNA (Ness et al. 1993). lkb - NEB lkb ladder. A - M0139 like pattern; B - M2390 like pattern.
- Figure 57 depicts growth of industrial yeast strains at 41° C. Strains were streaked for singles on YPD plate and incubated at 41° C for 4 days.
- FIG. 58 depicts maximum growth rate at 41° C in YPD of industrial strains described in Table 20. Growth rate measured by plate reader Synergy 2 (BioTek) following manufacture's instructions. Bottom - Corn flour fermentation in shake flasks at 72h of industrial strains described in Table 20. Raw corn flour was used as substrate. Fermentation was performed at 35% of total solids; at the temperature of 35° C for 24h followed by 32° C for the rest of fermentation. Strains marked with "*" were done in separate experiment at similar conditions but at 33% of total solids. Full commercial dose of exogenous GA was added to all strains at concentration 0.6 AGU/g of total solids. Experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 59 depicts a map of expression construct used to transform different industrial hosts.
- ENOl- S.cerevisiae ENOl promoter AE9 CO- codon optimized for S.cerevisiae Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1); S.cer ENOl ter- S.cerevisiae ENOl terminator; PDC1- S.cerevisiae PDC1 terminator; ADH1- S.cerevisiae ADH1 promoter; TEF- S.cerevisiae TEF2 promoter; natl- Streptomyces noursei natl genes that confers resistance to antibiotic Nourseothricin; TRI1- S.cerevisiae TRJl terminator. DNA fragments were PCRed separately and recombined in vivo during yeast transformation.
- Figure 60 depicts secreted amylolytic activity of industrial strains (Table 20) transformed with 4 copies of Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1). Top panel shows the names of host strains. Activity was measured by Starch assay. Several transformants were picked for each host. Supernatant of untransformed M0139 strain was used as negative control (C).
- Figure 61 depicts corn flour fermentation in shake flasks at 72h of industrial strains and their transformants engineered to express 4 copies of Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1).
- Raw corn flour was used as a substrate.
- the strains are described in the tables 20 and 22. Fermentation was performed at 35% of total solids; at the temperature of 35C for 24h followed by 32° C for the rest of fermentation. Exogenous GA was added to all strains at concentration 0.3 AGU/g of solids. Transformed strains were done in duplicates. Host strains were done in singles. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 62 depicts corn mash fermentation in shake flasks at 48h of industrial strains and their transformants engineered to express 4 copies of Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1). Liquefied corn pre-treated with alpha-amylases from conventional plant was used as substrate. The strains are described in the tables 20 and 22. Fermentation was performed at 35% of total solids and 35° C. Exogenous GA was added to all strains at concentration 0.3 AGU/g of solids. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 63 depicts secreted amylolytic activity of M2390 transformants engineered to express 4 copies of AE9- Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1). About 1000 transformants were screened by Starch assay. This experiment shows repeated Starch assay data for 30 the most active transformants. Experiment was done in triplicates. Supernatant of untransformed M2390 strain was used as negative control. Strains M211 1 and M2395 were used as positive control (see Tables 20 and 21 for strains description).
- Figure 64 depicts corn mash fermentation in mini vials at 72h of M2390 transformants engineered to express 4 copies of AE9- Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1). Seventeen best transformants from amylolytic activity screen ( Figure 63) were selected for this experiment. Fermentation was performed at 30% of total solids and 30° C. Exogenous GA was added to the untransfomed M2390 strain only, at concentration 0.3 AGU/g of solids. The experiment was done in duplicates. M2111, M2395 and M2390 strains were used as controls (see tables 20 and 21 for strains description). Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 65 depicts corn flour fermentation in minivials at 72h of M2390 transformants engineered to express 4 copies of AE9- Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1). Seventeen best transformants from amylolytic activity screen ( Figure 63) were selected for this experiment. Fermentation was performed at 30% of total solids and 30° C. Exogenous GA was added to the untransfomed M2390 strain at concentration 0.3 AGU/g of solids and at 0.1 AGU/g to all other strains. The experiment was done in duplicates. M21 1 1 , M2395 and M2390 strains were used as controls (see Tables 20 and 21 for strains description). Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 66 depicts corn flour fermentation in shake flasks at 72h of M2390 transformants engineered to express 4 copies of AE9- Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1). Seven best transformants from minivials fermentation screen ( Figures 64-65) were selected for this experiment. Fermentation was performed at 33% of total solids at the temperature of 35° C for 24h followed by 32° C for the rest of fermentation. Exogenous GA was added to the untransfomed M2390 strain at concentration 0.6 AGU/g of solids and at 0.1 AGU/g to all other strains. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 67 depicts time course of liquefied conventional corn mash fermentation in shake flasks of M2691 strain - the best M2390 transformant engineered to express 4 copies of AE9- Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1).
- Transformant PI 0-19 ( Figure 66) was re-named as M2691. Fermentation was performed at 32.5% of total solids at the temperature of 35° C for 24h followed by 32° C for the rest of fermentation. Exogenous GA was added to the untransfomed M2390 strain only, at concentration 0.3 AGU/g of solids. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 68 depicts time course of raw corn flour fermentation in shake flasks of
- M2691 strain the best M2390 transformant engineered to express 4 copies of AE9- Saccharomycopsis fibuligera glucoamylase gene (NCBI#CAC83969.1).
- Transformant P10-19 ( Figure 66) was re-named as M2691. Fermentation was performed at 33% of total solids at the temperature of 35° C for 24h followed by 32° C for the rest of fermentation. Exogenous GA was added to the untransfomed M2390 strain at concentration 0.6 AGU/g of solids and at 0.1 AGU/g to M2691. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 69 depicts exogenous glucoamylase dose response for untransformed
- Figure 70 depicts stability test of two M2390+AE9 transformants, M2519 (top) and M2691 (bottom). Both strains were propagated in YPD. Strains were grown to stationary phase and passaged with 100X dilution 1 1 times (1 passage - about 9 generations). Several samples between passages were stocked. All samples and original strain were plated and inoculated together and activity on starch was measured in the same assay. Experiment was done in triplicates.
- Figure 71 depicts Pullulan (top), Xylan (middle) and Pectin (bottom) assays of yeast secreted enzymes (Table 23).
- the genes were expressed under ENOl promoter and terminator from 2-micron plasmid pMU1575.
- the genes were inserted between Pacl/Asci sites of pMU1575 either by cloning or yeast mediated ligation.
- Expression contracts were transformed into an industrial background Mascoma strain Ml 744 and selected on minimal URA deficient media. Four colonies were analyzed for each transformation. Transformants were grown in YPD for 3 days and supernatants were analyzed for activity.
- Figure 72 depicts corn syrup assay of yeast made enzymes.
- BGL, XYL, and XLD were HPLC purified proteins.
- yeast strains expressing enzymes were grown for 3 days in YPD and supernatants were used as enzyme source (Table 24).
- Amounts of purified enzymes used in assay are summarized in the Table 25. 250 ⁇ 1 of M0139 (top) or M2111 (bottom) supe was added to all samples.
- Other supernatant derived enzymes were added in amount of 250ul. In no other supernatant enzymes needed in the sample, MO 139 supernatant was added instead.
- AE10+AE35 sample 125 ⁇ 1 of each supernatant was added in addition to 250 ⁇ 1 of M0139 or M2111 supernatant. NC-no other enzymes added except for MO 139 or M21 1 1 supernatant.
- Figure 73 depicts a map of the episomal 2-micron yeast expression vector pMU2382 used for construction of delta integration expression cassettes with genes in Table 26.
- Gene of interest under control of S.cerevisiae strong constitutive promoter and terminator was inserted between URA3 and Delta2 fragments of pMU2382 vector digested with BamHI and EcoRI.
- the cassette was inserted by yeast mediated ligation in the same orientation as URA3.
- S.ser. URA3 - S. cerevisiae URA3 auxotrophic marker; 2 mu ori - 2 micron S.
- cerevisiae plasmid origin of replication bla(AmpR) - Amp resistance marker
- pBR322 - E.coli pB322 plasmid origin of replication delta 1 and delta 2 - fragments of S. cerevisiae delta sites.
- Figure 74 depicts an example of corn flour assay of M2125 transformed with some genes and gene combos from Table 26. Transformations (T) are described in the Table 27. Number after dash means colony number for this transformation. Transformants that are highlighted were selected for screening by fermentation. BC60 - Ml 744 strain expressing only BC60 on 2 ⁇ plasmid under ENOl promoter. M2125 - parental strain (M21 1 1 with URA3 knockout). Untransformed MO 139 strain was used as negative control.
- Figure 75 depicts shake flask fermentation on homemade corn mash of strains expressing additional to AE9 saccharolytic enzymes. Strains selected based on highest ethanol titers reached in minivial corn mash fermentation assay. Homemade mash was used. The strains are described in the Table 28. Fermentation was performed at 30% of total solids and 32° C. Exogenous enzyme was added to the untransfomed M0139 strain only, at concentration 0.3 AGU/g of solids. Parental M2111 strain was used as background control. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol was measured by HPLC.
- Figure 76 depicts shake flask fermentation on corn flour of strains expressing additional to AE9 saccharolytic enzymes. Strains selected based on highest ethanol titers reached in minivial corn flour fermentation assay. The strains are described in the Table 29. Fermentation was performed at 30% of total solids and 32° C. Exogenous enzyme was added to the untransfomed M0139 strain at concentration 0.3 AGU/g of solids and at 0.1 AGU/g to all other strains. Parental M2111 strain was used as background control. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol and sugars were measured by HPLC. Potential ethanol was calculated based on glucose concentration (added theoretical ethanol from unconsumed glucose).
- Figure 77 depicts shake flask fermentation on homemade corn mash (top) and corn flour (bottom) of strains expressing AE9 only.
- the strains were result of repeating the same transformation as was done in M2111 construction with consequent screening of 1000 colonies for activity on starch.
- Strains for this shake flask experiment were selected based on highest ethanol titers reached in minivial corn homemade mash and flour fermentation assays. The strains are described in Tables 30 and 31. Fermentation was performed at 30% of total solids and 32° C. Exogenous enzyme was added to the untransfomed M0139 strain at concentration 0.3 AGU/g of solids.
- Figure 78 depicts shake flask fermentation on industrial corn mash of the best strains from shake flask screening experiments on homemade mash and corn flour ( Figures 75-77).
- the strains are described in Table 32. Fermentation was performed at 30% of total solids and 32° C. Exogenous enzyme was added to the untransfomed MO 139 strain only, at concentration 0.3 AGU/g of solids. M21 11 strain was included for comparison. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol and sugars concentration were measured by HPLC. Potential ethanol was calculated based on glucose concentration (added theoretical ethanol from unconsumed glucose).
- Figure 79 depicts shake flask fermentation on industrial corn mash of the best strains from shake flask screening experiments on homemade mash and corn flour ( Figures 75-77).
- the strains are described in Table 33. Fermentation was performed at 30% of total solids and 32° C. Exogenous enzyme was added to the untransfomed M0139 strain only, at concentration 0.3 AGU/g of solids. M21 1 1 strain was included for comparison. The experiment was done in duplicates. Commercial enzyme Spirizyme Ultra (Novozymes) was used as exogenous glucoamylase. Ethanol and sugars concentration were measured by HPLC. Potential ethanol was calculated based on glucose concentration (added theoretical ethanol from unconsumed glucose).
- Figure 80 depicts stability test of M2111 strain built by directed integration (top) and strains built by random integration (bottom).
- the strains were propagated in YPD, grown to stationary phase and passaged with 100X dilution 1 1 times (1 passage - about 9 generations). Several samples between passages were stocked. All samples and original strain were plated and inoculated together and activity on starch was measured in the same assay. Random strains are described in Table 32. The experiment was done in triplicates.
- Figure 81 depicts different possible strategies for directed strains construction.
- Figure 82 depicts a schematic of TeCBHl+HgCBD expression construct for integration at the ⁇ sites in S. cerevisiae.
- Figure 83 depicts assay of supernatants containing cellulases on pretreated hardwood made by several strains of S. cerevisiae. Supernatants were incubated with pretreated hardwood at 4% total solids, an exogenous cellulase preparation at a 2 mg enzyme/g total solids loading in the PHW assay. Accumulation of glucose in the reaction was measured by HPLC.
- Figure 84 depicts a comparison of cellulolytic strains containing either just one enzyme (CBH2, Ml 873), or seven enzymes (M2232) to the control non-cellulase producing M1577 for ethanol production in SSF. Both unwashed pretreated hardwood, and alkaline washed pretreated hardwood substrates were used. Data is presented from 160 hours of fermentation.
- CBH2, Ml 873 just one enzyme
- M2232 seven enzymes
- Figure 85 depicts SDS-PAGE (left) and Western blot (right) of yeast made alpha- glucuronidase.
- Alpha-glucuronidase, GH67 was PCR amplified from Pichia stipitis genomic DNA and cloned +/- C-terminal Histidine tag.
- Colonies from transformations were grown in yeast extract (10 g/L), peptone (20 g/L), and glucose (20 g/L) + 200 ⁇ g/mL Zeocin, pH 7.0 in 50 mL vented conical tubes for 48-60 hours. Cultures supernatants were filtered through a 2 ⁇ PE filter and concentrated approximately 20- fold in a 10,000 Da molecular weight cut off filter.
- Protein quality was screened via SDS- PAGE electrophoresis under non-reducing conditions and stained with Coomassie Blue dye (left) or examined by Western Blot (right) using an anti-Histidine primary antibody and alkaline phosphatase conjugated secondary antibody (only His tagged constructs visualized).
- Figure 86 depicts xyloglucanase activity on AZCL-xyloglucan agar plates. Equal amounts of culture were spotted onto SC agar plates containing 0.5% AZCL (Azurine- Crosslinked) tamarind xyloglucan Megazyme catalog # I-AZXYG. Xyloglucanase activity is indicated as blue zones such as those strains transformed with pMU2856 and pMU2858 +/- His tag. REF refers to control M01744 background strain supernatant.
- Figure 87 depicts xyloglucanase activity in AZCL-xyloglucan.
- 70 ⁇ of supernatant of 3 day old 2xSC "ura cultures were added to 280 ⁇ ⁇ of 50 mM Na-Acetate buffer (pH 5.0) containing 0.5% AZCL (Azurine-Crosslinked) tamarind xyloglucan Megazyme catalog # I-AZXYG in a deep-well microtiter plate. The plate was incubated in a microtiter plate shaker at 35°C at 800 rpm agitation.
- Figure 88 depicts SDS-PAGE (left) and Western (right) analysis of yeast expressed xyloglucanases +/- His tags.
- REF refers to control MO 1744 background strain supernatant.
- Figure 89 depicts SDS-PAGE analysis of esterases expressed in Saccharomyces cerevisiae.
- REF refers to control MO 1744 background strain supernatant.
- Figure 90 depicts 1 -Napthyl-acetate esterase assay of yeast made esterases.
- REF refers to control Ml 744 background strain supernatant.
- Figure 91 depicts Alpha-galactosidase activity asssay with yeast made alpha- galactosidases. Experiment was performed in duplicates. REF refers to control Ml 744 background strain supernatant.
- Figure 92 depicts Western blot analysis of T.reesei alpha-galactosidase (AGL3)
- FIG. 93 depicts SDS-PAGE analysis of alpha-galactosidases expression in Saccharomyces cerevisiae. Colonies from transformations were grown in yeast extract (10 g/L), peptone (20 g/L), and glucose (20 g/L) + 200 ug/niL Zeocin, pH 7.0 in 50 mL vented conical tubes for 48-60 hours. Cultures supernatants were filtered through a 2 ⁇ PE filter and concentrated approximately 20-fold in a 10,000 molecular weight cut off filter. Protein quality was screened via SDS-PAGE electrophoresis under non-reducing conditions and examined by Western Blot using an anti-Histidine primary antibody and alkaline phosphatase conjugated secondary antibody (only His tagged constructs visualized). [0142] Figure 93 depicts SDS-PAGE analysis of alpha-galactosidases expression in yeast extract (10 g/L), peptone (20 g/L), and glucose (20 g/L) + 200 u
- Saccharomyces cerevisiae Three day old cultures in double strength SC "URA media buffered to pH6.0 (3 mL cultures in test tubes incubated at 30°C on rotary wheel) were centrifuged and supernatants assayed, and ⁇ 5 ⁇ , (+5 ⁇ , loading buffer) was loaded onto 10% SDS-PAGE gels and silver stained.
- Figure 94 depicts a 2% total solids PWH assay with different combinations of commercial and yeast made purified enzymes and the resultant glucose release.
- the assay plate was incubated at 38° C and samples were removed at various time points for HPLC analysis on the BioRad 87H column
- Figure 95 depicts a 2% total solids PWH assay with different combinations of commercial and yeast made purified enzymes and the resultant glucose release.
- the assay plate was incubated at 38° C and samples were removed at various time points for HPLC analysis on the BioRad 87H column.
- Figure 96 depicts a 2% total solids PWH assay with different combinations of commercial and yeast made purified enzymes and the resultant glucose release.
- the assay plate was incubated at 38° C and samples were removed at various time points for HPLC analysis on the BioRad 87H column.
- Figure 97 depicts a 2% total solids paper sludge assay of different combinations of yeast made purified enzymes and the resultant glucose release.
- the assay plate was incubated at 38° C and samples were removed at various time points for HPLC analysis on the BioRad 87H column..
- Figure 98 depicts a 2% total solids paper sludge assay of different combinations of yeast made purified enzymes and the resultant xylose release.
- the assay plate was incubated at 38° C and samples were removed at various time points for HPLC analysis on the BioRad 87H column.
- Figure 99 depicts final ethanol titers (92 hours) for 2 different industrial paper sludges SSF.
- Sludge 1 first 5 bars; Sludge 2 - last 5 bars.
- Washed (1M Citric acid) 2% solids paper sludges were used.
- Strain M2108 was inoculated at 1.1 g/1. Fermentation was performed at pH5.0, 35° C, 220 rpm, 92 hrs.
- Figure 100 depicts ethanol and potential ethanol titers achieved on 30%TS corn flour with 0.1 AGU/g TS exogenous gluco-amylase.
- the control strain (M0139) has a full dose (0.3 AGU/g TS) of gluco-amylase.
- Figure 101 depicts ethanol and potential ethanol titers at 72 hours for xylanase and accessory enzyme screen on 30%TS corn flour (ELN afoster2 corn-090).
- Figure 102 depicts glucose, xylose and arabinose released from a hydrolysis of
- Figure 103 depicts hydrolysis yields from 190° C, 10 minutes water pretreated coarse fiber and 1% sulfuric acid pretreated coarse fiber.
- a "vector,” e.g., a "plasmid” or “YAC” (yeast artificial chromosome) refers to an extrachromosomal element often carrying one or more genes that are not part of the central metabolism of the cell, and is usually in the form of a circular double-stranded DNA molecule.
- Such elements may be autonomously replicating sequences, genome integrating sequences, phage or nucleotide sequences, linear, circular, or supercoiled, of a single- or double-stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA sequence for a selected gene product along with appropriate 3' untranslated sequence into a cell.
- the plasmids or vectors of the present invention are stable and self-replicating.
- An "expression vector” is a vector that is capable of directing the expression of genes to which it is operably associated.
- the term "intergrated” as used herein refers to genetic elements that are placed, through molecular biology techniques, into the genome of a host cell.
- genetic elements can be placed into the chromosomes of the host cell as opposed to in a vector such as a plasmid carried by the host cell.
- Methods for integrating genetic elements into the genome of a host cell are well known in the art and include homologous recombination.
- heterologous when used in reference to a polynucleotide, a gene, a polypeptide, or an enzyme refers to a polynucleotide, gene, polypeptide, or an enzyme not normally found in the host organism.
- Heterologous also includes a native coding region, or portion thereof, that is removed from the source organism and subsequently reintroduced into the source organism in a form that is different from the corresponding native gene, e.g. , not in its natural location in the organism's genome.
- the heterologous polynucleotide or gene may be introduced into the host organism by, e.g., gene transfer.
- a heterologous gene may include a native coding region that is a portion of a chimeric gene including non-native regulatory regions that is reintroduced into the native host.
- Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes.
- a heterologous polynucleotide, gene, polypeptide, or an enzyme may be derived from any source, e.g., eukaryotes, prokaryotes, viruses, or synthetic polynucleotide fragments.
- the term "heterologous” as used herein also refers to an element of a vector, plasmid or host cell that is derived from a source other than the endogenous source.
- heterologous sequence could be a sequence that is derived from a different gene or plasmid from the same host, from a different strain of host cell, or from an organism of a different taxonomic group (e.g., different kingdom, phylum, class, order, family genus, or species, or any subgroup within one of these classifications).
- taxonomic group e.g., different kingdom, phylum, class, order, family genus, or species, or any subgroup within one of these classifications.
- domain refers to a part of a molecule or structure that shares common physical or chemical features, for example hydrophobic, polar, globular, helical domains or properties, e.g., a DNA binding domain or an ATP binding domain. Domains can be identified by their homology to conserved structural or functional motifs. Examples of cellobiohydrolase (CBH) domains include the catalytic domain (CD) and the cellulose binding domain (CBD).
- CBH cellobiohydrolase
- nucleic acid is a polymeric compound comprised of covalently linked subunits called nucleotides.
- Nucleic acid includes polyribonucleic acid (RNA) and polydeoxyribonucleic acid (DNA), both of which may be single-stranded or double-stranded.
- DNA includes cDNA, genomic DNA, synthetic DNA, and semi-synthetic DNA.
- isolated nucleic acid molecule refers to the phosphate ester polymeric form of ribonucleosides (adenosine, guanosine, uridine or cytidine; "RNA molecules”) or deoxyribonucleosides (deoxyadenosine, deoxyguanosine, deoxythymidine, or deoxycytidine; "DNA molecules”), or any phosphoester analogs thereof, such as phosphorothioates and thioesters, in either single stranded form, or a double-stranded helix. Double stranded DNA-DNA, DNA-RNA and RNA-RNA helices are possible.
- nucleic acid molecule refers only to the primary and secondary structure of the molecule, and does not limit it to any particular tertiary forms.
- this term includes double-stranded DNA found, inter alia, in linear or circular DNA molecules (e.g., restriction fragments), plasmids, and chromosomes.
- sequences may be described herein according to the normal convention of giving only the sequence in the 5' to 3' direction along the non-transcribed strand of DNA (i.e., the strand having a sequence homologous to the mRNA).
- a “gene” refers to an assembly of nucleotides that encode a polypeptide, and includes cDNA and genomic DNA nucleic acids. “Gene” also refers to a nucleic acid fragment that expresses a specific protein, including intervening sequences (introns) between individual coding segments (exons), as well as regulatory sequences preceding (5' non-coding sequences) and following (3' non-coding sequences) the coding sequence. “Native gene” refers to a gene as found in nature with its own regulatory sequences.
- a nucleic acid molecule is "hybridizable" to another nucleic acid molecule, such as a cDNA, genomic DNA, or RNA, when a single stranded form of the nucleic acid molecule can anneal to the other nucleic acid molecule under the appropriate conditions of temperature and solution ionic strength.
- Hybridization and washing conditions are well known and exemplified, e.g., in Sambrook, J., Fritsch, E. F. and Maniatis, T.
- One set of conditions uses a series of washes starting with 6X SSC, 0.5% SDS at room temperature for 15 min, then repeated with 2X SSC, 0.5% SDS at 45°C for 30 min, and then repeated twice with 0.2X SSC, 0.5% SDS at 50°C for 30 min.
- washes are performed at higher temperatures in which the washes are identical to those above except for the temperature of the final two 30 min washes in 0.2X SSC, 0.5% SDS are increased to 60°C.
- Another set of highly stringent conditions uses two final washes in
- 0.1X SSC 0.1% SDS at 65°C.
- An additional set of highly stringent conditions are defined by hybridization at 0.1X SSC, 0.1% SDS, 65°C and washed with 2X SSC, 0.1% SDS followed by 0.1X SSC, 0.1% SDS.
- Hybridization requires that the two nucleic acids contain complementary sequences, although depending on the stringency of the hybridization, mismatches between bases are possible.
- the appropriate stringency for hybridizing nucleic acids depends on the length of the nucleic acids and the degree of complementation, variables well known in the art. The greater the degree of similarity or homology between two nucleotide sequences, the greater the value of Tm for hybrids of nucleic acids having those sequences.
- the relative stability (corresponding to higher Tm) of nucleic acid hybridizations decreases in the following order: RNA:RNA, DNA:RNA, DNA:DNA.
- equations for calculating Tm have been derived (see, e.g., Maniatis at 9.50-9.51).
- For hybridizations with shorter nucleic acids For hybridizations with shorter nucleic acids,
- the length for a hybridizable nucleic acid is at least about 10 nucleotides.
- a minimum length for a hybridizable nucleic acid is at least about 15 nucleotides; more preferably at least about 20 nucleotides; and most preferably the length is at least 30 nucleotides.
- the temperature and wash solution salt concentration may be adjusted as necessary according to factors such as length of the probe.
- identity is a relationship between two or more polypeptide sequences or two or more polynucleotide sequences, as determined by comparing the sequences, n the art, "identity” also means the degree of sequence relatedness between polypeptide or polynucleotide sequences, as the case may be, as determined by the match between strings of such sequences.
- Suitable nucleic acid sequences or fragments thereof encode polypeptides that are at least about 70% to 75% identical to the amino acid sequences reported herein, at least about 80%, 85%, or 90% identical to the amino acid sequences reported herein, or at least about 95%, 96%, 97%, 98%, 99%, or 100% identical to the amino acid sequences reported herein.
- Suitable nucleic acid fragments are at least about 70%, 75%, or 80% identical to the nucleic acid sequences reported herein, at least about 80%, 85%, or 90% identical to the nucleic acid sequences reported herein, or at least about 95%, 96%, 97%, 98%, 99%, or 100% identical to the nucleic acid sequences reported herein.
- Suitable nucleic acid fragments not only have the above identities/similarities but typically encode a polypeptide having at least 50 amino acids, at least 100 amino acids, at least 150 amino acids, at least 200 amino acids, or at least 250 amino acids.
- a DNA or RNA “coding region” is a DNA or RNA molecule which is transcribed and/or translated into a polypeptide in a cell in vitro or in vivo when placed under the control of appropriate regulatory sequences.
- Suitable regulatory regions refer to nucleic acid regions located upstream (5' non-coding sequences), within, or downstream (3' non- coding sequences) of a coding region, and which influence the transcription, RNA processing or stability, or translation of the associated coding region. Regulatory regions may include promoters, translation leader sequences, RNA processing site, effector binding site and stem-loop structure.
- a coding region can include, but is not limited to, prokaryotic regions, cDNA from mRNA, genomic DNA molecules, synthetic DNA molecules, or RNA molecules. If the coding region is intended for expression in a eukaryotic cell, a polyadenylation signal and transcription termination sequence will usually be located 3' to the coding region.
- An "isoform” is a protein that has the same function as another protein but which is encoded by a different gene and may have small differences in its sequence.
- a "paralogue” is a protein encoded by a gene related by duplication within a genome.
- orthologue is gene from a different species that has evolved from a common ancestral gene by speciation. Normally, orthologues retain the same function in the course of evolution as the ancestral gene.
- ORF Open reading frame
- nucleic acid either DNA, cDNA or RNA, that comprises a translation start signal or initiation codon, such as an ATG or AUG, and a termination codon and can be potentially translated into a polypeptide sequence.
- Promoter refers to a DNA fragment capable of controlling the expression of a coding sequence or functional RNA.
- a coding region is located 3' to a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental or physiological conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as “constitutive promoters”.
- a promoter is generally bounded at its 3' terminus by the transcription initiation site and extends upstream (5' direction) to include the minimum number of bases or elements necessary to initiate transcription at levels detectable above background. Within the promoter will be found a transcription initiation site (conveniently defined for example, by mapping with nuclease SI), as well as protein binding domains (consensus sequences) responsible for the binding of EMA polymerase.
- a coding region is "under the control" of transcriptional and translational control elements in a cell when RNA polymerase transcribes the coding region into mR A, which is then trans-RNA spliced (if the coding region contains introns) and translated into the protein encoded by the coding region.
- Transcriptional and translational control regions are DNA regulatory regions, such as promoters, enhancers, terminators, and the like, that provide for the expression of a coding region in a host cell.
- polyadenylation signals are control regions.
- operably associated refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other.
- a promoter is operably associated with a coding region when it is capable of affecting the expression of that coding region (i.e., that the coding region is under the transcriptional control of the promoter).
- Coding regions can be operably associated to regulatory regions in sense or antisense orientation.
- expression refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide.
- lignocellulose refers to material that is comprised of lignin and cellulose.
- a "cellulolytic enzyme” can be any enzyme involved in cellulose digestion, metabolism and/or hydrolysis.
- the term “cellulase” refers to a class of enzymes produced chiefly by fungi, bacteria, and protozoans that catalyze cellulolysis (i.e. the hydrolysis) of cellulose.
- cellulases produced by other types of organisms such as plants and animals. Several different kinds of cellulases are known, which differ structurally and mechanistically.
- endocellulase breaks internal bonds to disrupt the crystalline structure of cellulose and expose individual cellulose polysaccharide chains; exocellulase cleaves 2-4 units from the ends of the exposed chains produced by endocellulase, resulting in the tetrasaccharides or disaccharide such as cellobiose.
- exocellulases There are two main types of exocellulases (or cellobiohydrolases, abbreviate CBH) - one type working processively from the reducing end, and one type working processively from the non- reducing end of cellulose; cellobiase or beta-glucosidase hydrolyses the exocellulase product into individual monosaccharides; oxidative cellulases that depolymerize cellulose by radical reactions, as for instance cellobiose dehydrogenase (acceptor); cellulose phosphorylases that depolymerize cellulose using phosphates instead of water. In the most familiar case of cellulase activity, the enzyme complex breaks down cellulose to beta-glucose.
- CBH cellobiohydrolases
- a "cellulase” can be any enzyme involved in cellulose digestion, metabolism and/or hydrolysis, including an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, and feruoy! esterase protein.
- amylolytic enzyme can be any enzyme involved in amylase digestion, metabolism and/or hydrolysis.
- the term “amylase” refers to an enzyme that breaks starch down into sugar. Amylase is present in human saliva, where it begins the chemical process of digestion. Foods that contain much starch but little sugar, such as rice and potato, taste slightly sweet as they are chewed because amylase turns some of their starch into sugar in the mouth. The pancreas also makes amylase (a-amylase) to hydrolyse dietary starch into disaccharides and trisaccharides which are converted by other enzymes to glucose to supply the body with energy. Plants and some bacteria also produce amylase.
- amylases are glycoside hydrolases and act on a-l,4-glycosidic bonds. Some amylases, such as ⁇ -amylase (glucoamylase), also act on a-l,6-glycosidic bonds.
- Amylase enzymes include a-amylase (EC 3.2.1.1), ⁇ -amylase (EC 3.2.1.2), and ⁇ -amylase (EC 3.2.1.3).
- the a-amylases are calcium metalloenzymes, unable to function in the absence of calcium.
- a-amylase By acting at random locations along the starch chain, a-amylase breaks down long-chain carbohydrates, ultimately yielding maltotriose and maltose from amylose, or maltose, glucose and "limit dextrin" from amylopectin. Because it can act anywhere on the substrate, a-amylase tends to be faster-acting than ⁇ -amylase. In animals, it is a major digestive enzyme and its optimum pH is about 6.7-7.0. Another form of amylase, ⁇ -amylase is also synthesized by bacteria, fungi, and plants.
- ⁇ -amylase catalyzes the hydrolysis of the second a- 1,4 glycosidic bond, cleaving off two glucose units (maltose) at a time. Many microbes produce amylase to degrade extracellular starches. In addition to cleaving the last a(l- 4)glycosidic linkages at the nonreducing end of amylose and amylopectin, yielding glucose, ⁇ -amylase will cleave a(l-6) glycosidic linkages.
- amylolytic enzyme is alpha-glucosidase that acts on maltose and other short malto-oligosaccharides produced by alpha-, beta- , and gamma-amylases, converting them to glucose.
- Another amylolytic enzyme is pullulanase.
- Pullulanase is a specific kind of glucanase, an amylolytic exoenzyme, that degrades pullulan.
- Pullulan is regarded as a chain of maltotriose units linked by alpha- 1,6-glycosidic bonds.
- Pullulanase (EC 3.2.1.41) is also known as pullulan-6-glucanohydrolase (Debranching enzyme).
- amylolytic enzyme isopullulanase
- hydrolyses pullulan to isopanose (6-alpha-maltosylglucose).
- Isopullulanase (EC 3.2.1.57) is also known as pullulan 4-glucanohydrolase.
- An "amylase” can be any enzyme involved in amylase digestion, metabolism and/or hydrolysis, including a-amylase, ⁇ -amylase, glucoamylase, pullulanase, isopullulanase, and alpha-glucosidase.
- xylanolytic activity is intended to include the ability to hydrolyze glycosidic linkages in oligopentoses and polypentoses.
- xylanase is the name given to a class of enzymes which degrade the linear polysaccharide beta-l,4-xylan into xylose, thus breaking down hemicellulose, one of the major components of plant cell walls. As such, it plays a major role in micro-organisms thriving on plant sources (mammals, conversely, do not produce xylanase). Additionally, xylanases are present in fungi for the degradation of plant matter into usable nutrients. Xylanases include those enzymes that correspond to Enzyme Commission Number 3.2.1.8.
- a "xylose metabolizing enzyme” can be any enzyme involved in xylose digestion, metabolism and/or hydrolysis, including a xylose isomerase, xylulokinase, xylose reductase, xylose dehydrogenase, xylitol dehydrogenase, xylonate dehydratase, xylose transketolase, and a xylose transaldolase protein.
- pectinase is a general term for enzymes, such as pectolyase, pectozyme and polygalacturonase, commonly referred to in brewing as pectic enzymes.
- pectin a polysaccharide substrate that is found in the cell walls of plants.
- pectinases are commonly used in processes involving the degradation of plant materials, such as speeding up the extraction of fruit juice from fruit, including apples and sapota. Pectinases have also been used in wine production since the 1960s.
- a “saccharolytic enzyme” can be any enzyme involved in carbohydrate digestion, metabolism and/or hydrolysis, including amylases, cellulases, hemicellulases, cellulolytic and amylolytic accessory enzymes, inulinases, levanases, and pentose sugar utilizing enzymes.
- a "pentose sugar utilizing enzyme” can be any enzyme involved in pentose sugar digestion, metabolism and/or hydrolysis, including xylanase, arabinase, arabinoxylanase, arabinosidase, arabinofuranosidase, arabinoxylanase, arabinosidase, and arabinofuranosidase, arabinose isomerase, ribulose-5-phosphate 4-epimerase, xylose isomerase, xylulokinase, xylose reductase, xylose dehydrogenase, xylitol dehydrogenase, xylonate dehydratase, xylose transketolase, and/or xylose transaldolase.
- the present invention provides host cells expressing heterologous cellulases that can be effectively and efficiently utilized to produce products such as ethanol from cellulose.
- the host cells express heterologous amylases that can be effectively and efficiently utilized to produce products such as ethanol from biomass feedstock, such as grain feedstock.
- the host cells express heterologous enzymes that utilize pentose sugars.
- the host cell can be a yeast.
- the yeast host cell can be, for example, from the genera Saccharomyces, Kluyveromyces, Candida, Pichia, Schizosaccharomyces, Hansenula, Kloeckera, Schwanniomyces, and Yarrowia.
- Yeast species as host cells can include, for example, S. cerevisiae, S. bulderi, S. barnetti, S. exiguus, S. uvarum, S. diastaticus, K. lactis, K. marxianus, or K. fragilis.
- the yeast is selected from the group consisting of Saccharomyces cerevisiae, Schizzosaccharomyces pombe, Candida albicans, Pichia pastoris, Pichia stipitis, Yarrowia Hpolytica, Hansenula polymorpha, Phaffia rhodozyma, Candida utilis, Arxula adeninivorans, Debaryomyces hansenii, Debaryomyces polymorphus, Schizosaccharomyces pombe and Schwanniomyces occidentalis.
- the yeast is Saccharomyces cerevisiae. The selection of an appropriate host is deemed to be within the scope of those skilled in the art from the teachings herein.
- the host cell is an oleaginous cell.
- the oleaginous host cell can be an oleaginous yeast cell.
- the oleaginous yeast host cell can be from the genera Blakeslea, Candida, Cryptococcus, Cunninghamella, Lipomyces, Mortierella, Mucor, Phycomyces, Pythium, Rhodosporidum, Rhodotorula, Trichosporon or Yarrowia.
- the oleaginous host cell can be an oleaginous microalgae host cell.
- the oleaginous microalgea host cell can be from the genera Thraustochytrium or Schizochytrium .
- the host cell is a thermotolerant host cell.
- Thermotolerant host cells can be particularly useful in simultaneous saccharification and fermentation processes by allowing externally produced cellulases and ethanol-producing host cells to perform optimally in similar temperature ranges.
- Thermotolerant host cells of the invention can include, for example, Issatchenkia orientalis, Pichia mississippiensis, Pichia mexicana, Pichia farinosa, Clavispora op ntiae, Clavispora lusitaniae, Candida mexicana, Hansenula polymorpha and Kluyveromyces host cells.
- the host cell is a
- the Kluyveromyces host cell can be a K. lactis, K. marxianus, K. blattae, K. phqffii, K. yarrowii, K. aestuarii, K dobzhanskii, K. wickerhamii, K. thermotolerans, or K waltii host cell.
- the host cell is a K. lactis, or K. marxianus host cell.
- the host cell is a K. marxianus host cell.
- thermotolerant host cell can grow at temperatures above about 30° C, about 31° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41 ° C or about 42° C.
- thermotolerant host cell can produce ethanol from cellulose at temperatures above about 30° C, about 31 ° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41° C, about 42° C, or about 50° C.
- the thermotolerant host cell can grow at temperatures from about 30° C to 60° C, about 30° C to 55° C, about 30° C to 50° C, about 40° C to 60° C, about 40° C to 55° C or about 40° C to 50° C.
- the thermotolterant host cell can produce ethanol from cellulose at temperatures from about 30° C to 60° C, about 30° C to 55° C, about 30° C to 50° C, about 40° C to 60° C, about 40° C to 55° C or about 40° C to 50° C.
- Host cells are genetically engineered (transduced or transformed or transfected) with the polynucleotides encoding saccharolytic enzymes (amylases, cellulases, hemicellulases, cellulolytic and amylolytic accessory enzymes, inulinases, levanases, pentose sugar hydrolases and others) of this invention which are described in more detail herein.
- saccharolytic enzymes as mylases, cellulases, hemicellulases, cellulolytic and amylolytic accessory enzymes, inulinases, levanases, pentose sugar hydrolases and others
- the polynucleotides encoding saccharolytic enzymes can be introduced to the host cell on a vector of the invention, which may be, for example, a cloning vector or an expression vector comprising a sequence encoding a heterologous saccharolytic enzyme.
- the host cells can comprise polynucleotides of the invention
- the present invention relates to host cells containing the polynucleotide constructs described herein.
- the host cells of the present invention express one or more heterologous polypeptides of saccharolytic enzymes.
- the host cell comprises a combination of polynucleotides that encode heterologous saccharolytic enzymes or fragments, variants or derivatives thereof.
- the host cell can, for example, comprise multiple copies of the same nucleic acid sequence, for example, to increase expression levels, or the host cell can comprise a combination of unique polynucleotides.
- the host cell comprises a single polynucleotide that encodes a heterologous saccharolytic enzyme or a fragment, variant or derivative thereof.
- such host cells expressing a single heterologous saccharolytic enzyme can be used in co-culture with other host cells of the invention comprising a polynucleotide that encodes at least one other heterologous saccharolytic enzyme or fragment, variant or derivative thereof.
- Introduction of a polynucleotide encoding a heterologous saccharolytic enzyme into a host cell can be done by methods known in the art.
- Introduction of polynucleotides encoding heterologous saccharolytic enzyme into, for example yeast host cells can be effected by lithium acetate transformation, spheroplast transformation, or transformation by electroporation, as described in Current Protocols in Molecular Biology, 13.7.1- 13.7.10. Introduction of the construct in other host cells can be effected by calcium phosphate transfection, DEAE-Dextran mediated transfection, or electroporation. (Davis, L., et al, Basic Methods in Molecular Biology, (1986)).
- the transformed host cells or cell cultures, as described above, can be examined for protein content of an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase protein, alpha-amylase, beta- amylase, glucoamylase, pullulanase, isopullulanase, alpha-glucosidase
- protein content can be determined by analyzing the host (e.g., yeast) cell supematants.
- host e.g., yeast
- high molecular weight material can be recovered from the yeast cell supernatant either by acetone precipitation or by buffering the samples with disposable de-salting cartridges.
- Proteins, including tethered heterologous saccharolytic enzymes can also be recovered and purified from recombinant yeast cell cultures by methods including spheroplast preparation and lysis, cell disruption using glass beads, and cell disruption using liquid nitrogen for example.
- Protein analysis methods include methods such as the traditional Lowry method, the BCA assay, absorbance at 280 nm, or the protein assay method according to BioRad's manufacturer's protocol. Using such methods, the protein content of saccharolytic enzymes can be estimated.
- a heterologous cellulase can be expressed with a tag, for example a His-tag or HA-tag and purified by standard methods using, for example, antibodies against the tag, a standard nickel resin purification technique or similar approach.
- the transformed host cells or cell cultures, as described above, can be further analyzed for hydrolysis of cellulose, or starch, or pentose sugar utilization ⁇ e.g., by a sugar detection assay), for a particular type of saccharolytic enzyme activity (e.g., by measuring the individual endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruo
- Endoglucanase activity can be determined, for example, by measuring an increase of reducing ends in an endoglucanase specific CMC or hydroxyethylcellulose (HEC) substrate.
- Cellobiohydrolase activity can be measured, for example, by using insoluble cellulosic substrates such as the amorphous substrate phosphoric acid swollen cellulose (PASC) or microcrystalline cellulose (Avicel) and determining the extent of the substrate's hydrolysis.
- PASC amorphous substrate phosphoric acid swollen cellulose
- Avicel microcrystalline cellulose
- B-glucosidase activity can be measured by a variety of assays, e.g., using cellobiose. Assays for activity of other saccharolytic enzyme types are known in the art and are exemplified below.
- a total saccharolytic enzyme activity which can include the activity of endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase protein, alpha-amylase, beta-amylase, glucoamylase, alpha- glucosidase, beta-glucosidase, galactosidase, arabina
- total cellulase activity can thus be measured using insoluble substrates including pure cellulosic substrates such as Whatman No. 1 filter paper, cotton linter, microcrystalline cellulose, bacterial cellulose, algal cellulose, and cellulose- containing substrates such as dyed cellulose, alpha-cellulose or pretreated lignocellulose.
- Specific activity of cellulases can also be detected by methods known to one of ordinary skill in the art, such as by the Avicel assay (described supra) that would be normalized by protein (cellulase) concentration measured for the sample.
- Total saccharolytic activity could be also measured using complex substrate containing starch, cellulose and hemicellulose such as corn mash by measuring released monomeric sugars.
- saccharolytic enzyme can be any enzyme involved in carbohydrate digestion, metabolism and/or hydrolysis, including amylases, cellulases, hemicellulases, cellulolytic and amylolytic accessory enzymes, inulinases, levanases, and pentose sugar hydrolasing enzymes.
- a “cellulase” can be any enzyme involved in cellulase digestion, metabolism and/or hydrolysis, including an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, and feruoyl esterase protein.
- amylase can be any enzyme involved in amylase digestion and/or metabolism, including alpha-amylase, beta- amylase, glucoamylase, pullulanase, isopullulanase, and alpha-glucosidase.
- a pentose sugar hydrolyzing enzyme can be any enzyme involved in pentose sugar digestion, and/or metabolism, including xylanase, arabinase, arabinoxylanase, arabinosidase, arabinofuranosidase, arabinoxylanase, arabinosidase, and arabinofuranosidase, arabinose isomerase, ribulose-5-phosphate 4-epimerase, xylose isomerase, xylulokinase, xylose reductase, xylose dehydrogenase, xylitol dehydrogenase, xylonate dehydratase, xylose transketolase, and/or xylose transaldolase.
- the transformed host cells or cell cultures are assayed for ethanol production.
- Ethanol production can be measured by techniques known to one or ordinary skill in the art, e.g., by a standard HPLC refractive index method.
- the expression of heterologous saccharolytic enzymes in a host cell can be used advantageously to produce products such as ethanol from biomass sources.
- cellulases from a variety of sources can be heterologously expressed to successfully increase efficiency of ethanol production.
- the saccharolytic enzymes can be from fungi, yeast, bacteria, plant, protozoan or termite sources.
- the saccharolytic enzyme is from K grisea, T. aurantiacus, T. emersonii, T. reesei, C. lacteus, C. formosanus, K takasagoensis, C. acinaciformis, M.
- darwinensis K walkeri, S. fibuligera, C. luckowense R. speratus, Thermobfida fusca, Clostridum thermocellum, Clostridium cellulolyticum, Clostridum josui, Bacillus pumilis, Cellulomonas fimi, Saccharophagus degradans, Piromyces equii, Neocallimastix patricarum or Arabidopsis thaliana.
- the cellulase of the invention is any cellulase disclosed in
- the cellulase is encoded by a nucleic acid sequence at least about 80%, at least about 85%, at least about 90%, at least about 95%o, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or 100% identical to any one of SEQ ID NOs: 1-218.
- the cellulase has an amino acid sequence that is at least about 80%, at least about 85%, at least about 90%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or 100% identical to any one of SEQ ID NOs: 219-436.
- the celluiase of the invention is any cel!uiase suitable for expression in. an appropriate host cell.
- amylase of the invention is any amylase disclosed in
- the amylase is encoded by a nucleic acid sequence at least about 80%, at least about 85%, at least about 90%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or 100% identical to any one of SEQ ID NOs: 437-441.
- the celluiase has an amino acid sequence that is at least about 80%, at least about 85%), at least about 90%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or 100% identical to any one of SEQ ID NOs: 442-446.
- the amylase of the invention is any amylase suitable for expression in an appropriate host cell.
- multiple saccharolytic enzymes from a single organism are co-expressed in the same host cell.
- multiple saccharolytic enzymes from different organisms are co-expressed in the same host cell.
- saccharolytic enzymes from two, three, four, five, six, seven, eight, nine or more organisms can be co-expressed in the same host cell.
- the invention can encompass co-cultures of yeast strains, wherein the yeast strains express different saccharolytic enzymes.
- Co-cultures can include yeast strains expressing heterologous saccharolytic enzymes from the same organisms or from different organisms.
- Co-cultures can include yeast strains expressing saccharolytic enzymes from two, three, four, five, six, seven, eight, nine or more organisms.
- Lignocellulases of the present invention include both endoglucanases and exoglucanases.
- Other lignocellulases of the invention include accesory enzymes which can act on the lignocellulosic material.
- the lignocellulases can be, for example, endoglucanases, glucosidases, cellobiohydrolases, xylanases, glucanases, xylosidases, xylan esterases, arabinofuranosidases, galactosidases, cellobiose phosphorylases, cellodextrin phosphorylases, mannanases, mannosidases, xyloglucanases, endoxylanases, glucuronidases, acetylxylanesterases, arabinofuranohydrolases, swollenins, glucuronyl esterases, expansins, pec
- the lignocellulases of the invention can be any suitable enzyme for digesting the desired lignocellulosic material.
- the lignocellulase can be an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, and feruoyl esterase paralogue or orthologue.
- the lignocellulase is derived from any species named in Tables 4 and 7.
- the lignocellulase comprises an amino acid sequence selected from SEQ ID NOs: 219-436.
- the lignocellulase comprises an amino acid sequence that is at least about 70, about 80, about 90, about 95, about 96, about 97, about 98, about 99, or 100% identical to an amino acid sequence selected from SEQ ID NOs: 219-436.
- the amylases can be alpha-amylases, beta- amylases, glucoamylases, alpha-glucosidases, pullulanase, or isopullulanase paralogues or orthologues.
- 95%, 96%, 97%, 98%, 99% or 100% identical to a polypeptide of the present invention can be determined conventionally using known computer programs. Methods for determining percent identity, as discussed in more detail below in relation to polynucleotide identity, are also relevant for evaluating polypeptide sequence identity.
- the saccharolytic enzyme comprises a sequence selected from the saccharolytic enzymes disclosed in Table 4, or Table 7, or Table 19 presented herein.
- the saccharolytic enzymes of the invention also include saccharolytic enzymes that comprise a sequence at least about 70, about 80, about 90, about 95, about 96, about 97, about 98, about 99 or 100% identical to the sequences of Table 4, or Table 7, or Table 19.
- Amino acid and nucleic acid sequences are readily determined for a gene, protein or other element by a accession number upon consulting the proper database, for example Genebank. However, sequences for the genes and proteins of the present invention are also disclosed herein (SEQ ID NOs: 1-445).
- Some embodiments of the invention encompass a polypeptide comprising at least
- polypeptides and polynucleotides of the present invention are provided in an isolated form, e.g., purified to homogeneity.
- the present invention also encompasses polypeptides which comprise, or alternatively consist of, an amino acid sequence which is at least about 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% similar to the polypeptide of any of SEQ ID NOs: 219-436, or SEQ ID NOs:442-446, and to portions of such polypeptide with such portion of the polypeptide generally containing at least 30 amino acids and more preferably at least 50 amino acids.
- the present invention further relates to a domain, fragment, variant, derivative, or analog of the polypeptide of any of SEQ ID NOs: 219-436, or SEQ ID NOs:442-446.
- Fragments or portions of the polypeptides of the present invention can be employed for producing the corresponding full-length polypeptide by peptide synthesis.
- fragments can be employed as intermediates for producing the full-length polypeptides.
- Fragments of lignocellulases of the invention encompass domains, proteolytic fragments, deletion fragments and in particular, fragments of any of the genes named in Tables 4 and 7, which retain any specific biological activity of the endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, and feruoyl esterase proteins.
- Polypeptide fragments further include any portion of the polypeptide which retains a catalytic activity of endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, and feruoyl esterase protein.
- Fragments of amylases of the invention encompass domains, proteolytic fragments, deletion fragments and in particular, fragments of any of the genes named in Tables 15, 16, and 19, which retain any specific biological activity of the alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, and alpha-glucosidase proteins.
- Polypeptide fragments further include any portion of the polypeptide which retains a catalytic activity of alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, and alpha-glucosidase protein.
- SEQ ID NOs:442-446 may be (i) one in which one or more of the amino acid residues are substituted with a conserved or non-conserved amino acid residue (preferably a conserved amino acid residue) and such substituted amino acid residue may or may not be one encoded by the genetic code, or (ii) one in which one or more of the amino acid residues includes a substituent group, or (iii) one in which the mature polypeptide is fused with another compound, such as a compound to increase the half-life of the polypeptide (for example, polyethylene glycol), or (iv) one in which the additional amino acids are fused to the mature polypeptide for purification of the polypeptide or (v) one in which a fragment of the polypeptide is soluble, i.e., not membrane bound, yet still binds ligands to the membrane bound receptor.
- a conserved or non-conserved amino acid residue preferably a conserved amino acid residue
- substituted amino acid residue may or may not be
- the polypeptides of the present invention further include variants of the polypeptides.
- a "variant" of the polypeptide can be a conservative variant, or an allelic variant.
- a conservative variant refers to alterations in the amino acid sequence that do not adversely affect the biological functions of the protein.
- a substitution, insertion or deletion is said to adversely affect the protein when the altered sequence prevents or disrupts a biological function associated with the protein.
- the overall charge, structure or hydrophobic-hydrophilic properties of the protein can be altered without adversely affecting a biological activity.
- the amino acid sequence can be altered, for example to render the peptide more hydrophobic or hydrophilic, without adversely affecting the biological activities of the protein.
- an "allelic variant” is intended alternate forms of a gene occupying a given locus on a chromosome of an organism. Genes II, Lewin, B., ed., John Wiley & Sons, New York (1985). Non-naturally occurring variants may be produced using art-known mutagenesis techniques.
- Allelic variants though possessing a slightly different amino acid sequence than those recited above, will still have the same or similar biological functions associated with the endoglucanases, glucosidases, cellobiohydrolases, xylanases, glucanases, xylosidases, xylan esterases, arabinofuranosidases, galactosidases, cellobiose phosphorylases, cellodextrin phosphorylases, mannanases, mannosidases, xyloglucanases, endoxylanases, glucuronidases, acetylxylanesterases, arabinofuranohydrolases, swollenins, glucuronyl esterases, expansins, pectinases, feruoyl esterases, alpha-amylase, beta-amylase, glucoamylase, alpha-glucosidas
- allelic variants, the conservative substitution variants, and members of the endoglucanase, cellobiohydrolase, ⁇ -glucosidase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, or alpha-glucosidase protein families can have an amino acid sequence having at least 75%, at least 80%, at least 90%, at least 95% amino acid sequence identity with endoglucanases, glucosidases, cellobiohydrolases, xylanases, glucanases, xylosidases, xylan esterases, arabinofuranosidases, galactosidases, cellobiose phosphorylases, cellodextrin phosphorylases, mannanases, mannosidases, xyloglucanases, endoxylanases, glucuronidases, ace
- Identity or homology with respect to such sequences is defined herein as the percentage of amino acid residues in the candidate sequence that are identical with the known peptides, after aligning the sequences and introducing gaps, if necessary, to achieve the maximum percent homology, and not considering any conservative substitutions as part of the sequence identity. N-terminal, C-terminal or internal extensions, deletions, or insertions into the peptide sequence shall not be construed as affecting homology.
- proteins and peptides of the present invention include molecules comprising the amino acid sequence of SEQ ID NOs: 219-436, or and SEQ ID NOs: 442-446 or fragments thereof having a consecutive sequence of at least about 3, 4, 5, 6, 10, 15, 20, 25, 30, 35 or more amino acid residues of the endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, fer
- Contemplated variants farther include those containing predetermined mutations by, e.g., homologous recombination, site-directed or PCR mutagenesis, and the corresponding proteins of other animal species, including but not limited to bacterial, fungal, insect, rabbit, rat, porcine, bovine, ovine, equine and non- human primate species, the alleles or other naturally occurring variants of the family of proteins; and derivatives wherein the protein has been covalently modified by substitution, chemical, enzymatic, or other appropriate means with a moiety other than a naturally occurring amino acid (for example, a detectable moiety such as an enzyme or radioisotope).
- a detectable moiety such as an enzyme or radioisotope
- variants may be generated to improve or alter the characteristics of the polypeptides of saccharolytic enzymes. For instance, one or more amino acids can be deleted from the N- terminus or C-terminus of the secreted protein without substantial loss of biological function.
- the invention further includes endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha- glucosidase, beta-glucosidase, gal
- the first strategy exploits the tolerance of amino acid substitutions by natural selection during the process of evolution. By comparing amino acid sequences in different species, conserved amino acids can be identified. These conserved amino acids are likely important for protein function. In contrast, the amino acid positions where substitutions have been tolerated by natural selection indicates that these positions are not critical for protein function. Thus, positions tolerating amino acid substitution could be modified while still maintaining biological activity of the protein.
- the second strategy uses genetic engineering to introduce amino acid changes at specific positions of a cloned gene to identify regions critical for protein function. For example, site directed mutagenesis or alanine- scanning mutagenesis (introduction of single alanine mutations at every residue in the molecule) can be used. (Cunningham and Wells, Science 244:1081-1085 (1989).) The resulting mutant molecules can then be tested for biological activity.
- tolerated conservative amino acid substitutions involve replacement of the aliphatic or hydrophobic amino acids Ala, Val, Leu and lie; replacement of the hydroxyl residues Ser and Thr; replacement of the acidic residues Asp and Glu; replacement of the amide residues Asn and Gin, replacement of the basic residues Lys, Arg, and His; replacement of the aromatic residues Phe, Tyr, and Trp, and replacement of the small-sized amino acids Ala, Ser, Thr, Met, and Gly.
- derivatives and analogs refer to a polypeptide differing from the endoglucanases, glucosidases, cellobiohydrolases, xylanases, glucanases, xylosidases, xylan esterases, arabinofuranosidases, galactosidases, cellobiose phosphorylases, cellodextrin phosphorylases, mannanases, mannosidases, xyloglucanases, endoxylanases, glucuronidases, acetylxylanesterases, arabinofuranohydrolases, swollenins, glucuronyl esterases, expansins, pectinases, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha
- derivatives and analogs are overall closely similar, and, in many regions, identical to the endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha-glucosidase, beta-
- derivatives and analogs when referring to endoglucanases, glucosidases, cellobiohydrolases, xylanases, glucanases, xylosidases, xylan esterases, arabinofuranosidases, galactosidases, cellobiose phosphorylases, cellodextrin phosphorylases, mannanases, mannosidases, xyloglucanases, endoxylanases, glucuronidases, acetylxylanesterases, arabinofuranohydrolases, swollenins, glucuronyl esterases, expansins, pectinases, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha-glucosidase
- Derivatives of the saccharolytic enzymes disclosed herein are polypeptides which have been altered so as to exhibit features not found on the native polypeptide.
- Derivatives can be covalently modified by substitution, chemical, enzymatic, or other appropriate means with a moiety other than a naturally occurring amino acid (for example, a detectable moiety such as an enzyme or radioisotope). Examples of derivatives include fusion proteins.
- An analog is another form of an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha- glucosidase, beta-glucosidase, galacto
- polypeptide of the present invention may be a recombinant polypeptide, a natural polypeptide or a synthetic polypeptide. In some particular embodiments, the polypeptide is a recombinant polypeptide.
- allelic variants, orthologs, and/or species homologs are also provided in the present invention. Procedures known in the art can be used to obtain full-length genes, allelic variants, splice variants, full-length coding portions, orthologs, and/or species homologs of genes corresponding to any of SEQ ID NOs: 1-218, or SEQ ID NOs: 437- 441 using information from the sequences disclosed herein or the clones deposited with the ATCC. For example, allelic variants and/or species homologs may be isolated and identified by making suitable probes or primers from the sequences provided herein and screening a suitable nucleic acid source for allelic variants and/or the desired homologue.
- the host cell expresses a combination of heterologous saccharolytic enzymes.
- the host cell can contain at least two heterologous saccharolytic enzymes, at least three heterologous saccharolytic enzymes, at least four heterologous saccharolytic enzymes, at least five heterologous saccharolytic enzymes, at least six heterologous saccharolytic enzymes, at least seven heterologous saccharolytic enzymes, at least eight heterologous saccharolytic enzymes, at least nine heterologous saccharolytic enzymes, at least ten heterologous saccharolytic enzymes, at least eleven heterologous saccharolytic enzymes, at least twelve heterologous saccharolytic enzymes, at least thirteen heterologous saccharolytic enzymes, at least fourteen heterologous saccharolytic enzymes, or at least fifteen heterologous saccharolytic enzymes.
- the heterologous saccharolytic enzymes in the host cell can be from the same or from different species.
- the host cell expresses heterologous enzymes comprising cellobiohydrolases, endo-gluconases, beta- glucosidases, xylanases, xylosidases, glucoamylases, alpha-amylases, alpha-glucosidases, pullulanases, isopullulanases, pectinases, and acetylxylan esterases.
- the saccharolytic enzymes can be either tethered or secreted.
- a protein is "tethered" to an organism's cell surface if at least one terminus of the protein is bound, covalently and/or electrostatically for example, to the cell membrane or cell wall.
- a tethered protein can include one or more enzymatic regions that can be joined to one or more other types of regions at the nucleic acid and/or protein levels (e.g., a promoter, a terminator, an anchoring domain, a linker, a signaling region, etc.). While the one or more enzymatic regions may not be directly bound to the cell membrane or cell wall (e.g., such as when binding occurs via an anchoring domain), the protein is nonetheless considered a "tethered enzyme" according to the present specification.
- Tethering can, for example, be accomplished by incorporation of an anchoring domain into a recombinant protein that is heterologously expressed by a cell, or by prenylation, fatty acyl linkage, glycosyl phosphatidyl inositol anchors or other suitable molecular anchors which may anchor the tethered protein to the cell membrane or cell wall of the host cell.
- a tethered protein can be tethered at its amino terminal end or optionally at its carboxy terminal end.
- secreted means released into the extracellular milieu, for example into the media.
- tethered proteins may have secretion signals as part of their immature amino acid sequence, they are maintained as attached to the cell surface, and do not fall within the scope of secreted proteins as used herein.
- flexible linker sequence refers to an amino acid sequence which links two amino acid sequences, for example, a cell wall anchoring amino acid sequence with an amino acid sequence that contains the desired enzymatic activity.
- the flexible linker sequence allows for necessary freedom for the amino acid sequence that contains the desired enzymatic activity to have reduced steric hindrance with respect to proximity to the cell and may also facilitate proper folding of the amino acid sequence that contains the desired enzymatic activity.
- the tethered cellulase enzymes are tethered by a flexible linker sequence linked to an anchoring domain.
- the anchoring domain is of CWP2 (for carboxy terminal anchoring) or FLOl (for amino terminal anchoring) from S. cerevisiae.
- heterologous secretion signals may be added to the expression vectors of the present invention to facilitate the extra-cellular expression of cellulase proteins.
- the heterologous secretion signal is the secretion signal from ⁇ . reesei Xyn2.
- the heterologous secretion signal is the S. cerevisiae Invertase signal.
- the heterologous secretion signal is the S. cerevisiae AF mating signal.
- the present invention also encompasses fusion proteins.
- the fusion proteins can be a fusion of a heterologous saccharolytic enzyme and a second peptide.
- the heterologous saccharolytic enzyme and the second peptide can be fused directly or indirectly, for example, through a linker sequence.
- the fusion protein can comprise for example, a second peptide that is N-terminal to the heterologous saccharolytic enzyme and/or a second peptide that is C-terminal to the heterologous saccharolytic enzyme.
- the polypeptide of the present invention comprises a first polypeptide and a second polypeptide, wherein the first polypeptide comprises a heterologous saccharolytic enzyme.
- the fusion protein can comprise a first and second polypeptide wherein the first polypeptide comprises a heterologous saccharolytic enzyme and the second polypeptide comprises a signal sequence.
- the fusion protein can comprise a first and second polypeptide, wherein the first polypeptide comprises a heterologous saccharolytic enzyme and the second polypeptide comprises a polypeptide used to facilitate purification or identification or a reporter peptide.
- the polypeptide used to facilitate purification or identification or the reporter peptide can be, for example, a HIS-tag, a GST-tag, an HA- tag, a FLAG-tag, a MYC-tag, or a fluorescent protein.
- the fusion protein can comprise a first and second polypeptide, wherein the first polypeptide comprises a heterologous saccharolytic enzyme and the second polypeptide comprises an anchoring peptide.
- the anchoring domain is of CWP2 (for carboxy terminal anchoring) or FLOl (for amino terminal anchoring) from S. cerevisiae.
- the fusion protein can comprise a first and second polypeptide, wherein the first polypeptide comprises a heterologous saccharolytic enzyme and the second polypeptide comprises a cellulose binding module (CBM or SBM).
- CBM is from, for example, T. reesei Cbhl or Cbh2 or from C. lucknowense Cbh2b.
- the CBM is fused to a endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha-glucosidase, beta-glucosidase,
- the polypeptide of the present invention encompasses a fusion protein comprising a first polypeptide and a second polypeptide, wherien the first polypeptide is an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulana
- the polypeptides of the present invention encompasses a fusion protein comprising a first saccharolytic enzyme polypeptide, where the first polypeptide is a domain, derivative or fragment of any saccharolytic enzyme polypeptide disclosed herein, and a second polypeptide, where the second polypeptide is a T. emersonii Cbhl , H grisea Cbhl, or T. aurantiacusi Cbhl, T. emersonii Cbh2, T. reesei Cbhl or T, reesei Cbh2, C.
- the first polypeptide is either N-terminal or C-terminal to the second polypeptide.
- the first polypeptide and/or the second polypeptide are encoded by codon-optimized polynucleotides, for example, polynucleotides codon-optimized for S. cerevisiae or Kluveromyces.
- the first polypeptide and the second polypeptide are fused via a linker sequence.
- the linker sequence can, in some embodiments, be encoded by a codon-optimized polynucelotide.
- Codon-optimized polynucleotides are described in more detail below.
- An amino acid sequence corresponding to a codon-optimized linker 1 according to the invention is a flexible linker - strep tag - TEV site - FLAG - flexible linker fusion and corresponds to GGGGSGGGGS AWHPQFGG ENLYFQG DYKDDDK GGGGSGGGGS
- An amino acid sequence corresponding to optimized linker 2 is a flexible linker - strep tag -linker- TEV site - flexible linker and corresponds to GGGGSGGGGS WSHPQFEK GG ENLYFQG GGGGSGGGGS.
- the DNA sequence is as follows: ggtggcggtggatctggaggaggcggttcttggtcacccacaatttgaaagggtggagaaaacttgtacttttcaaggcggtg gtggaggttctggcggaggtggctca.
- the present invention is directed to co-cultures comprising at least two yeast host cells wherein the at least two yeast host cells each comprise an isolated polynucleotide encoding a saccharolytic enzyme.
- co-culture refers to growing two different strains or species of host cells together in the same vessel.
- At least one host cell of the co-culture comprises a heterologous polynucleotide comprising a nucleic acid which encodes an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mamiosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, alpha- glu
- the co-culture can comprise two or more strains of yeast host cells and the heterologous saccharolytic enzymes can be expressed in any combination in the two or more strains of host cells.
- the co-culture can comprise two strains: one strain of host cells that expresses an endoglucanase and a second strain of host cells that expresses a ⁇ -glucosidase, a cellobiohydrolase and a second cellobiohydrolase.
- the co-culture can comprise one strain of host cells that expresses two saccharolytic enzymes, for example an endoglucanase and a beta- glucosidase and a second strain of host cells that expresses one or more saccharolytic enzymes, for example one or more endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoy
- the co-culture can, in addition to the at least two host cells comprising heterologous saccharolytic enzymes, also include other host cells which do not comprise heterologous saccharolytic enzymes.
- the co-culture can comprise one strain expressing an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amy
- the various host cell strains in the co-culture can be present in equal numbers, or one strain or species of host cell can significantly outnumber another second strain or species of host cells.
- the ratio of one host cell to another can be about 1 :1, 1 :2, 1 :3, 1 :4, 1 :5, 1 :10, 1 :100, 1 :500 or 1 :1000.
- the strains or species of host cells may be present in equal or unequal numbers.
- Biomass feedstocks contain varying proportions of starch, lignocellulose, and pentose sugars. Therefore, in one aspect, yeast strains express different saccharolytic enzymes at different levels. In one embodiment, the one or more amylolytic enzymes are expressed at higher levels in yeast strain(s) as compared to one or more lignocellulases and/or the one or more pentose sugar utilizing enzymes. In another embodiment, the one or more lignocellulases are expressed at higher levels in yeast strain(s) as compared to one or more amylolytic enzymes and/or the one or more pentose sugar utilizing enzymes.
- the one or more pentose sugar utilizing enzymes are expressed at higher levels in yeast strain(s) as compared to one or more lignocellulases and/or the one or more amylolytic enzymes.
- the one or more amylolytic enzymes, one or more cellulases, and one or more pentose sugar utilizing enzymes are all expressed at approximately equal levels in the yeast strain(s).
- the ratio of expression of amylolytic enzymes to cellulolytic enzymes in the yeast strain(s) is about 1 :5, about 1:2, about 1 :1, about 2:1, or about 5:1.
- the relative expression levels of the amylolytic enzymes and cellulolytic enzymes can be determined using chromatographic techniques, such as HPLC, ion-exchange chromatography, size exclusion chromatography, or by 2D gel electrophoresis, immunoblotting, mass spectrometry, MALDI TOF, or functional assays.
- chromatographic techniques such as HPLC, ion-exchange chromatography, size exclusion chromatography, or by 2D gel electrophoresis, immunoblotting, mass spectrometry, MALDI TOF, or functional assays.
- the co-cultures of the present invention can include tethered saccharolytic enzymes, secreted saccharolytic enzymes or both tethered and secreted saccharolytic enzymes.
- the co-culture comprises at least one yeast host cell comprising a polynucleotide encoding a secreted heterologous saccharolytic enzymes.
- the co-culture comprises at least one yeast host cell comprising a polynucleotide encoding a tethered heterologous saccharolytic enzymes.
- all of the heterologous saccharolytic enzymes in the co-culture are secreted, and in another embodiment, all of the heterologous saccharolytic enzymes in the co-culture are tethered.
- other saccharolytic enzymes such as externally added saccharolytic enzymes may be present in the co-culture.
- the present invention includes isolated polynucleotides encoding saccharolytic enzymes of the present invention.
- the polynucleotides of the invention can encode endoglucanases, exoglucanases, amylases, or pentose sugar utilizing enzymes.
- the polynucleotides can encode an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphoryiase, cellodextrin phosphoryiase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha- glucosidase, beta-glucos
- the present invention also encompasses an isolated polynucleotide comprising a nucleic acid that is at least about 70%, 75%, or 80% identical, at least about 90% to about 95% identical, or at least about 96%, 97%, 98%, 99% or 100% identical to a nucleic acid encoding an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphoryiase, cellodextrin phosphoryiase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pect
- the present invention also encompasses variants of the saccharolytic enzymes genes, as described above.
- Variants may contain alterations in the coding regions, non- coding regions, or both. Examples are polynucleotide variants containing alterations which produce silent substitutions, additions, or deletions, but do not alter the properties or activities of the encoded polypeptide.
- nucleotide variants are produced by silent substitutions due to the degeneracy of the genetic code.
- the present invention also encompasses an isolated polynucleotide encoding a fusion protein.
- the nucleic acid encoding a fusion protein comprises a first polynucleotide encoding for a endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase,
- the first and second polynucleotides are in the same orientation, or the second polynucleotide is in the reverse orientation of the first polynucleotide.
- the first polynucleotide encodes a polypeptide that is either N-terminal or C-terminal to the polypeptide encoded by the second polynucleotide.
- the first polynucleotide and/or the second polynucleotide are encoded by codon-optimized polynucleotides, for example, polynucleotides codon-optimized for >S. cerevisiae, Kluyveromyces or for both S. cerevisiae and Kluyveromyces.
- allelic variants, orthologs, and/or species homologs are also provided in the present invention. Procedures known in the art can be used to obtain full-length genes, allelic variants, splice variants, full-length coding portions, orthologs, and/or species homologs of genes corresponding to any of SEQ ID NOs: 1-218, or any of SEQ ID NOs: 437-441, using information from the sequences disclosed herein or the clones deposited with the ATCC or otherwise publically available.
- allelic variants and/or species homologs may be isolated and identified by making suitable probes or primers from the sequences provided herein and screening a suitable nucleic acid source for allelic variants and/or the desired homologue.
- nucleotide sequence of the nucleic acid is identical to the reference sequence except that the nucleotide sequence may include up to five point mutations per each 100 nucleotides of the reference nucleotide sequence encoding the particular polypeptide.
- nucleotide sequence may include up to five point mutations per each 100 nucleotides of the reference nucleotide sequence encoding the particular polypeptide.
- up to 5% of the nucleotides in the reference sequence may be deleted or substituted with another nucleotide, or a number of nucleotides up to 5% of the total nucleotides in the reference sequence may be inserted into the reference sequence.
- the query sequence may be an entire sequence shown of any of SEQ ID NOs: 1-218, or any of SEQ ID NOs: 437-441, or any fragment or domain specified as described herein.
- nucleic acid molecule or polypeptide is at least 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% identical to a nucleotide sequence or polypeptide of the present invention can be determined conventionally using known computer programs.
- a method for determining the best overall match between a query sequence (a sequence of the present invention) and a subject sequence can be determined using the FASTDB computer program based on the algorithm of Brutlag et al . (Comp. App. Biosci. (1990) 6:237-245.)
- sequence alignment the query and subject sequences are both DNA sequences.
- RNA sequence can be compared by converting U's to T's.
- the result of said global sequence alignment is in percent identity.
- the percent identity is corrected by calculating the number of bases of the query sequence that are 5' and 3' of the subject sequence, which are not matched/aligned, as a percent of the total bases of the query sequence. Whether a nucleotide is matched/aligned is determined by results of the FASTDB sequence alignment.
- This percentage is then subtracted from the percent identity, calculated by the above FASTDB program using the specified parameters, to arrive at a final percent identity score.
- This corrected score is what is used for the purposes of the present invention. Only bases outside the 5' and 3' bases of the subject sequence, as displayed by the FASTDB alignment, which are not matched/aligned with the query sequence, are calculated for the purposes of manually adjusting the percent identity score.
- a 90 base subject sequence is aligned to a 100 base query sequence to determine percent identity.
- the deletions occur at the 5' end of the subject sequence and therefore, the F ASTDB alignment does not show a matched/alignment of the first 10 bases at 5' end.
- the 10 unpaired bases represent 10% of the sequence (number of bases at the 5' and 3' ends not matched/total number of bases in the query sequence) so 10% is subtracted from the percent identity score calculated by the FASTDB program. If the remaining 90 bases were perfectly matched the final percent identity would be 90%.
- a 90 base subject sequence is compared with a 100 base query sequence.
- deletions are internal deletions so that there are no bases on the 5' or 3' of the subject sequence which are not matched/aligned with the query.
- percent identity calculated by FASTDB is not manually corrected.
- bases 5' and 3' of the subject sequence which are not matched/aligned with the query sequence are manually corrected for. No other manual corrections are to be made for the purposes of the present invention.
- Some embodiments of the invention encompass a nucleic acid molecule comprising at least 10, 20, 30, 35, 40, 50, 60, 70, 80, 90, 100, 200, 300, 400, 500, 600, 700, or 800 consecutive nucleotides or more of any of SEQ ID NOs: 1-218, or any of SEQ ID NOs: 437-441, or domains, fragments, variants, or derivatives thereof.
- the polynucleotide of the present invention may be in the form of RNA or in the form of DNA, which DNA includes cDNA, genomic DNA, and synthetic DNA.
- the DNA may be double stranded or single-stranded, and if single stranded can be the coding strand or non-coding (anti-sense) strand.
- the coding sequence which encodes the mature polypeptide can be identical to the coding sequence encoding SEQ ID NO: 219-436, or SEQ ID NO: 442-446, or may be a different coding sequence which coding sequence, as a result of the redundancy or degeneracy of the genetic code, encodes the same mature polypeptide as the nucleic acid sequences of any one of SEQ ID NOs: 1-218, or any one of SEQ ID NOs: 437-441.
- the present invention provides an isolated polynucleotide comprising a nucleic acid fragment which encodes at least 10, at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 95, or at least 100 or more contiguous amino acids of SEQ ID NOs: 219-436, or SEQ ID NO: 442-446.
- SEQ ID NO: 442-446 may include: only the coding sequence for the mature polypeptide; the coding sequence of any domain of the mature polypeptide; and the coding sequence for the mature polypeptide (or domain-encoding sequence) together with non coding sequence, such as introns or non-coding sequence 5' and/or 3' of the coding sequence for the mature polypeptide.
- polynucleotide encoding a polypeptide encompasses a polynucleotide which includes only sequences encoding for the polypeptide as well as a polynucleotide which includes additional coding and/or non-coding sequences.
- nucleic acid molecules having sequences at least about 90%, 95%, 96%, 97%, 98% or 99% identical to the nucleic acid sequences disclosed herein encode a polypeptide having an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphory!ase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-
- nucleic acid molecules having a sequence at least 90%, 95%, 96%, 97%, 98%, or 99% identical to the nucleic acid sequence of any of SEQ ID NOs: 1-218, or any of SEQ ID NOs: 437-441, or fragments thereof, will encode polypeptides having functional activity.
- degenerate variants of any of these nucleotide sequences all encode the same polypeptide, in many instances, this will be clear to the skilled artisan even without performing the above described comparison assay. It will be further recognized in the art that, for such nucleic acid molecules that are not degenerate variants, a reasonable number will also encode a polypeptide having functional activity.
- the polynucleotides of the present invention also comprise nucleic acids encoding an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha-glucosidas
- expression of the marker is independent from expression of the saccharolytic enzyme.
- the marker sequence may be a yeast selectable marker selected from the group consisting of URA3, HIS3, LEU2, TRP1, LYS2, ADE2 or any other suitable selectable marker known in the art. Casey, G.P. et ah, "A convenient dominant selection marker for gene transfer in industrial strains of Saccharomyces yeast: SMR1 encoded resistance to the herbicide sulfometuron methyl," J Inst. Brew. 94:93-97 (1988).
- the polynucleotides encoding heterologous saccharolytic enzymes can be codon-optimized.
- codon-optimized coding region means a nucleic acid coding region that has been adapted for expression in the cells of a given organism by replacing at least one, or more than one, or a significant number, of codons with one or more codons that are more frequently used in the genes of that organism.
- CAI codon adaptation index
- the CAI of codon optimized sequences of the present invention corresponds to between about 0.8 and 1.0, between about 0.8 and 0.9, or about 1.0.
- a codon optimized sequence may be further modified for expression in a particular organism, depending on that organism's biological constraints. For example, large runs of "As" or "Ts" (e.g., runs greater than 4, 5, 6, 7, 8, 9, or 10 consecutive bases) can be removed from the sequences if these are known to effect transcription negatively.
- specific restriction enzyme sites may be removed for molecular cloning purposes. Examples of such restriction enzyme sites include Pad, Ascl, BamHI, Bglll, EcoRI and Xhol.
- the DNA sequence can be checked for direct repeats, inverted repeats and mirror repeats with lengths of ten bases or longer, which can be modified manually by replacing codons with "second best" codons, i.e., codons that occur at the second highest frequency within the particular organism for which the sequence is being optimized.
- Deviations in the nucleotide sequence that comprise the codons encoding the amino acids of any polypeptide chain allow for variations in the sequence coding for the gene. Since each codon consists of three nucleotides, and the nucleotides comprising DNA are restricted to four specific bases, there are 64 possible combinations of nucleotides, 61 of which encode amino acids (the remaining three codons encode signals ending translation). The "genetic code” which shows which codons encode which amino acids is reproduced herein as Table 1. As a result, many amino acids are designated by more than one codon.
- amino acids alanine and proline are coded for by four triplets, serine and arginine by six, whereas tryptophan and methionine are coded by just one triplet.
- This degeneracy allows for DNA base composition to vary over a wide range without altering the amino acid sequence of the proteins encoded by the DNA.
- Codon preference or codon bias differences in codon usage between organisms, is afforded by degeneracy of the genetic code, and is well documented among many organisms. Codon bias often correlates with the efficiency of translation of messenger RNA (mRNA), which is in turn believed to be dependent on, inter alia, the properties of the codons being translated and the availability of particular transfer RNA (tRNA) molecules.
- mRNA messenger RNA
- tRNA transfer RNA
- the predominance of selected tRNAs in a cell is generally a reflection of the codons used most frequently in peptide synthesis. Accordingly, genes can be tailored for optimal gene expression in a given organism based on codon optimization.
- Codon usage Tables are readily available, for example, at http://phenotype.biosci.umbc.edii/codon/sgd/index.php (visited May 7, 2008) or at http://www.kaz.usa. or.jp/codon/ (visited March 20, 2008), and these tables can be adapted in a number of ways. See Nakamura, Y., et al., "Codon usage tabulated from the international DNA sequence databases: status for the year 2000," Nucl. Acids Res. 28:292 (2000).
- Codon usage tables for yeast calculated from GenBank Release 128,0 [15 February 2002], are reproduced below as Table 2.
- This Table uses mRNA nomenclature, and so instead of thymine (T) which is found in DNA, the tables use uracil (U) which is found in RNA.
- T thymine
- U uracil
- the Table has been adapted so that frequencies are calculated for each amino acid, rather than for all 64 codons.
- Codon-optimized coding regions can be designed by various different methods.
- a codon usage Table is used, to find the single most frequent codon used for any given amino acid, and that codon is used each time that particular amino acid appears in the polypeptide sequence. ' For example, referring to Table 2 above, for leucine, the most frequent codon is UUG, which is used 27.2% of the time. Thus all the leucine residues in a given amino acid sequence would be assigned the codon UUG.
- the actual frequencies of the codons are distributed randomly throughout the coding sequence.
- Table 2 for frequency of usage in the S. cerevisiae, about. 5, or 5% of the leucine codons would be CUC, about 11, or 1 1% of the leucine codons would be CUG. about 12, or 12% of the leucine codons would be CUU, about 13, or 13% of the leucine codons would be CUA, about 26, or 26% of the leucine codons would be UUA, and about 27, or 27% of the leucine codons would be UUG.
- the term “about” is used precisely to account for fractional percentages of codon frequencies for a given amino acid.
- “about” is defined as one amino acid more or one amino acid less than the value given. The whole number value of amino acids is rounded up if the fractional frequency of usage is 0.50 or greater, and is rounded down if the fractional frequency of use is 0.49 or less.
- the fractional frequency of codon usage would be calculated by multiplying 62 by the frequencies for the various codons.
- 7.28 percent of 62 equals 4.51 UUA codons, or "about 5,” i.e., 4, 5, or 6 UUA codons, 12.66 percent of 62 equals 7.85 UUG codons or "about 8," i.e., 7, 8, or 9 UUG codons, 12.87 percent of 62 equals 7.98 CUU codons, or "about 8," i.e., 7, 8, or 9 CUU codons, 19.56 percent of 62 equals 12.13 CUC codons or "about 12,” i.e., 11, 12, or 13 CUC codons, 7.00 percent of 62 equals 4.34 CUA codons or "about 4," i.e., 3, 4, or 5 CUA codons, and 40.62 percent of 62 equals 25.19 CUG codons, or "about 25,” i.e., 24, 25, or 26 CUG codons.
- Randomly assigning codons at an optimized frequency to encode a given polypeptide sequence can be done manually by calculating codon frequencies for each amino acid, and then assigning the codons to the polypeptide sequence randomly.
- various algorithms and computer software programs are readily available to those of ordinary skill in the art. For example, the "EditSeq” function in the Lasergene Package, available from DNAstar, Inc., Madison, WI, the backtranslation function in the VectorNTI Suite, available from InforMax, Inc., Bethesda, MD, and the "backtranslate” function in the GCG ⁇ Wisconsin Package, available from Accelrys, Inc., San Diego, CA.
- oligonucleotide pairs are synthesized such that upon annealing, they form double stranded fragments of 80-90 base pairs, containing cohesive ends, e.g., each oligonucleotide in the pair is synthesized to extend 3, 4, 5, 6, 7, 8, 9, 10, or more bases beyond the region that is complementary to the other oligonucleotide in the pair.
- the single-stranded ends of each pair of oligonucleotides is designed to anneal with the single-stranded end of another pair of oligonucleotides.
- the oligonucleotide pairs are allowed to anneal, and approximately five to six of these double-stranded fragments are then allowed to anneal together via the cohesive single stranded ends, and then they ligated together and cloned into a standard bacterial cloning vector, for example, a TOPO ® vector available from Invitrogen Corporation, Carlsbad, CA.
- the construct is then sequenced by standard methods. Several of these constructs consisting of 5 to 6 fragments of 80 to 90 base pair fragments ligated together, i.e., fragments of about 500 base pairs, are prepared, such that the entire desired sequence is represented in a series of plasmid constructs.
- the inserts of these plasmids are then cut with appropriate restriction enzymes and ligated together to form the final construct.
- the final construct is then cloned into a standard bacterial cloning vector, and sequenced. Additional methods would be immediately apparent to the skilled artisan. In addition, gene synthesis is readily available commercially.
- an entire polypeptide sequence, or fragment, variant, or derivative thereof is codon optimized by any of the methods described herein.
- Various desired fragments, variants or derivatives are designed, and each is then codon-optimized individually.
- partially codon-optimized coding regions of the present invention can be designed and constructed.
- the invention includes a nucleic acid fragment of a codon-optimized coding region encoding a polypeptide in which at least about 1%, 2%, 3%, 4%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 100% of the codon positions have been codon-optimized for a given species. That is, they contain a codon that is preferentially used in the genes of a desired species, e.g., a yeast species such as Saccharomyces cerevisiae or Kluveromyces, in place of a codon that is normally used in the native nucleic acid sequence.
- a desired species e.g., a yeast species such as Saccharomyces cerevisiae or Kluveromyces
- a full-length polypeptide sequence is codon-optimized for a given species resulting in a codon-optimized coding region encoding the entire polypeptide, and then nucleic acid fragments of the codon-optimized coding region, which encode fragments, variants, and derivatives of the polypeptide are made from the original codon-optimized coding region.
- nucleic acid fragments encoding fragments, variants, and derivatives would not necessarily be fully codon optimized for the given species.
- the codon-optimized coding regions can be, for example, versions encoding an endoglucanase, glucosidase, cellobiohydrolase, xylanase, glucanase, xylosidase, xylan esterase, arabinofuranosidase, galactosidase, cellobiose phosphorylase, cellodextrin phosphorylase, mannanase, mannosidase, xyloglucanase, endoxylanase, glucuronidase, acetylxylanesterase, arabinofuranohydrolase, swollenin, glucuronyl esterase, expansin, pectinase, feruoyl esterase, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha-glucosidase, beta-
- Codon optimization is carried out for a particular species by methods described herein, for example, in certain embodiments codon-optimized coding regions encoding polypeptides disclosed in the present application or domains, fragments, variants, or derivatives thereof are optimized according to yeast codon usage, e.g., Saccharomyces cerevisiae, Kluyveromyces lactis and/or Kluyveromyces marxianus. Also provided are polynucleotides, vectors, and other expression constructs comprising codon-optimized coding regions encoding polypeptides disclosed herein, or domains, fragments, variants, or derivatives thereof, and various methods of using such polynucleotides, vectors and other expression constructs.
- a codon-optimized coding region encoding any of SEQ ID NOs: 219-436, or any of SEQ ID NOs: 442-446, or domain, fragment, variant, or derivative thereof, is optimized according to codon usage in yeast ⁇ e.g. Saccharomyces cerevisiae, Kluyveromyces lactis or Kluyveromyces marxianus).
- the sequences are codon-optimized specifically for expression in Saccharomyces cerevisiae.
- a codon-optimized coding region encoding any of SEQ ID NOs: 219-436, or any of SEQ ID NOs: 442-446 may be optimized according to codon usage in any plant, animal, or microbial species.
- the present invention relates to vectors which include polynucleotides of the present invention, host cells which are genetically engineered with vectors of the invention and the production of polypeptides of the invention by recombinant techniques.
- Host cells are genetically engineered (transduced or transformed or transfected) with the vectors of this invention which may be, for example, a cloning vector or an expression vector.
- the vector may be, for example, in the form of a plasmid, a viral particle, a phage, etc.
- the engineered host cells can be cultured in conventional nutrient media modified as appropriate for activating promoters, selecting transformants or amplifying the genes of the present invention.
- the culture conditions such as temperature, pH and the like, are those previously used with the host cell selected for expression, and will be apparent to the ordinarily skilled artisan.
- the polynucleotides of the present invention can be employed for producing polypeptides by recombinant techniques.
- the polynucleotide may be included in any one of a variety of expression vectors for expressing a polypeptide.
- expression vectors include chromosomal, nonchromosomal and synthetic DNA sequences, e.g., derivatives of SV40; bacterial plasmids; and yeast plasmids.
- any other vector may be used as long as it is replicable and viable in the host.
- the appropriate DNA sequence can be inserted into the vector by a variety of procedures.
- the DNA sequence is inserted into an appropriate restriction endonuclease site(s) by procedures known in the art. Such procedures and others are deemed to be within the scope of those skilled in the art.
- the DNA sequence in the expression vector is operatively associated with an appropriate expression control sequence(s) (promoter) to direct mRNA synthesis.
- promoter an appropriate expression control sequence(s) to direct mRNA synthesis.
- promoters are as follows:
- promoter sequences from stress and starvation response genes are useful in the present invention.
- promoter regions from the S. cerevisiae genes GAC1, GETS, GLC7, GSH1, GSH2, HSF1, HSP12, LCB5, LRE1, LSP1, NBP2, PDC1, PIL1, PIM1, SGT2, SLG1, WHI2, WSC2, WSC3, WSC4, YAP1, YDC1, ESP 104, HSP26, ENA1, MSN2, MSN 4, SIP 2, SIP 4, SIP 5, DPL1, IRS4, KOG1, PEP 4, HAP4, PRB1, TAX4, ZPR1, ATG1, ATG2, ATG10, ATG11, ATG12, ATG13, ATG14, ATG15, ATG16, ATG17, ATG18, and ATG19 may be used.
- Any suitable promoter to drive gene expression in the host cells of the invention may be used.
- the E. coli, lac or tip, and other promoters known to control expression may be used.
- the expression vectors may contain one or more selectable marker genes to provide a phenotypic trait for selection of transformed host cells such as URA3, HIS3, LEU2, TRPl, LYS2 or ADE2, dihydrofolate reductase, neomycin (G418) resistance or zeocin resistance for eukaryotic cell culture, or tetracycline or ampicillin resistance in E. coli.
- selectable marker genes such as URA3, HIS3, LEU2, TRPl, LYS2 or ADE2, dihydrofolate reductase, neomycin (G418) resistance or zeocin resistance for eukaryotic cell culture, or tetracycline or ampicillin resistance in E. coli.
- the expression vector may also contain a ribosome binding site for translation initiation and/or a transcription terminator.
- the vector may also include appropriate sequences for amplifying expression, or may include additional regulatory regions.
- the vector containing the appropriate DNA sequence as disclosed herein, as well as an appropriate promoter or control sequence, may be employed to transform an appropriate host to permit the host to express the protein.
- the present invention relates to host cells containing the above-described constructs.
- the host cell can be a host cell as described elsewhere in the application.
- the host cell can be, for example, a lower eukaryotic cell, such as a yeast cell, e.g., Saccharomyces cerevisiae or Kluyveromyces, or the host cell can be a prokaryotic cell, such as a bacterial cell.
- bacterial cells such as E. coli, Streptomyces, Salmonella typhimurium
- thermophilic or mesophlic bacteria such as E. coli, Streptomyces, Salmonella typhimurium
- fungal cells such as yeast
- plant cells etc.
- the selection of an appropriate host is deemed to be within the scope of those skilled in the art from the teachings herein.
- yeast is selected from the group consisting of Saccharomyces cerevisiae, Kluyveromyces lactis, Schizzosaccharomyces pombe, Candida albicans, Pichia pastoris, Pichia stipitis, Yarrowia lipolytica, Hansenula polymorpha, Phaffia rhodozyma, Candida utilis, Arxula adeninivorans, Debaryomyces hansenii, Debaryomyces polymorphus, Schwanniomyces occidentalis, Issatchenkia orientalis, Kluyveromyces marxianus, Blakeslea, Candida, Cryptococcus, Cunninghamella, Lipomyces, Mortierella, Mucor, Phycomces, Pythium, Rhodosporidium, Rhodotorula, Trichosporon and Yarrowia.
- the present invention is directed to the use of host cells and co- cultures to produce ethanol or other products from a biomass feedstock comprising starch, lignocellulosic matter, hexose and pentose sugars.
- a biomass feedstock comprising starch, lignocellulosic matter, hexose and pentose sugars.
- Fermentation products include, but are not limited to products such as butanol, acetate, amino acids, and vitamins.
- biomass feedstocks can be used in accordance with the present invention.
- Substrates for saccharolytic enzyme activity assays can be divided into two categories, soluble and insoluble, based on their solubility in water.
- Soluble substrates include alpha-dextrins, cellodextrins or derivatives, carboxymethyl cellulose (CMC), or hydroxyethyl cellulose (HEC).
- Insoluble substrates include insoluble starch, crystalline cellulose, microcrystalline cellulose (Avicel), amorphous cellulose, such as phosphoric acid swollen cellulose (PASC), dyed or fluorescent cellulose, and lignocellulosic biomass. These substrates are generally highly ordered cellulosic material and thus only sparingly soluble.
- suitable lignocellulosic material may be any feedstock that contains soluble and/or insoluble cellulose, where the insoluble cellulose may be in a crystalline or non-crystalline form.
- the lignocellulosic biomass comprises, for example, wood, corn, corn stover, sawdust, bark, leaves, agricultural and forestry residues, grasses such as switchgrass, ruminant digestion products, municipal wastes, paper mill effluent, newspaper, cardboard or combinations thereof.
- the invention is directed to a method for hydrolyzing a biomass feedstock, for example a biomass feedstock as described above, by contacting the biomass feedstock with a host cell of the invention. In some embodiments, the invention is directed to a method for hydrolyzing a biomass feedstock, for example a biomass feedstock as described above, by contacting the feedstock with a co-culture comprising yeast cells expressing heterologous saccharolytic enzymes.
- the necessity of adding external saccharolytic enzymes to the fermentation medium is reduced because cells of the invention express polypeptides of the invention.
- the invention is directed to a method for fermenting a biomass feedstock. Such methods can be accomplished, for example, by culturing a host cell or co-culture in a medium that contains insoluble biomass feedstock to allow saccharification and fermentation of the biomass feedstock.
- host cells of the present invention can have further genetic modifications to make them more suitable for fermenting biomass feedstock to ethanol.
- host cells of the present invention may express xylose isomerase and/or arabinose isomerase inorder to more efficiently use pentose sugars for fermentation.
- the xylose isomerase is from a Pyromyces species.
- host cells of the invention in some embodiments, can over-express genes related to the pentose phosphate pathway. These genes include, but are not limited to transkelolase and transaldolase genes.
- a host cell is able to use xylose and other pentose sugars such as arabinose by incorporating the carbons from pentose sugars into fermentative pathways via the pentose phosphate pathway.
- the xylose-utilizing host cell heterologously expresses xylose isomerase, e.g. Pyromyces sp.
- E2 XylA overexpresses xylulokinase, ribulose 5-phosphate isomerase, ribulose 5-phophate epimerase, transketolase and transaldolase, and does not express an aldose reductase such as the GRE3 gene (encoding an aldose reductase).
- the production of ethanol can, according to the present invention, be performed at temperatures of at least about 25° C, about 28 ° C, about 30° C, about 31° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41° C, about 42° C, or about 50° C.
- the thermotolerant host cell can produce ethanol from cellulose at temperatures above about 30° C, about 31° C, about 32° C, about 33° C, about 34° C, about 35° C, about 36° C, about 37° C, about 38° C, about 39° C, about 40° C, about 41° C, about 42° C, or about 50° C.
- the thermotolterant host cell can produce ethanol from cellulose at temperatures from about 30° C to 60° C, about 30° C to 55° C, about 30° C to 50° C, about 40° C to 60° C, about 40° C to 55° C or about 40° C to 50° C.
- methods of producing ethanol can comprise contacting a biomass feedstock with a host cell or co-culture of the invention and additionally contacting the biomass feedstock with externally produced saccharolytic enzymes.
- exemplary externally produced saccharolytic enzymes are commercially available and are known to those of skill in the art and are further exemplified below.
- the invention is also directed to methods of reducing the amount of externally produced saccharolytic enzymes required to produce a given amount of ethanol from the biomass feedstock comprising contacting the saccharolytic enzyme with externally produced saccharolytic enzymes and with a host cell or co-culture of the invention, in some embodiments, the same amount of ethanol production can be achieved using at least about 5%, 10%, 15%, 20%, 25%, 30%, or 50% fewer externally produced saccharolytic enzymes.
- the methods comprise producing ethanol at a particular rate.
- ethanol is produced at a rate of at least about 0.1 mg per hour per liter, at least about 0.25 mg per hour per liter, at least about 0.5 mg per hour per liter, at least about 0.75 mg per hour per liter, at least about 1.0 mg per hour per liter, at least about 2.0 mg per hour per liter, at least about 5.0 mg per hour per liter, at least about 10 mg per hour per liter, at least about 15 mg per hour per liter, at least about 20.0 mg per hour per liter, at least about 25 mg per hour per liter, at least about 30 mg per hour per liter, at least about 50 mg per hour per liter, at least about 100 mg per hour per liter, at least about 200 mg per hour per liter, or at least about 500 mg per hour per liter.
- the host cells of the present invention can produce ethanol at a rate of at least about 0.1 mg per hour per liter, at least about 0.25 mg per hour per liter, at least about 0.5 mg per hour per liter, at least about 0.75 mg per hour per liter, at least about 1.0 mg per hour per liter, at least about 2.0 mg per hour per liter, at least about 5.0 mg per hour per liter, at least about 10 mg per hour per liter, at least about 15 mg per hour per liter, at least about 20.0 mg per hour per liter, at least about 25 mg per hour per liter, at least about 30 mg per hour per liter, at least about 50 mg per hour per liter, at least about 100 mg per hour per liter, at least about 200 mg per hour per liter, or at least about 500 mg per hour per liter more than a control st ain (lacking heterologous biomass feedstock hydrolyzing enzymes) and grown under the same conditions.
- the ethanol can be produced in the absence
- Ethanol production can be measured using any method known in the art. For example, the quantity of ethanol in fermentation samples can be assessed using HPLC analysis. Many ethanol assay kits are commercially available that use, for example, alcohol oxidase enzyme based assays. Methods of determining ethanol production are within the scope of those skilled in the art from the teachings herein.
- the expression of two or more enzymes of the present invention results in synergistic enzymatic activity with respect to substrate digestion.
- the presence of two distinct paralogs or orthologs containing the same enzymatic activity can significantly enhance the digestion of a substrate compared to a comprarable amount of either enzyme by itself
- synergistically acting enzymes do not need to have exactly identical chemical activity, but can still operate to liberate sugars in a capacity greater than either is capable of individually.
- enzymatic synergy allows biomass feedstock digestion and fermentation to take place using reduced amounts of external saccharolytic enzymes.
- the two or more enzymes acting synergistically are endoglucanases, glucosidases, cellobiohydrolases, xylanases, glucanases, xylosidases, xylan esterases, arabinofuranosidases, galactosidases, cellobiose phosphorylases, cellodextrin phosphorylases, mannanases, mannosidases, xyloglucanases, endoxylanases, glucuronidases, acetylxylanesterases, arabinofuranohydrolases, swollenins, glucuronyl esterases, expansins, pectinases, feruoyl esterases, alpha-amylase, beta-amylase, glucoamylase, pullulanase, isopullulanase, alpha-glucosi
- the two or more enzymes acting synergistically do not have the same enzymatic activity. In other embodiments, the two or more enzymes acting synergistically have the same enzyme activity.
- the enzyme pairs acting synergistically are (Streptomyces avermitilis endo-l,4-beta-glucanase celA2 (Accession No. NP_823030.1) and Streptomyces avermitilis endo-l,4-beta- glucanase celA5 (Accession No. NP 828072.1 )); (Streptomyces avermitilis endo- 1,4- beta-glucanase celA2 (Accession No.
- NP_823030.1 Bacillus subtilis endo- 1 ,4-beta- glucanase (Accession No CAB 13696.2)); (Streptomyces avermitilis endo- 1 ,4-beta- glucanase celA3 (Accession No. NP_823032.1) and Streptomyces avermitilis endo-1,4- beta-glucanase (Accession No. NP_826394.1)); (Streptomyces avermitilis endo-l,4-beta- glucanase celA4 (Accession No.
- NP_823744.1 and Streptomyces avermitilis xylanase (Accession No. NP_827548.1)); (Bacillus subtilis endo-l,4-beta-glucanase (Accession No CAB 13696.2) and Streptomyces avermitilis endo-l,4-beta-glucanase (Accession No. NP_826394.1)); (Streptomyces avermitilis endo-l ,4-beta-glucanase celA4 (Accession No.
- NP 823744.1 Bacillus subtilis endo-l,4-beta-glucanase (Accession No CAB 13696.2)); (Streptomyces avermitilis endo-l,4-beta-glucanase celA5 (Accession No. NP_828072.1) and Streptomyces avermitilis endo-l,4-beta-glucanase celA4 (Accession No. NP_823744.1)); (Streptomyces avermitilis endo-l,4-beta-glucanase celA5 (Accession No.
- NP_828072.1 and Clostridium phytofermentans xylanase (Accession No. YP_001557750.1)); (Saccharophagus degradans 2-40 mannanase (Accession No. YP_525985.1) and Streptomyces avermitilis endo-l,4-beta-glucanase (Accession No. NP_826394.1)); (Streptomyces avermitilis xylanase (Accession No. NP_827548.1) and Saccharophagus degradans 2-40 mannanase (Accession No.
- NP 828072.1 and Streptomyces avermitilis xylanase (Accession No. NP_827548.1)); (Streptomyces avermitilis endo-l,4-beta- glucanase (Accession No. NP_823744.1) and Saccharophagus degradans 2-40 mannanase (Accession No. YP_525985.1)); (Streptomyces avermitilis endo-l,4-beta- glucanase celA2 (Accession No. NP_823030.1) and Saccharophagus degradans 2-40 mannanase (Accession No.
- the enzyme triplets acting synergistically include, but are not limited to (SEQ ID NO: 442, SEQ ID NO: 445 and SEQ ID NO: 446); (SEQ ID NO: 444, SEQ ID NO: 445 and SEQ ID NO: 446); or (SEQ ID NO: 442, SEQ ID NO: 445 and SEQ ID NO: 446).
- the enzyme combinations acting synergistically include, but are not limited to (SEQ ID NO: 442, SEQ ID NO: 444, SEQ ID NO: 445 and SEQ ID NO: 446); (SEQ ID NO: 443, SEQ ID NO: 444, SEQ ID NO: 445 and SEQ ID NO: 446).
- enzymatic synergy may be achieved by expressing 3, 4, 5,
- two or more enzymes acting synergistically with same enzymatic activity include, but are not limited to (SEQ ID NO: 444 and SEQ ID NO: 444); (SEQ ID NO: 445 and SEQ ID NO: 445).
- Anaerobic growth conditions require the production of endogenouse electron acceptors, such as the coenzyme nicotinamide adenine dinucleotide (NAD + ).
- NAD + coenzyme nicotinamide adenine dinucleotide
- the NAD + /NADH couple plays a vital role as a reservoir and carrier of reducing equivalents.
- Cellular glycerol production which generates an NAD + , serves as a redox valve to remove excess reducing power during anaerobic fermentation in yeast. Glycerol production is, however, an energetically wasteful process that expends ATP and results in the loss of a reduced three- carbon compound.
- GPD glycerol 3 -phosphate dehydrogenase
- GPP glycerol 3 -phosphatase
- GPD is encoded by two isogenes, gpdl and gpd2.
- GPD1 encodes the major isoform in anaerobically growing cells, while GPD2 is required for glycerol production in the absence of oxygen, which stimulates its expression.
- the first step in the conversion of dihydroxyacetone phosphate to glycerol by GPD is rate controlling. Guo, Z.P., et al, Metab. Eng. 73:49-59 (2011).
- GPP is also encoded by two isogenes, gppl and gpp2.
- Liden and Medina both deleted the gpdl and gpd2 genes and attempted to bypass glycerol formation using additional carbon sources.
- GPN NADP+-dependent glyceraldehydes-3 -phosphate dehydrogenase
- glycerol exporters such as FPS1
- FPS1 glycerol exporters
- FPS1 is a channel protein located in the plasma membrane that controls the accumulation and release of glycerol in yeast osmoregulation. Null mutants of this strain accumulate large amounts of intracellular glycerol, grow much slower than wild-type, and consume the sugar substrate at a slower rate. Tamas, M.J., et al, Mol. Microbiol. 31: 1087- 1004 (1999). Despite slower growth under anaerobic conditions, an fpslA strain can serve as an alternative to eliminating NAD + -dependant glycerol activity. An fpslA strain has reduced glycerol formation yet has a completely functional NAD + -dependant glycerol synthesis pathway.
- constitutively active mutants of FPS1 or homologs from other organisms can be used to regulate glycerol synthesis while keep the NAD + -dependant glycerol activity intact.
- the recombinant host cells can still synthesize and retain glycerol and achieve improved robustness relative to strains that are unable to make glycerol.
- one or more endogenous glycerol-producing or regulating genes are deleted to create yeast strains with altered glycerol production.
- one or more endogenous glycerol-producing genes are downregulated to create yeast strains with altered glycerol production.
- one or more endogenous glycerol-regulating genes are downregulated to create yeast strains with altered glycerol production.
- one or more endogenous glycerol-regulating genes are downregulated to create yeast strains with altered glycerol production.
- glycerol production in such yeast strains is downregulated in comparison with wild type yeast cell.
- PFL pyruvate formate lyase
- PFL is the primary enzyme responsible for the production of formate.
- PFL is a dimer of PflB that requires the activating enzyme PflAE, which is encoded by pflA, radical S-adenosylmethionine, and a single electron donor.
- PflAE pyruvate formate lyase
- PFL enzymes for use in the recombinant host cells of the invention can come from a bacterial or eukaryotic source.
- bacterial PFL include, but are not limited to, Bacillus licheniformis DSM13, Bacillus licheniformis ATCC 14580, Streptococcus thermophilus CNRZ1066, Streptococcus thermophilus LMG1831 1, Streptococcus thermophilus LMD-9, Lactobacillus plantarum WCFS1 (Gene Accession No. lp_2598), Lactobacillus plantarum WCFS1 (Gene Accession No. lp_3313), Lactobacillus plantarum JDMl (Gene Accession No.
- Lactobacillus plantarum JDMl (Gene Accession No. JDM1_2087), Lactobacillus casei bl23, Lactobacillus casei ATCC 334, Bifidobacterium adolescentis, Bifidobacterium longum NCC2705, Bifidobacterium longum DJO10A, Bifidobacterium animalis DSM 10140, Clostridium cellulolyticum, or Escherichia coli.
- Additional PFL enzymes may be from the PFL1 family, the RNR pfl superfamily, or the PFL2 superfamily.
- Examples of eukaryotic PFL include, but are not limited to, Chlamydomonas reinhardtii PflAl, Piromyces sp. E2, or Neocallimastix frontalis, Acetabularia acetabulum, Haematococcus pluvialis, Volvox carteri, Ostreococcus tauri, Ostreococcus lucimarinus, Micromonas pusilla, Micromonas sp., Porphyra haitanensis, and Cyanophora paradoxa), an opisthokont (Amoebidium parasiticum), an amoebozoan (Mastigamoeba balamuthi), a stramenopile (Thalassiosira pseudonana (2)) and a haptophyte (Prymnesium parvum), M, pusilla, Micromonas sp.
- Neocallimastix frontalis Acetabularia ace
- acetaldehyde dehydrogenase activity can positively affect the in vivo kinetics of the reaction providing for improved growth of the host strain.
- AADH acetaldehyde/alcohol dehydrogenase
- genes can be replaced or complimented with either an improved acetaldehyde dehydrogenase (e.g. , from C. phytofermentans or other source) to convert acetyl-CoA to acetaldehyde, or a bifunctional acetaldehyde/alcohol dehydrogenase (AADH) to convert acetyl-CoA to acetaldehyde and acetaldehyde to ethanol.
- an improved acetaldehyde dehydrogenase e.g. , from C. phytofermentans or other source
- AADH bifunctional acetaldehyde/alcohol dehydrogenase
- the bi-functional alcohol/aldehyde dehydrogenase can come from a variety of microbial sources, including but not limited to E. coli, C. Qcetobutylicum, T. saccharolyticum, C. thermocelhim, C. phytofermentans, Piro yces SP E2, or Bifidobacterium, adolescentis.
- glycerol deletion strains When glycerol deletion strains are grown anaerobically, they are not capable of growth or fermentation and cannot consume sugar during glycolysis. However, if these glycerol deletion strains are complemented with an AADH, the strains are able to grow with the supplementation of acetate in the media.
- AADH enzymes for use in the recombinant host cells of the invention can come from a bacterial or eukaryotic source.
- bacterial AADH include, but are not limited to, Clostridium phytofermentans, Escherichia coli, Bacillus coagulans, Bacillus lentus, Bacillus licheniformis, Bacillus pumilus, Bacillus subtilis y Bacieroides amylophilus, Bacieroides capillosus, Bacieroides ruminocola, Bacieroides suis, Bifidobacterium adolesceniis.
- Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium infant is, Bifidobacterium longurn, Bifidobacterium thermophilum, Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus huchneri (cattle only), Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus cellobiosus, Lactobacillus curvaius, Lactobacillus delbruekii, Lactobacillus farciminis (swine only), Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus lactis, Lactobacillus plantarum, Lactobacillus reuierii, Leuconostoc mesenteroides, Pediococcus acidilacticii, Pediococcus pentosaceus, Propionibacterium acidpropionici (
- Enterococcus cremoris Enterococcus cremoris
- Enterococcus diacetylactis Enterococcus faecium
- Enterococcus intermedins Enterococcus lactis
- Enterococcus thermophil.es Enterococcus thermophil.es.
- Xylose is a five-carbon monosaccharide that can be metabolized into useful products by a variety of organisms. There are two main pathways of xylose metabolism, each unique in the characteristic enzymes they utilize. One pathway is called the "Xylose Reductase-Xylitol Dehydrogenase" or XR-XDH pathway. Xylose reductase (XR) and xylitol dehydrogenase (XDH) are the two main enzymes used in this method of xylose degradation. XR, encoded by the XYL1 gene, is responsible for the reduction of xylose to xylitol and is aided by cofactors NADH or NADPH.
- Xylitol is then oxidized to xylulose by XDH, which is expressed through the XYL2 gene, and accomplished exclusively with the cofactor NAD " . Because of the varying cofactors needed in this pathway and the degree to which they are available for usage, an imbalance can result in an overproduction of xylitol byproduct and an inefficient production of desirable ethanol. Varying expression of the XR and XDH enzyme levels have been tested in the laboratory in the attempt to optimize the efficiency of the xylose metabolism pathway. [0334] The other pathway for xylose metabolism is called the "Xylose Isomerase" (XI) pathway.
- XI Xylose Isomerase
- Enzyme XI is responsible for direct conversion of xylose into xylulose, and does not proceed via a xylitol intermediate. Both pathways create xylulose, although the enzymes utilized are different. After production of xylulose both the XR-XDH and XI pathways proceed through the enzyme xylulokinase (XK), encoded on gene XKS1, to further modify xylulose into xylulose-5-phosphate where it then enters the pentose phosphate pathway for further catabolism.
- XK xylulokinase
- the recombinant microorganisms of the invention have the ability to metabolize xylose using one or more of the above enzymes.
- Arabinose is a five-carbon monosaccharide that can be metabolized into useful products by a variety of organisms. L-Arabinose residues are found widely distributed among many heteropolysaccharides of different plant tissues, such as arabinans, arabinogalactans, xylans and arabinoxylans. Bacillus species in the soil participate in the early stages of plant material decomposition, and B. subtilis secretes three enzymes, an endo-arabanase and two arabinosidases, capable of releasing arabinosyl oligomers and L- arabinose from plant cell.
- L-arabinose is converted to L-2-keto-3-deoxyarabonate (L-KDA) by the consecutive action of enzymes arabinose dehydrogenase (ADH), arabinolactone (AL), and arabinonate dehydratase (AraC).
- ADH arabinose dehydrogenase
- AL arabinolactone
- AraC arabinonate dehydratase
- L-KDA can be further metabolized in two alternative pathways: 1) L-KDA conversion to 2- ketoglutarate via 2-ketoglutaric semialdehyde (KGSA) by L-KDA dehydratase and KGSA dehydrogenase or 2) L-KDA conversion to pyruvate and glycolaldehyde by L- KDA aldolase.
- KGSA 2-ketoglutaric semialdehyde
- KGSA dehydrogenase L-KDA conversion to pyruvate and glycolaldehyde by L- KDA aldolase.
- L-arabinose is converted to D-xylulose-5- phosphate through L-arabinitol, L-xylulose, and xylitol, by enzymes such as NAD(P)H- dependent aldose reductase (AR), L-arabinitol 4-dehydrogenase (ALDH), L-xylulose reductase (LXR), xylitol dehydrogenase (XylD), and xylulokinase (XylB).
- AR NAD(P)H- dependent aldose reductase
- ALDH L-arabinitol 4-dehydrogenase
- LXR L-xylulose reductase
- XylD xylitol dehydrogenase
- XylB xylulokinase
- AraC protein regulates expression of its own synthesis and the other genes of the
- AraC Ara system. See Schleif, R., Trends Genet. 7 (12):559-65 (2000).
- the AraC protein positively and negatively regulates expression of the proteins required for the uptake and catabolism of the sugar L-arabinose.
- Homologs of AraC such as regulatory proteins RhaR and RhaS of the rhamnose operon, have been identified that contain regions homologous to the DNA-binding domain of AraC (Leal, T.F. and de Sa- Nogueira, I., FEMS Microbiol Lett. 247(l):41-48 (2004)).
- Such arabinose regulatory proteins are referred to as the AraC/XylS family.
- the recombinant microorganisms of the invention have the ability to metabolize arabinose using one or Tnore of the above enzymes.
- Example 2 Characterizing the expression and activity of auxiliary eeiiiiiases
- strains expressing the fungal EGl candidates were grown in 50 mL shake flask cultures with 100 ug/mL zeocin and tested for activity on CMC and avicel.
- Figure 3 demonstrates that several active EGls were found and that several were superior in activity to the comparable enzyme previously used ⁇ Trichoderma reesei EGl, Ml 276). From these data, the top 6 candidates were selected based on activity on avicel for further testing on PHW ( Figures 4 and 5).
- the PHW assay was carried out with a pretreated wood substrate (MS 149), both in the presence and absence of yeast made, purified CBH1 and CBH2 (2 mg/g of each), and Novozyme 188 BGL. 2mL of supernatant was used from each EGl expressing strain in the assay. A strain expressing TrEG2 from the same plasmid was again used as a control. The results from these assays can be found in Figures 4 and 5. Several EGls showed the ability to act with CBH1 and CBH2 to increase hydrolysis, although not to the level that TrEG2 is capable of.
- the plasmids were all transformed to S. cerevisiae M0509 (an industrially hearty strain expressing xylose isomerase) using YPD containing 250 ⁇ g/ml zeocin as selective medium and transformants were confirmed with PCR.
- the reference strain containing pMU1531
- a strain expressing the T, reesei eg2 pRDH180
- the eg2/eg3 expressing strains were tested for activity on avicel and CMC.
- the strains were grown in YPD or double strength SC medium (3.4 g/L YNB; 3 g/L amino acid pool; 10 g/L ammonium sulfate; 20 g/L glucose) that was buffered to pH 6 (20 g/L succinic acid; 12 g/L NaOH, set pH to 6 with NaOH).
- Glucose was added after autoclaving of the other components from a 50% glucose stock solution.
- Zeocin was added to a final concentration of 100 g/ml for liquid cultures. 10 mL cultures in 125 mL erlenmeyer flasks were grown at 30°C for three days (YPD) or four days (SC).
- chrysosporium eg3 gene products The . reesei, N. fischeri and C. brasiliense egS gene products were visible as 30, 25 and 35 kDa bands, respectively. Again, the extra weight may represent hyperglycosylation. However, the N. fischeri Eg3 was found to be at or very near to its predicted size - this protein contains no putative N-glycosylation sites.
- fischeri eg3 expressing strain (166) consistently yielded larger clearing zones than the other EGs on the plate assays. Due to the smaller size of this protein ( Figure 6B) and apparent lack of glycosylation this enzyme may have superior diffusion qualities in this media.
- Strain M0509 was also transformed with 2um plasmids containing EG4s, EG5s,
- EG6s and xyloglucanases (GH74/XG). These strains were then spotted on YNB plates with CMC, grown overnight at 30 degrees and stained with Congo red to check for activity of the cloned gene (Data for some of the strains shown in Figure 9).
- the EG4 genes showed only weak activity on CMC, while both EG5 candidates showed large clearing zones, and all EG6s showed intermediate clearing zone size.
- the XG candidates all showed very small clearing zones on CMC. All enzyme types gave functional candidates.
- the candidates were also tested for activity in the PHW assay in the presence of other enzymes.
- Purified, yeast made CBH1, CBH2, EG2, and BGL were used as partners for the assay loaded at a 4mg enzyme protein per gram of solids, and a 40%:40%: 15%:5% (by mass) mixture (Figure 10).
- M0509 supernatant (negative) or Ml 179 supernatant (positive control strain expressing CBH1, CBH2, EG2, and BGL) were used.
- Xylanases and xylosidases were examined for expression in yeast in order to broaden the enzymatic activity spectrum of the yeast made lignocellulolytic system.
- Xylanases were selected from the public databases and their functional expression in yeast was tested on substituted xylans.
- Xylosidases were selected based on homology to A. niger xlnD (a GH family 3 enzyme) and to include xylosidases from GH family 43.
- Table 5 (condensed version of Table 4) indicates the genes chosen for synthesis as well as the designation of the expression vector. All the genes were cloned under control of the ENOl promoter/terminator using the pMU1531 expression plasmid. The plasmids were all transformed to S. cerevisiae M0509 and transformants were confirmed with PCR.
- a large smear at > 90 kDa may represent heterogeneously glycosylated forms of the A. niger XLND xylosidase.
- the Cochliobolus carbonum, Penicillium herquei, and Pyrenophora tritici-repentis xylosidases are present as 45, 50 and 55 kDa bands (slightly smeared), larger than the predicted -37 kDa also indicating likely hyperglycosylation.
- Xylosidase assays were performed in the same manner as for ⁇ -glucosidase assays (see above protocol) but with pNPX as substrate at pH5, 35°C for 2-5 minutes depending on the activity. Activity data from strains grown on YPD and SC can be seen in Figure 14.
- T.r.xyn2 (pRDH182) produced the highest levels of secreted xylanase activity. It was surprising that the strain containing a codon optimized version of this gene (sequence verified) displayed no secreted activity.
- the GH family 11 xylanase encoded by Chaetomium thermophilum xynllA did give notable activity, however, far less than that generated by the strain expressing native T.r.xyn2.
- the strain expressing Aureobasidium pullulans xynlO (GH family 10) also yielded appreciable activity. This is particularly encouraging as it is known that family 10 xylanases often have only 10% of the specific activity of GH family 11 enzymes.
- family 10 xylanases are less restricted in their action by side chain substitutions on the xylan backbone.
- the GH family 43 xylosidases encoded by the genes from Cochliobolus carbonum and Pyrenophora tritici-repentis gave substantial xylanase activity.
- These enzymes are also classed as "exo-xylanases” and it will be very interesting to see how they interact with other xylan degrading enzymes.
- the strains producing these two enzymes also displayed far greater xylosidase activity on pNPX than the strain expressing native A.n.xlnD.
- the strain expressing native A.n.xlnD secreted only about 36% of the total xylanase activity it produced when grown in YPD whereas 76% and 99% of the C. carbonum and P. tritici-repentis heterologous xylosidases were secreted.
- the secreted xylosidase activities of the strains producing C. carbonum and P. tritici-repentis xylosidases in YPD were respectively 3.3 and 6.9 fold higher than the secreted activity of the strain expressing native A.n.xlnD.
- arabinofuranosidase activity and esterase activity were carried out to assess whether any of the accessory enzymes were functional.
- the arabinofuranosidase assay was carried out as follows: Substrate (ImM 4-nitrophenyl-L-arabinofuranoside (Sigma #N-3641)) was made up in 50mM citrate buffer pH 5.4 and preheated to 35C. 20ul of yeast supernatant plus 180ul of substrate was added to 96 well plate, and incubated at 35 degrees for 30 minutes. The reaction was stopped by adding lOOul of 1M Na 2 C0 3 and an OD measurement was taken at 405nM.
- Figures 17 and 18 show the results for the assays that were carried out. Only the
- PHW assays were set up to screen several accessory components and assess their impact in the presence of other yeast made enzymes.
- Figure 19 shows the results of the first screen, which demonstrate that both the Neosartorya fischeri and the Trichoderma reesei AXE genes expressed in M0544 yield increased xylan and glucan hydrolysis from unwashed pretreated hardwood substrate (MS630). In fact, without the AXEs present, there is no measurable release of xylose from this substrate using the yeast made xylanase and xylosidase.
- MS630 (a pretreated hardwood substrate).
- zoomerase (1 mg/g) the accessories are having only a small impact on hydrolysis glucan in MS630 at the loadings tested.
- xylan hydrolysis is substantially increased by the presence either the N.f. AXE (acetylxylanesterase) or the T.r. AXE, with the best combinations yielding -90% conversion.
- these enzymes increased the hydrolysis of both glucan and xylan.
- Figure 21 demonstrates that BC 60 displayed significant xylanase activity, and also, the strains containing a fungal GH10 xylanase from A. pullulans (Ml 379), and two GH7 EGl 's from Aspergillus fumigatus (Ml 311) and Trichoderma longibrachiatum (Ml 317) did have activity on birchwood xylan, although it was less than BC60 and T, reesei xyn2 (Con5).
- Table 7 gives the full list of the bacterial genes screened for expression in yeast.
- Bacillus subtilis synergy with expansin exlX CABi 3755.l Bacillus subtilis synergy with expansin exlX CABi 3755.l
- Example 7 Screening bacterial endoglucanases for expression/activity m yeast
- CMC Figure 22. Fifty seven yeast, strains expressing bacterial endoglucanases were screened. For each enzyme two different transformation clones were assayed. The strains were patched on YPD+Zeo plates (Zeo 250mg/L) for 2 days and inoculated in 600 uL YPD in 96 well plates. The strains were grown for 3 days at 35C at 900 rpm, and the CMC assay (see above) was performed on the supernatants. NegCont is M0749 transformed with empty expression vector pMU1575. TrEG2 in pMU1575 was used as positive control construct.
- Figure 22 demonstrates that 15 bacterial enzymes (26%) displayed secreted activity on CMC.
- Bacillus subtilis EglS and Clostridium cellulolyticum Cel5A had secreted activity on CMC similar to the well expressed control, which was T. reesei EG2.
- the enzymes that demonstrated activity on CMC are listed in the Table 8 below. All genes except BC77, BC80 and BC81 are not codon optimized for yeast; therefore the expression level of the best genes could be increased further by codon optimization.
- Example 8 Synergy of bacterial endoglucanases with yeast made CBHs on PHW
- the PHW assay was performed with several yeast made bacterial EGs selected by screening on CMC in the presence of yeast made purified CBHl and CBH2 ( Figure 23). The assay was also supplemented with Novozyme-188 BGL.
- Figure 23 demonstrates that almost all tested bacterial EGs significantly increase glucose release from PHW. Additive effect of bacterial EGs was similar or higher compared to the positive control— Trichoderma reesei EG2. Thermobifida fusca celE was particularly successful among the EGs.
- Example 9 Characterizing bacterial xylanases for expression/activity in yeast
- Figure 25 demonstrates that 8 bacterial enzymes (32%) had secreted activity on xylan.
- Several xylanases including Clostridium phytofermentans Cphyl510 (GHF10) and Thermobifida fusca xyll 1 had secreted activity on xylan similar to or higher than T reesei Xyn2.
- the enzymes that demonstrated activity on xylan are listed in Table 9 below.
- Example 10 Synergy of bacterial xylanases with yeast made CBHs and EG
- a PHW assay was performed with several yeast made bacterial xylanases previously selected by screening on xylan in the presence of yeast made purified CBH1, CBH2, TrEG2, and yeast made GH43 xylosidase (from Pyrenophora tritici-repentis) (Figure 26).
- Trichoderma reesei Xyn2 was used as the positive control, and a strain expressing an empty vector served as a negative control.
- the assay was also supplemented with AB BGL.
- Figure 25 demonstrates that some bacterial xylanases significantly increase glucose release from PHW, especially when external enzyme is not present.
- these xylanases help release glucose. It is possible that some xylanases also possess endoglucanase or other hydrolase activity, and thus hydrolyze cellulose directly. Additionally, it is possible that digestion of xylan in the PHW may make the cellulose more accessible for the cellulases present in the reaction. Increased release of xylose was not measured in the reaction, likely due to the lack of appropriate complementary activities (xylosidase and/or acetylxylanesterase).
- Example 11 Cloning and screening Thermoanaerobacter saccharolyticum xylanases
- T. saccharolyticum xylanases were cloned from genomic DNA and fused to the
- Enol promoter for expression in S. cerevisiae A total of 12 xylanase-related genes were cloned into the pMU1575 backbone (Table 4). The strains were screened for both xylanase and xylosidase activities using the birchwood xylanase assay and the pNPX xylosidase assay, respectively ( Figure 26). Ml 594 was the only strain that demonstrated significant xylanase activity. No xylosidase activity was detected from these strains. Table 10. Descri tion of T, saccharolyticum xylanases cloned and expressed in yeast.
- Example 12 Screening of bacterial genes with mannanase activity
- Xylanases that demonstrated activity by this plate assay matched the ones that were active in previously applied birchwood xylan assay (see above).
- Three functionally secreted yeast made bacterial mannanases (BC68, BC69, and BC70 from C. phytofermentens) were discovered by the mannanase plate assay.
- Bacterial accessory enzymes expressed by yeast were also screened for synergy with yeast made enzymes (CBH1, CBH2, EG2, BGL, xylanase, xylosidase) by PHW assay without any external enzymes added (Figure 28).
- yeast made enzymes CBH1, CBH2, EG2, BGL, xylanase, xylosidase
- Figure 28 One enzyme - Clostridium phytofermentans mannosidase (Cphy_2276, GH26, BC70), has a noticeable effect on glucose release from PHW. None of the enzymes had significant effect on xylose release. It is possible that other activities may be needed in a system in order to notice the effect of some accessory enzymes.
- Table 1 Summar of functional, "best in class” components expressed in yeast.
- Example 13 Combinations of components to enhance hydrolysis: Effect of different EG combinations (pair wise combinations) on PHW conversion by yeast made CBHs in the presence of external enzymes (EE)
- PHW assays were used to analyze EG combinations with the goal of determining synergistic relationships. If the EGs had similar functions, then combinations of the EGs should be no better than a single EG (either) loaded at twice the concentration. However, if the EGs were synergistic, then combinations should yield greater hydrolysis than a 2X concentration of either enzyme.
- a PHW assay was performed with the supernatants of yeast strains expressing individual EGs (Table 4 ) combined in pairs (lml+lml) in all possible combinations.
- the EG expressing strains were patched on YPD+Zeo plates for 1 day (except Ml 023 that was patched on SD-URA), inoculated in YPD in shake flasks and grown for 72 hours.
- the strain expressing an empty vector was used as negative control (2ml, NC).
- the strains expressing single EGs (2ml or lml+lmlNC) were used as positive controls.
- NC All samples including NC were supplemented withlmg/g CBH1, lmg/g CBH2, and lmg/g AB BGL ( Figure 29) or lmg/g CBH1, lmg/gCBH2, 0.2mg/g BGL, and lmg/g Zoomerase ( Figure 29).
- EG combinations have a definite advantage in PHW cellulose conversion compared to single EGs.
- Gray numbers denote activity - increase in glucose release compared to
- NegCont CBHs+EE
- g/1 EG couple activity minus NC
- Example 14 Testing of higher EG combinations for Enhanced PHW activity
- Figure 30 demonstrates that yeast cellulytic system, when used with EE, does benefit from more complex EG compositions. Based on 48 hrs data two best EG triplets were selected for further experiments: GH9+GH5+GH12 and GH9+GH5+GH7. [0399] The best triplets were combined with each of the remaining EGs and the PHW assay was repeated again at two different concentrations of EE (Figure 31). Figure 31 demonstrates that:
- EG combinations have a definite advantage in PHW glycan conversion compared to single EGs.
- the best EG combos include: Cel9A(GH9), EG3(GH12), EG1(GH7) and EG2(GH5).
- Figure 32 demonstrates that the four EG combination has a definite advantage over the best single EGs at the same volume. Also, Figure 32 demonstrates that the best EG combination provides increase in PHW conversion equivalent to 2mg/g EE.
- Example 15 Expression of a "complete" system of enzymatic components to digest Mgnoce! lose
- CEN refers to centromeric, and CEN elements allow high fidelity dispersion of genetic elements into mother and daughter cells during cell division.
- YACs Yeast artificial chromosomes
- Krzywinski M Wallis J, Gosele C, et al., "Integrated and sequence-ordered BAC- and YAC-based physical maps for the rat genome," Genome Res. 2004 Apr;14(4):766- 79). They are able to maintain up to 3 megabases of DNA.
- YACs have been developed whose copy number can be amplified (Smith DR, Smyth AP, Moir DT., "Amplification of large artificial chromosomes,” Proc Natl Acad Sci U S A. 1990 Nov;87(21):8242-6). This is based on disrupting CEN function, and selecting for cells with asymmetric segregation of the YAC.
- CEN constructs for expression of multiple genes in multiple copies.
- These vectors were constructed with one of two markers (hph or zeocin marker), with the ARS1 origin of replication from S. cerevisiae, with a disruptable centromere (CEN 4), and with a 2 micron element present. This disruptable element was made by placing the inducible Gall promoter upstream of the centromere. During growth on galactose, the plasmid becomes unstable.
- Figure 33 demonstrates the ability to assemble four endoglucanases simultaneously into a single vector (EGl from A. fumigatus under the control of the ENOl promoter/PY terminator, EG4 from C. globosum under the control of the FBA promoter/PGI terminator, EG5 from C. lucknowense under control of the GPMl promoter and TPI terminator, and EG6 from C. globosum under control of the EN02 promoter and TDH3 terminator).
- Each cassette for expression was amplified by PCR with overlapping sequences that could recombine to form the final vector shown (actual vector is circular, not linear).
- Several colonies picked from this transformation all had activity on CMC, indicating that the EGs were functionally expressed.
- the construct (pMU1943) was verified by carrying out PCR across all of the junctions of the individual pieces that were assembled.
- the yeast strain containing this cassette was called Ml 509.
- CEN vectors were also built that had either 7 genes or 1 1 genes via yeast mediated ligation. Schematics for these two vectors are shown in Figure 34. These vectors were tested to verify the presence of the inserts via PCR. The two vectors below demonstrate that vectors as large as 23 kB and 35 kB, respectively can be generated in this manner.
- Example 17 Amplification of CEN vectors for multicopy expression
- Ml 553 is a strain containing a CEN vector with the zeocin resistance cassette and four endoglucanases EG1, EG4, EG5 and EG6. This strain was tested for antibiotic resistance and EG activity. Initially Ml 553 could grow up to a zeocin concentration of 50 ⁇ g/ml in YPD plates, and this strain passaged in YPG (galactose) and zeocin at 50 ⁇ g/ ml showed colonies when plated on YPD plates with zeocin at 100 ⁇ g/ m.
- Figure 37 shows a comparison of the average performance of the top 3 colonies from each of these plates at the different dilutions. Colonies from the 100 ug/mL zeocin plate perform better than the zeocin 50 ug/mL colonies indicating that amplification of the CEN vector has occurred. Depending on the dilution analyzed (the CMC assay appears to be at saturation in some dilutions), a 1.5 to 2X difference in CMCase activity can be observed between the two sets of top colonies.
- Example 18 Activity of a CEN vector with multiple EGs on PHW
- the genes were either synthesized (Gene Art or DNA2.0) or PCR amplified. Synthetic genes were either native DNA sequences or codon optimized for S. cerevisiae. When PCR was used to obtain genes, either genomic DNA or cDNA was used as template. The genes used are described in the Tables 15, 16, or Table 7. The sequences of the important genes used for construction of CBP strains are listed in Table 19. The genes were expressed under ENOl promoter and terminator from 2 -micron plasmid pMU1575 ( Figure 41). The genes were inserted between Pacl/Ascl sites of pMU1575 either by cloning or yeast mediated ligation. Yeast and fungal genes were expressed with their native signal sequences.
- Bacterial genes (such as AE49) were attached to S. cerevisiae Invertase signal sequence. Expression constructs were transformed into an industrial background strain Ml 744, M509, or MO 139 and selected on minimal URA deficient media. Transformants were grown in YPD for 3 days and supernatants were analyzed for activity. Data for the most active alpha-amylases (AA), glucoamylases (GA) and alpha-glucosidases (AGL) screened by starch-DNS, starch-GHK, maltose and Corn mash assays are summarized in Table 17. The example of screening of several enzymes for functional expression in yeast demonstrated on Figure 42. Secreted activity of strains expressing synthetic genes was measured by Starch-DNS, Starch-GHK, and Maltose assays. Figure 42 demonstrates that different enzymes have different activity on different substrates revealing different mechanisms of action.
- AA alpha-amylases
- GA glucoamylase
- Bacteria Bacillus subtilis Maltogenic alpha-amylase AAF23874.1 j is : Bacteria Bacillus subtilis Isomaltase? BAA23408.1 j I AE# Organism Source Enzyme Protein ID
- thermophilum Type I Bacteria Anaerocellum Alpha-amylase/pullulanase ACM59580 ] thermophilum Type II
- Table 17 Activity screening summary for yeast made alpha-amylases (AA), glucoamylases (GA), and alpha-glucosidases (AGL). Amount of pluses reflects relative activity level. NT - not tested. CO - codon optimized. Strains express individual enzymes on 2u vector pMU1575 in M0509 or M0139 background strains.
- Example 20 Screening of amylolytic and accessory enzymes for synergy with AE8
- hydrolytic enzymes were selected for the best conversion of particular substrates such as corn mash. This was achieved due to screening of over one hundred enzymes for functional expression in yeast, synergy with each other, and performance in industrially relevant bioprocess conditions. Particular combinations include: AE9; AE9+AE8; AE9+AE1 ; AE9+AE7; AE9+AE10; AE9+AE8+AE10; AE9+AE7+AE10; AE9+AE7+AE8+AE10; AE1+AE8+AE9+AE10; and all other combinations of AE1, AE7, AE8, AE9, and AE10 (see Tables 16 and 19).
- hydrolytic enzymes that demonstrated high glucose release from substrates such as pretreated corn fiber and corn syrup (concentrated liquid fraction left after corn mash fermentation) include: "core” cellulases, xylanase, xylosidase, glucoamylase (AE9), alpha-amylase (AE7), isopullulanase (SE35), alpha- glucosidase (AE10), acetylxylan esterase (T.reesei AXE), and pectinase.
- core cellulases
- xylanase xylosidase
- AE7 alpha-amylase
- SE35 isopullulanase
- AE10 alpha- glucosidase
- T.reesei AXE acetylxylan esterase
- pectinase pectinase
- FIG. 43-45 demonstrate examples of screening enzymes in combination.
- Several amylolytic enzymes were screened for synergy with AE8 by Starch-DNS, Corn Mash and Fiber assays.
- Supernatants of strains grown for 3 days in YPD were mixed with supernatant with AE8 at 50:50 ratio.
- AE8 supernatant was 100%.
- Supernatant of M0509 host strain was used as negative control.
- Figure 43 shows that several AAs and SE1 1 glucoamylases had positive effect on glucose release when added to AE8 compared to when additional AE8 added.
- AE7 alpha-amylase had particularly strong effect.
- Figure 44 shows that on corn mash SE14 alpha-glucosidase had positive effect on glucose release when combined with AE8.
- the directed integration approach creates transgenic strains with integration events that are easier to characterize. Any mistargeting events can be easily identified with a Southern blot. Additionally, strains engineered by directed approach are potentially more stable since each expression cassette at the chromosome is integrated into a unique site (not tested). URA3 and FCY1 negative selection approaches were both developed. FCY1 was eventually chosen as the marker of choice since fey mutation did not effect robustness of the strains. Using this technology, many clean strains were built in the industrial strain background.
- Figure 49 demonstrates how glucoamylase expression cassettes were integrated into FCYl locus. In this case, counter selection for the FCY1 knock out also selects for integration of the glucoamylase expression cassette.
- the glucoamylase genes are under control of a strong promoter from various central metabolism genes.
- the expression cassettes containing the same sequences are oriented toward each other to decrease the chance of spontaneous recombination.
- the glucoamylase expression cassettes were transformed into industrial strain M0139 as PCR products with homologous ends targeting the upstream and downstream regions of the FCY locus. Since removal of both copies of FCY is necessary for resistance to 5-fluorocytosine (5-FC), each expression cassette was found to be integrated on both chromosomes.
- a 2- ⁇ plasmid which contains a cassette to expresses the Hygromycin restisatnce gene marker (Hyg), was co- transforrned with the PCR products.
- the transformants were first cultivated in liquid YPD+Hyg (300ug/ml) media overnight and then plated on media containing 5- fluorocytosine. Precultivation on media with antibiotic increases efficiency of double FCY1 knock-out. This approach was also utilized with other negative selection markers such as URA3. Genetic manipulations at the FCY locus result in strains that are marker free and can be easily modified by recycling the FCY marker. For instance, additional copies of AE8 and AE9 could be placed at other loci.
- Figure 50 demonstrates how more glucoamylase copies could be integrated into another site such as an Adenine-phosphoribosyltransferase 2 (APT2) locus.
- APT2 Adenine-phosphoribosyltransferase 2
- four additional GA expression cassettes are amplified by PCR with homologous tails for each other and a region upstream and down stream of the APT2 locus.
- Dominant markers (Nat and Kan) and the FCY1 marker were integrated into APT2 locus into industrial strain Ml 973 (already expressing 4 GA copies, Figure 49) as PCR products with overlapping ends together with 4 additional GAs.
- the transformants were plated on YPD+Nat+Kan plates that allow growth of cells that have both dominant markers integrated on the chromosome.
- Transformants were screened for the high amylolytic activity by Starch-DNS assay.
- the strain demonstrating the highest activity was chosen and the Kan and Nat markers were removed by transformation of two PCR products that have homologous ends for each other, the APT2 upstream flanking region and the 5'- part of AE9 expression cassette.
- the transformants were plated on 5- fluorocytosine containing media that selects for strains that have lost FCY1.
- expression cassettes can be integrated into any yeast site as long is the event does not perturb an essential function.
- the strains with the highest, activity on starch were evaluated farther by corn mash fermentation in bioreactors.
- Example 23 Evaluation of amylolytic strains by cor mash fermentation
- PAYTCPYQNYIPGVSN tcaaactatgatgaccaagctcaggttcaaag
- PTLLTNFVENHDNERFA cagttttcaattcttggg taagattttgttggca
- GDGiPViYYGQEQGLS aaacatgtggaccaaggcttttcccggaitttg
- IVTNHYAWNGAGSSVA ctgatgatactggttatggttatgcitaccacgg
- AE9 Gene was codon MIRLTVFLTAVFAAVAS atgatcagattgaccgttttcttgaccgctgttttt optimized for CVPVELDKRNTGHFQA gctgctgttgcttcttgtgttccagttgaattggat S erevisiae and YSGYTVARSNFTQWIH aagagaaacaccggtcatttccaagcttattct synthetized by EQPAVSWYYLLQNIDY ggttataccgttgctagatctaacttcacccaat GeneArt PEGQFKSAKPGVWAS ggattcatgaacaaccagctgtttcttggtacta (PubMed#CAC83969.
- QRVSNPSGNFDSPNHD aatggactagagataccgctattaccttcttgtc
- AVGRYPEDVYNGVGTS aaggctttgtcttacggtattccattgtctaagac
- N RYTGFQAGAVSLTWS cattcaatgttgataactcctacgttttgaactcc
- GNPLVFSNQFIQFNTSL cgataacgttttcattttgccagaatccttggttg
- GYHQCRWGYDTIEELD gaaatgaaccaggtatcgtcaaaaccttgtac
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2801577A CA2801577A1 (en) | 2010-06-03 | 2011-06-03 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
CN2011800357812A CN103124783A (en) | 2010-06-03 | 2011-06-03 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US13/701,652 US20130323822A1 (en) | 2010-06-03 | 2011-06-03 | Yeast Expressing Saccharolytic Enzymes for Consolidated Bioprocessing Using Starch and Cellulose |
EP11790526.5A EP2576762A4 (en) | 2010-06-03 | 2011-06-03 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
BR112012031362A BR112012031362A2 (en) | 2010-06-03 | 2011-06-03 | yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US14/178,653 US9206444B2 (en) | 2010-06-03 | 2014-02-12 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US14/936,840 US10294484B2 (en) | 2010-06-03 | 2015-11-10 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US15/584,473 US10385345B2 (en) | 2010-06-03 | 2017-05-02 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US16/426,563 US11193130B2 (en) | 2010-06-03 | 2019-05-30 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US17/500,501 US20230028975A1 (en) | 2010-06-03 | 2021-10-13 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35116510P | 2010-06-03 | 2010-06-03 | |
US61/351,165 | 2010-06-03 | ||
US42014210P | 2010-12-06 | 2010-12-06 | |
US61/420,142 | 2010-12-06 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/701,652 A-371-Of-International US20130323822A1 (en) | 2010-06-03 | 2011-06-03 | Yeast Expressing Saccharolytic Enzymes for Consolidated Bioprocessing Using Starch and Cellulose |
US14/178,653 Continuation US9206444B2 (en) | 2010-06-03 | 2014-02-12 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011153516A2 true WO2011153516A2 (en) | 2011-12-08 |
WO2011153516A3 WO2011153516A3 (en) | 2012-03-29 |
Family
ID=45067335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/039192 WO2011153516A2 (en) | 2010-06-03 | 2011-06-03 | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
Country Status (6)
Country | Link |
---|---|
US (6) | US20130323822A1 (en) |
EP (2) | EP2576762A4 (en) |
CN (1) | CN103124783A (en) |
BR (1) | BR112012031362A2 (en) |
CA (2) | CA2801577A1 (en) |
WO (1) | WO2011153516A2 (en) |
Cited By (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012103322A1 (en) * | 2011-01-26 | 2012-08-02 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2013028701A1 (en) * | 2011-08-22 | 2013-02-28 | Codexis, Inc. | Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity |
WO2012134626A3 (en) * | 2011-01-31 | 2013-03-21 | Novozymes North America, Inc. | Processes for enzymatic refining of pretreated cellulosic material for saccharification |
WO2013063460A2 (en) | 2011-10-28 | 2013-05-02 | Danisco Us Inc. | Variant maltohexaose-forming alpha-amylase variants |
WO2013081456A3 (en) * | 2011-11-30 | 2013-08-15 | Dsm Ip Assets B.V. | Yeast strains engineered to produce ethanol from acetic acid and glycerol |
EP2660319A1 (en) * | 2012-05-02 | 2013-11-06 | Clariant Produkte (Deutschland) GmbH | Endoglucanases with improved properties |
WO2013169645A1 (en) | 2012-05-11 | 2013-11-14 | Danisco Us Inc. | Use of alpha-amylase from aspergillus clavatus for saccharification |
WO2013175074A1 (en) * | 2012-05-24 | 2013-11-28 | Roal Oy | Improved endoglucanases for treatment of cellulosic material |
WO2013182671A1 (en) * | 2012-06-08 | 2013-12-12 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of aureobasidium pullulans and uses thereof |
WO2013184577A1 (en) | 2012-06-08 | 2013-12-12 | Danisco Us Inc. | Alpha-amylase variants derived from the alpha amylase of cytophaga sp.amylase|(cspamy2). |
WO2013160247A3 (en) * | 2012-04-23 | 2013-12-19 | Novozymes A/S | Polypeptides having glucuronyl esterase activity and polynucleotides encoding same |
CN103562384A (en) * | 2011-01-26 | 2014-02-05 | 诺维信公司 | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2014028434A2 (en) | 2012-08-16 | 2014-02-20 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus clavatus and pullulanase for saccharification |
WO2014035458A1 (en) | 2012-08-29 | 2014-03-06 | Mascoma Corporation | Expression of enzymes in yeast for lignocellulose derived oligomer cbp |
US8669076B1 (en) | 2013-03-11 | 2014-03-11 | E I Du Pont De Nemours And Company | Cow rumen xylose isomerases active in yeast cells |
WO2014043288A1 (en) | 2012-09-12 | 2014-03-20 | Butamax Advanced Biofuels Llc | Processes and systems for the production of fermentation products |
WO2014059273A1 (en) | 2012-10-11 | 2014-04-17 | Butamax Advanced Biofuels Llc | Processes and systems for the production of fermentation products |
WO2014064331A1 (en) * | 2012-10-26 | 2014-05-01 | Roal Oy | Novel esterases in the treatment of cellulosic and lignocellulosic material |
WO2014092960A1 (en) | 2012-12-11 | 2014-06-19 | Danisco Us Inc. | Trichoderma reesei host cells expressing a glucoamylase from aspergillus fumigatus and methods of use thereof |
WO2014093125A1 (en) | 2012-12-14 | 2014-06-19 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus fumigatus and isoamylase for saccharification |
WO2014099525A1 (en) | 2012-12-21 | 2014-06-26 | Danisco Us Inc. | Paenibacillus curdlanolyticus amylase, and methods of use, thereof |
WO2014099523A1 (en) | 2012-12-21 | 2014-06-26 | Danisco Us Inc. | Alpha-amylase variants |
WO2014099415A1 (en) | 2012-12-20 | 2014-06-26 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus terreus and pullulanase for saccharification |
WO2014098939A1 (en) | 2012-12-20 | 2014-06-26 | E. I. Du Pont De Nemours And Company | Expression of xylose isomerase activity in yeast |
US8771993B1 (en) * | 2013-02-12 | 2014-07-08 | Novozymes A/S | Polypeptides having endoglucanse activity and polynucleotides encoding same |
US8778639B1 (en) * | 2013-02-12 | 2014-07-15 | Novozymes Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US8802423B2 (en) * | 2010-12-30 | 2014-08-12 | Novozymes A/S | Method for treating textile with endoglucanase |
WO2014151447A1 (en) | 2013-03-15 | 2014-09-25 | Butamax Advanced Biofuels Llc | Processes and systems for the production of fermentative alcohols |
WO2014151805A2 (en) | 2013-03-15 | 2014-09-25 | Mascoma Corporation | Expression of beta-glucosidases for hydrolysis of lignocellulose and associated oligomers |
WO2014164410A1 (en) | 2013-03-11 | 2014-10-09 | E. I. Du Pont De Nemours And Company | Bacterial xylose isomerases active in yeast cells |
WO2014164777A1 (en) | 2013-03-11 | 2014-10-09 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2014200658A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from promicromonospora vindobonensis |
WO2014200657A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces xiamenensis |
WO2014200656A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces umbrinus |
WO2014202621A1 (en) * | 2013-06-20 | 2014-12-24 | Dsm Ip Assets B.V. | Carbohydrate degrading polypeptide and uses thereof |
WO2014204596A1 (en) | 2013-06-17 | 2014-12-24 | Danisco Us Inc. | Alpha-amylase from bacillaceae family member |
US8956851B2 (en) | 2011-04-05 | 2015-02-17 | Lallemand Hungary Liquidity Management, LLC | Methods for the improvement of product yield and production in a microorganism through the addition of alternate electron acceptors |
WO2015023989A1 (en) * | 2013-08-15 | 2015-02-19 | Lallemand Hungary Liquidity Management Llc | Methods for the improvement of product yield and production in a microorganism through glycerol recycling |
WO2015031477A1 (en) | 2013-08-30 | 2015-03-05 | Novozymes A/S | Enzyme composition and uses thereof |
US8975058B2 (en) | 2012-05-24 | 2015-03-10 | Roal Oy | Endoglucanases for treatment of cellulosic material |
WO2015006843A3 (en) * | 2013-07-15 | 2015-04-02 | Centro Nacional De Pesquisa Em Energia E Materiais - Cnpem | Bifunctional enzyme used to degrade biomass and produce xylose in a single operation |
WO2015050724A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
WO2015065978A1 (en) | 2013-10-28 | 2015-05-07 | Danisco Us Inc. | Trehalase in fermentations |
WO2015066669A1 (en) | 2013-11-04 | 2015-05-07 | Danisco Us Inc. | Proteases in corn processing |
WO2015066667A1 (en) | 2013-11-04 | 2015-05-07 | Danisco Us Inc. | Proteases in wheat processing |
WO2015075391A1 (en) * | 2013-11-22 | 2015-05-28 | IFP Energies Nouvelles | Endoglucanase variants having improved activity, and uses of same |
WO2015075392A1 (en) * | 2013-11-22 | 2015-05-28 | IFP Energies Nouvelles | Endoglucanase variants having improved activity, and uses of same |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015094809A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Chimeric fungal alpha-amylases comprising carbohydrate binding module and the use thereof |
WO2015094714A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Proteases in grain processing |
WO2015041940A3 (en) * | 2013-09-19 | 2015-07-23 | Shell Oil Company | Novel yeast strains |
US9096859B2 (en) | 2011-01-26 | 2015-08-04 | The Regents Of The University Of California | Microbial conversion of plant biomass to advanced biofuels |
CN104293812B (en) * | 2014-10-09 | 2016-09-14 | 中国农业科学院生物技术研究所 | Heat-resistance neutral cellulase Cel6C and encoding gene thereof and application |
WO2016160584A1 (en) * | 2015-03-27 | 2016-10-06 | Cargill, Incorporated | Glucoamylase-modified yeast strains and methods for bioproduct production |
EP2880158A4 (en) * | 2012-08-03 | 2016-10-26 | Dupont Nutrition Biosci Aps | Enzymes |
US9493802B2 (en) | 2010-08-20 | 2016-11-15 | Codexis, Inc. | Use of glycohydrolase 61 protein variants with improved thermostability for processing cellulose |
WO2017037614A1 (en) | 2015-09-04 | 2017-03-09 | Lallemand Hungary Liquidity Management Llc | Yeast strains for the expression and secretion of heterologous proteins at high temperatures |
US9598689B2 (en) | 2011-11-10 | 2017-03-21 | Lallemand Hungary Liquidity Management Llc | Genetically modified strain of S. cerevisiae engineered to ferment xylose and arabinose |
US9605269B2 (en) | 2010-05-05 | 2017-03-28 | Lallemand Hungary Liquidity Management Llc | Detoxification of biomass derived acetate via metabolic conversion to ethanol, acetone, isopropanol, or ethyl acetate |
WO2017077504A1 (en) | 2015-11-06 | 2017-05-11 | Lallemand Hungary Liquidity Management Llc | Limiting yeast-produced trehalose in fermentation |
WO2017100720A1 (en) | 2015-12-09 | 2017-06-15 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
EP3165609A4 (en) * | 2014-06-12 | 2017-09-27 | Biocelere Agroindustrial Ltda. | Expression cartridge for the transformation of eukaryotic cells, method for transforming eukaryotic cells, genetically modified organism, method for producing biofuels and/or biochemicals, and thus produced biofuel and/or biochemical |
WO2017173324A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017173190A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017176875A1 (en) | 2016-04-08 | 2017-10-12 | E I Du Pont De Nemours And Company | Arabinose isomerases for yeast |
WO2018002360A1 (en) | 2016-07-01 | 2018-01-04 | Lallemand Hungary Liquidity Management Llc | Alpha-amylases for combination with glucoamylases for improving saccharification |
WO2018115513A1 (en) | 2016-12-22 | 2018-06-28 | Lallemand Hungary Liquidity Management Llc | Sulfite tolerance in recombinant yeast host cells |
WO2018184004A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Alpha-amylase combinatorial variants |
WO2018215956A1 (en) | 2017-05-23 | 2018-11-29 | Lallemand Hungary Liquidity Management Llc. | Optimization of biomass-based fermentations |
WO2018222990A1 (en) | 2017-06-02 | 2018-12-06 | Novozymes A/S | Improved yeast for ethanol production |
WO2018226569A1 (en) | 2017-06-06 | 2018-12-13 | Danisco Us Inc | Use of betaine to stabilize and/or increase the activity of enzymes in stressful environments |
WO2019036721A2 (en) | 2017-08-18 | 2019-02-21 | Danisco Us Inc | Alpha-amylase variants |
WO2019099235A1 (en) | 2017-11-14 | 2019-05-23 | Danisco Us Inc | Alpha-amylase, composition and method |
US10364421B2 (en) | 2015-02-06 | 2019-07-30 | Cargill, Incorporated | Modified glucoamylase enzymes and yeast strains having enhanced bioproduct production |
WO2019148192A1 (en) | 2018-01-29 | 2019-08-01 | Novozymes A/S | Microorganisms with improved nitrogen utilization for ethanol production |
WO2019186371A1 (en) | 2018-03-26 | 2019-10-03 | Lallemand Hungary Liquidity Management Llc | Chimeric amylases comprising an heterologous starch binding domain |
CN110438019A (en) * | 2019-06-06 | 2019-11-12 | 浙江工业大学 | A kind of composite bacteria agent and its fermented garbage from kitchen prepare the application of organic liquid fertilizer |
WO2019231944A2 (en) | 2018-05-31 | 2019-12-05 | Novozymes A/S | Processes for enhancing yeast growth and productivity |
WO2020023411A1 (en) | 2018-07-25 | 2020-01-30 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
WO2020058914A1 (en) | 2018-09-19 | 2020-03-26 | Danstar Ferment Ag | Expression of heterologous enzymes in yeast for reducing diacetyl and dextrin |
JP2020510442A (en) * | 2017-03-13 | 2020-04-09 | ラレマンド ハンガリー リクィディティー マネジメント エルエルシーLallemand Hungary Liquidity Management Llc | Recombinant yeast host cells expressing cell-associated heterologous proteins |
WO2020076697A1 (en) | 2018-10-08 | 2020-04-16 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
WO2020089847A1 (en) | 2018-11-02 | 2020-05-07 | Lallemand Hungary Liquidity Management Llc | Process for preventing or limiting microbial contamination during continuous culture |
WO2020100069A1 (en) | 2018-11-13 | 2020-05-22 | Lallemand Hungary Liquidity Management Llc | Modulation of formate oxidation by recombinant yeast host cell during fermentation |
WO2020100072A1 (en) | 2018-11-13 | 2020-05-22 | Lallemand Hungary Liquidity Management Llc | Synergistic bacterial and yeast combinations |
WO2020100062A1 (en) | 2018-11-13 | 2020-05-22 | Lallemand Hungary Liquidity Management Llc | Combined expression of trehalose producing and trehalose degrading enzymes |
WO2020115716A1 (en) | 2018-12-07 | 2020-06-11 | Lallemand Hungary Liquidity Management Llc | Modulation of nadph generation by recombinant yeast host cell during fermentation |
US10711259B2 (en) | 2014-12-19 | 2020-07-14 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
US10836837B2 (en) | 2015-11-26 | 2020-11-17 | Novozymes A/S | Wet milling process |
WO2021021458A1 (en) | 2019-07-26 | 2021-02-04 | Novozymes A/S | Microorganisms with improved nitrogen transport for ethanol production |
WO2021025872A1 (en) | 2019-08-06 | 2021-02-11 | Novozymes A/S | Fusion proteins for improved enzyme expression |
WO2021119304A1 (en) | 2019-12-10 | 2021-06-17 | Novozymes A/S | Microorganism for improved pentose fermentation |
CN113201519A (en) * | 2012-05-07 | 2021-08-03 | 诺维信公司 | Polypeptides having xanthan degrading activity and nucleotides encoding same |
WO2021229429A2 (en) | 2020-05-11 | 2021-11-18 | Lallemand Hungary Liquidity Management Llc | Recombinant yeast host cell expressing an hydrolase |
US11180786B2 (en) | 2016-11-25 | 2021-11-23 | Novozymes A/S | GH10 xylanase, GH62 arabinofuranosidase, milling process and other application |
WO2022049250A1 (en) | 2020-09-04 | 2022-03-10 | Novozymes A/S | Improved fermenting organism for ethanol production |
US11421212B2 (en) | 2016-08-05 | 2022-08-23 | Cargill, Incorporated | Engineered yeast strains with signal sequence-modified glucoamylase polypeptides and enhanced ethanol production |
WO2022261003A1 (en) | 2021-06-07 | 2022-12-15 | Novozymes A/S | Engineered microorganism for improved ethanol fermentation |
WO2023028521A1 (en) * | 2021-08-24 | 2023-03-02 | Inscripta, Inc. | Genome-wide rationally-designed mutations leading to enhanced cellobiohydrolase i production in s. cerevisiae |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
EP4081645A4 (en) * | 2019-12-23 | 2023-12-27 | CARGILL, Incorporated | Fermentation method and uses thereof |
WO2024064901A2 (en) | 2022-09-23 | 2024-03-28 | Novozymes A/S | Improved fermenting organism for ethanol production |
US11999987B2 (en) | 2020-03-19 | 2024-06-04 | Lallemand Hungary Liquidity Management Llc | Bacterial cocultures expressing a bacteriocin system |
WO2024137704A2 (en) | 2022-12-19 | 2024-06-27 | Novozymes A/S | Processes for producing fermentation products using fiber-degrading enzymes with engineered yeast |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2964245C (en) | 2008-11-21 | 2020-10-27 | Universiteit Stellenbosch | Yeast expressing cellulases for simultaneous saccharification and fermentation using cellulose |
CA2801577A1 (en) * | 2010-06-03 | 2011-12-08 | Mascoma Corporation | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
EP2697252B1 (en) * | 2011-04-11 | 2016-08-10 | Cargill, Incorporated | Compositions and methods for increased ethanol production from biomass |
EP2540170A1 (en) * | 2011-06-29 | 2013-01-02 | Evonik Degussa GmbH | Dermatological yeast extract |
US10035996B2 (en) * | 2012-10-08 | 2018-07-31 | Novozymes, Inc. | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
CN104419718B (en) * | 2013-08-29 | 2017-07-07 | 天津大学 | A kind of saccharomyces cerevisiae module cotransformation combined sorting method |
US9988657B2 (en) | 2014-02-27 | 2018-06-05 | E I Du Pont De Nemours And Company | Enzymatic hydrolysis of disaccharides and oligosaccharides using alpha-glucosidase enzymes |
CN103820443B (en) * | 2014-03-10 | 2016-01-13 | 湖北工业大学 | Produce yeast strain and the structure thereof with Mierocrystalline cellulose restriction endonuclease and Polyglucosidase double activated albumen |
DK3125962T3 (en) * | 2014-04-01 | 2019-11-25 | Lifecell Corp | MICROBIAL ENZYMES FOR REDUCING ALFA-GALACTOSE FROM COLLAGEN-BASED Tissue |
CN105802990B (en) * | 2015-01-19 | 2020-04-07 | 远东新世纪股份有限公司 | Recombinant saccharomycete cell and its prepn and use |
CN105985969B (en) | 2015-02-15 | 2019-11-12 | 安琪酵母股份有限公司 | Gene engineering yeast and its preparation method and application with saccharification function |
US20160068870A1 (en) * | 2015-03-03 | 2016-03-10 | Edward Brian HAMRICK | Methods for fermenting carbohydrate-rich crops |
CN108368496A (en) * | 2015-10-15 | 2018-08-03 | 慕尼黑工业大学 | Mutation β-glucosyl enzym variant with increased thermal stability |
US11667680B2 (en) | 2016-03-18 | 2023-06-06 | Lallemand Hungary Liquidity Management Llc | Regulation of the RAS/cAMP/PKA signaling pathway in yeasts for obtaining a fermentation product during fermentation |
KR101804050B1 (en) * | 2016-04-29 | 2017-12-04 | 고려대학교 산학협력단 | Novel β-1,3-1,6-endoglucanase for producing oligosaccharides and glucose from β-glucan |
CN106566821B (en) * | 2016-10-11 | 2019-03-26 | 中国农业科学院饲料研究所 | The endoglucanase NfEG12A mutant and its encoding gene and application that catalytic efficiency improves |
CA3047306A1 (en) * | 2016-12-15 | 2018-06-21 | Danisco Us Inc. | Method for increasing the production of ethanol from corn fiber in a starch hydrolysis process |
EP3596200B1 (en) * | 2017-03-13 | 2024-05-29 | Danstar Ferment AG | Cell-associated heterologous food and/or feed enzymes |
WO2018167670A1 (en) * | 2017-03-13 | 2018-09-20 | Lallemand Hungary Liquidity Management Llc | Recombinant yeast host cells expressing cell-associated heterologous proteins |
CN109251938B (en) * | 2017-07-13 | 2022-08-23 | 华东理工大学 | Construction method of pediococcus acidilactici for producing L-lactic acid by co-fermenting glucose and xylose |
BR112020004021A2 (en) * | 2017-08-29 | 2020-09-08 | Danisco Us Inc. | modified yeast comprising glucose-specific atp-mediated transporters |
TWI640633B (en) * | 2017-10-24 | 2018-11-11 | 國立清華大學 | Consortium, method of decomposing hemicellulose and method of manufacturing alcohol using the same |
EP3488854A1 (en) * | 2017-11-22 | 2019-05-29 | Technische Universität München | Method for preparing xyloglucan-oligosaccharides |
EP3502126A1 (en) * | 2017-12-19 | 2019-06-26 | CIC nanoGUNE - Asociación Centro de Investigación Cooperativa en Nanociencias | Ancestral cellulases and uses thereof |
WO2019175807A1 (en) * | 2018-03-13 | 2019-09-19 | Lallemand Hungary Liquidity Management Llc | Yeast expressing thermostable alpha-amylases for hydrolysis of starch |
CN108660084B (en) * | 2018-05-23 | 2021-11-12 | 河南农业大学 | Preparation method of large amount of Saccharomycopsis fibuligera |
FR3083245B1 (en) * | 2018-07-02 | 2022-06-17 | Lesaffre & Cie | STRAIN OF SACCHAROMYCES CEREVISIAE EXPRESSING EXOGENOUS GLUCOAMYLASE AND XYLANASE ENZYMES AND THEIR USE IN THE PRODUCTION OF BIOETHANOL |
CN109456917B (en) * | 2018-11-21 | 2020-09-18 | 中国科学院植物研究所 | TT-09 bacteria for degrading patulin and application thereof |
CN110982850B (en) * | 2018-12-25 | 2022-07-29 | 华侨大学 | Method for synthesizing xylitol by aspergillus oryzae engineering bacteria with enhanced hemicellulose saccharification capacity |
CN111699252B (en) * | 2019-01-16 | 2024-04-30 | 福尼亚生物处理股份有限公司 | Endoglucanase compositions and methods |
US11198881B2 (en) | 2019-11-29 | 2021-12-14 | Lallemand Hungary Liquidity Management Llc | Yeast expressing heterologous glucoamylase |
CN111057694B (en) * | 2019-12-17 | 2022-05-03 | 云南农业大学 | High-activity cellulase derived from rumen of Daqu cattle and gene thereof |
US11939557B2 (en) | 2020-03-20 | 2024-03-26 | Danstar Ferment Ag | Beta-glucosidase expressing yeast for enhanced flavor and aroma in beverage production |
CN113025642B (en) * | 2021-03-30 | 2024-01-02 | 安琪酵母股份有限公司 | Construct for recombinant expression of saccharifying enzyme and application thereof |
CN113308424B (en) * | 2021-04-25 | 2022-12-06 | 天津科技大学 | Bacillus pumilus for producing feruloyl esterase and application thereof |
CN113549644B (en) * | 2021-05-14 | 2024-02-02 | 中南民族大学 | Recombinant yeast displaying three NSP enzymes together, construction method and application thereof |
WO2023062542A2 (en) | 2021-10-11 | 2023-04-20 | Lallemand Hungary Liquidity Management Llc | Recombinant yeast cell having increased pyruvate decarboxylase activity |
CN114410505B (en) * | 2021-12-17 | 2023-10-24 | 苏州聚维元创生物科技有限公司 | Clostridium thermocellum and its application in lignocellulose hydrolysis |
CN114561377B (en) * | 2022-02-24 | 2023-05-19 | 齐鲁工业大学 | Trivalent saccharomyces cerevisiae industrial strain with high robustness, high xylose utilization and oligosaccharide hydrolysis and application thereof |
CN114807067A (en) * | 2022-03-31 | 2022-07-29 | 苏州聚维元创生物科技有限公司 | Engineering strain capable of secreting laccase and construction method and application thereof |
CN116179516B (en) * | 2022-12-29 | 2024-01-26 | 云南师范大学 | alpha-L-arabinofuranosidase and application thereof |
CN117296994B (en) * | 2023-11-30 | 2024-03-22 | 潍坊新希望六和饲料科技有限公司 | Application of chicken stomach microorganism source cellulase in preparation of chicken feed additive |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075363A1 (en) * | 2006-11-22 | 2010-03-25 | The Trustees Of Dartmouth College | Recombinant Yeast Strains Expressing Tethered Cellulase Enzymes |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5422267A (en) | 1984-05-22 | 1995-06-06 | Robert R. Yocum | Industrial yeast comprising an integrated glucoamylase gene |
AU715423B2 (en) | 1995-03-17 | 2000-02-03 | Novozymes A/S | Novel endoglucanases |
CA2374524A1 (en) | 1999-05-26 | 2000-11-30 | Lonnie O'neal Ingram | Recombinant hosts suitable for simultaneous saccharification and fermentation |
KR20020026456A (en) * | 2000-04-13 | 2002-04-10 | 에말파브 마크 아론 | High-throughput screening of expressed dna libraries in filamentous fungi |
PT1468093E (en) | 2002-01-23 | 2009-04-15 | Royal Nedalco B V | Fermentation of pentose sugars |
GB0227435D0 (en) | 2002-11-25 | 2002-12-31 | Univ Denmark Tech Dtu | Metabolically engineered micro-organisms having reduced production of undesired metobolic products |
EP1626979B1 (en) | 2003-05-02 | 2012-06-06 | Cargill, Incorporated | Genetically modified yeast species and fermentation processes using genetically modified yeast |
ZA200406714B (en) * | 2003-05-27 | 2005-11-30 | Univ Of Stellenbosch | Recombinant saccharomyces cerevisiae strains expressing alpha-amylase and glucoamylase genes and the use of such strains |
JP4769724B2 (en) | 2003-05-29 | 2011-09-07 | ジェネンコー・インターナショナル・インク | A novel Trichoderma gene |
PL1781772T3 (en) | 2004-07-16 | 2017-03-31 | Dsm Ip Assets B.V. | Metabolic engineering of xylose fermenting eukaryotic cells |
WO2007143245A2 (en) | 2006-06-01 | 2007-12-13 | Midwest Research Institute | An l-arabinose fermenting yeast |
CA2964245C (en) | 2008-11-21 | 2020-10-27 | Universiteit Stellenbosch | Yeast expressing cellulases for simultaneous saccharification and fermentation using cellulose |
US9315833B2 (en) * | 2009-02-20 | 2016-04-19 | Lallemand Hungary Liquidity Management Llc | Yeast cells expressing an exogenous cellulosome and methods of using the same |
GB2468134A (en) | 2009-02-26 | 2010-09-01 | Uws Ventures Ltd | Yeast for fructan utilisation |
EP2277989A1 (en) | 2009-07-24 | 2011-01-26 | Technische Universiteit Delft | Fermentative glycerol-free ethanol production |
CA2801577A1 (en) | 2010-06-03 | 2011-12-08 | Mascoma Corporation | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
-
2011
- 2011-06-03 CA CA2801577A patent/CA2801577A1/en active Pending
- 2011-06-03 BR BR112012031362A patent/BR112012031362A2/en not_active Application Discontinuation
- 2011-06-03 WO PCT/US2011/039192 patent/WO2011153516A2/en active Application Filing
- 2011-06-03 CN CN2011800357812A patent/CN103124783A/en active Pending
- 2011-06-03 EP EP11790526.5A patent/EP2576762A4/en not_active Withdrawn
- 2011-06-03 EP EP16192843.7A patent/EP3168300A1/en not_active Withdrawn
- 2011-06-03 US US13/701,652 patent/US20130323822A1/en not_active Abandoned
- 2011-06-03 CA CA3152266A patent/CA3152266A1/en active Pending
-
2014
- 2014-02-12 US US14/178,653 patent/US9206444B2/en active Active
-
2015
- 2015-11-10 US US14/936,840 patent/US10294484B2/en active Active
-
2017
- 2017-05-02 US US15/584,473 patent/US10385345B2/en active Active
-
2019
- 2019-05-30 US US16/426,563 patent/US11193130B2/en active Active
-
2021
- 2021-10-13 US US17/500,501 patent/US20230028975A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100075363A1 (en) * | 2006-11-22 | 2010-03-25 | The Trustees Of Dartmouth College | Recombinant Yeast Strains Expressing Tethered Cellulase Enzymes |
Non-Patent Citations (2)
Title |
---|
DATABASE UNIPROT [Online] 05 July 2005 Database accession no. Q4WCM9 * |
See also references of EP2576762A2 * |
Cited By (179)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9605269B2 (en) | 2010-05-05 | 2017-03-28 | Lallemand Hungary Liquidity Management Llc | Detoxification of biomass derived acetate via metabolic conversion to ethanol, acetone, isopropanol, or ethyl acetate |
US8877474B2 (en) | 2010-08-20 | 2014-11-04 | Codexis, Inc. | GH61 glycoside hydrolase protein variants and cofactors that enhance GH61 activity |
US9493802B2 (en) | 2010-08-20 | 2016-11-15 | Codexis, Inc. | Use of glycohydrolase 61 protein variants with improved thermostability for processing cellulose |
US8802423B2 (en) * | 2010-12-30 | 2014-08-12 | Novozymes A/S | Method for treating textile with endoglucanase |
CN103562384A (en) * | 2011-01-26 | 2014-02-05 | 诺维信公司 | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US10131893B2 (en) | 2011-01-26 | 2018-11-20 | Novozymes. Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
CN103562384B (en) * | 2011-01-26 | 2017-01-18 | 诺维信公司 | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2012103322A1 (en) * | 2011-01-26 | 2012-08-02 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US9068176B2 (en) | 2011-01-26 | 2015-06-30 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US9096859B2 (en) | 2011-01-26 | 2015-08-04 | The Regents Of The University Of California | Microbial conversion of plant biomass to advanced biofuels |
US10815468B2 (en) | 2011-01-26 | 2020-10-27 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US9663774B2 (en) | 2011-01-26 | 2017-05-30 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US9434972B2 (en) | 2011-01-31 | 2016-09-06 | Novozymes North America, Inc. | Processes for enzymatic refining of pretreated cellulosic material for saccharification |
WO2012134626A3 (en) * | 2011-01-31 | 2013-03-21 | Novozymes North America, Inc. | Processes for enzymatic refining of pretreated cellulosic material for saccharification |
US9719098B2 (en) | 2011-04-05 | 2017-08-01 | Lallemand Hungary Liquidity Management Llc | Methods for the improvement of product yield and production in a microorganism through the addition of alternate electron acceptors |
US11034967B2 (en) | 2011-04-05 | 2021-06-15 | Lallemand Hungary Liquidity Management Llc | Methods for the improvement of product yield and production in a microorganism through the addition of alternate electron acceptors |
US8956851B2 (en) | 2011-04-05 | 2015-02-17 | Lallemand Hungary Liquidity Management, LLC | Methods for the improvement of product yield and production in a microorganism through the addition of alternate electron acceptors |
WO2013028701A1 (en) * | 2011-08-22 | 2013-02-28 | Codexis, Inc. | Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity |
US8951758B2 (en) | 2011-08-22 | 2015-02-10 | Codexis, Inc. | GH61 glycoside hydrolase protein variants and cofactors that enhance GH61 activity |
EP3845641A1 (en) | 2011-10-28 | 2021-07-07 | Danisco US Inc. | Variant maltohexaose-forming alpha-amylase variants |
EP4345161A2 (en) | 2011-10-28 | 2024-04-03 | Danisco Us Inc | Variant maltohexaose-forming alpha-amylase variants |
EP3246404A1 (en) | 2011-10-28 | 2017-11-22 | Danisco US Inc. | Variant maltohexaose-forming alpha-amylase variants |
WO2013063460A2 (en) | 2011-10-28 | 2013-05-02 | Danisco Us Inc. | Variant maltohexaose-forming alpha-amylase variants |
EP3572505A2 (en) | 2011-10-28 | 2019-11-27 | Danisco US Inc. | Variant maltohexaose-forming alpha-amylase variants |
US10047380B2 (en) | 2011-11-10 | 2018-08-14 | Lallemand Hungary Liquidity Management Llc | Genetically modified strain of S. cerevisiae engineered to ferment xylose and arabinose |
US9598689B2 (en) | 2011-11-10 | 2017-03-21 | Lallemand Hungary Liquidity Management Llc | Genetically modified strain of S. cerevisiae engineered to ferment xylose and arabinose |
US9988649B2 (en) | 2011-11-30 | 2018-06-05 | Dsm Ip Assets B.V. | Yeast strains engineered to produce ethanol from acetic acid and glycerol |
WO2013081456A3 (en) * | 2011-11-30 | 2013-08-15 | Dsm Ip Assets B.V. | Yeast strains engineered to produce ethanol from acetic acid and glycerol |
US10941421B2 (en) | 2011-11-30 | 2021-03-09 | Dsm Ip Assets B.V. | Yeast strains engineered to produce ethanol from acetic acid and glycerol |
EP3321368A3 (en) * | 2011-11-30 | 2018-05-23 | DSM IP Assets B.V. | Yeast strains engineered to produce ethanol from acetic acid and glycerol |
US10190103B2 (en) | 2012-04-23 | 2019-01-29 | Novozymes A/S | Polypeptides having glucuronyl esterase activity and polynucleotides encoding same |
US10731140B2 (en) | 2012-04-23 | 2020-08-04 | Novozymes A/S | Polypeptides having glucuronyl esterase activity and polynucleotides encoding same |
US9394556B2 (en) | 2012-04-23 | 2016-07-19 | Novozymes A/S | Polypeptides having glucuronyl esterase activity and polynucleotides encoding same |
WO2013160247A3 (en) * | 2012-04-23 | 2013-12-19 | Novozymes A/S | Polypeptides having glucuronyl esterase activity and polynucleotides encoding same |
CN104245930A (en) * | 2012-04-23 | 2014-12-24 | 诺维信公司 | Polypeptides having glucuronyl esterase activity and polynucleotides encoding same |
EP2660319A1 (en) * | 2012-05-02 | 2013-11-06 | Clariant Produkte (Deutschland) GmbH | Endoglucanases with improved properties |
EA034175B1 (en) * | 2012-05-02 | 2020-01-14 | Клариант Продукте (Дойчланд) Гмбх | Protein having endoglucanase activity and use thereof for saccharification of lignocellulose |
US9677059B2 (en) | 2012-05-02 | 2017-06-13 | Clariant Produkte (Deutschland) Gmbh | Endoglucanases with improved properties |
WO2013164340A1 (en) * | 2012-05-02 | 2013-11-07 | Clariant Produkte (Deutschland) Gmbh | Endoglucanases with improved properties |
CN104271738B (en) * | 2012-05-02 | 2018-05-11 | 科莱恩产品(德国)有限公司 | The endoglucanase that characteristic improves |
CN104271738A (en) * | 2012-05-02 | 2015-01-07 | 科莱恩产品(德国)有限公司 | Endoglucanases with improved properties |
CN113201519A (en) * | 2012-05-07 | 2021-08-03 | 诺维信公司 | Polypeptides having xanthan degrading activity and nucleotides encoding same |
WO2013169645A1 (en) | 2012-05-11 | 2013-11-14 | Danisco Us Inc. | Use of alpha-amylase from aspergillus clavatus for saccharification |
US8945889B2 (en) | 2012-05-11 | 2015-02-03 | Danisco Us Inc. | Method of using alpha-amylase from Aspergillus clavatus for saccharification |
WO2013175074A1 (en) * | 2012-05-24 | 2013-11-28 | Roal Oy | Improved endoglucanases for treatment of cellulosic material |
US8975058B2 (en) | 2012-05-24 | 2015-03-10 | Roal Oy | Endoglucanases for treatment of cellulosic material |
EP2855673A4 (en) * | 2012-05-24 | 2016-05-11 | Roal Oy | Improved endoglucanases for treatment of cellulosic material |
WO2013184577A1 (en) | 2012-06-08 | 2013-12-12 | Danisco Us Inc. | Alpha-amylase variants derived from the alpha amylase of cytophaga sp.amylase|(cspamy2). |
WO2013182671A1 (en) * | 2012-06-08 | 2013-12-12 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of aureobasidium pullulans and uses thereof |
EP4389885A2 (en) | 2012-06-08 | 2024-06-26 | Danisco Us Inc | Alpha-amylase variants |
EP3967757A1 (en) | 2012-06-08 | 2022-03-16 | Danisco US Inc. | Alpha-amylase variants derived from the alpha amylase of cytophaga sp. amylase (cspamy2). |
EP3225634A1 (en) * | 2012-08-03 | 2017-10-04 | DuPont Nutrition Biosciences ApS | Xylanase enzyme activity |
EP2880158A4 (en) * | 2012-08-03 | 2016-10-26 | Dupont Nutrition Biosci Aps | Enzymes |
WO2014028434A2 (en) | 2012-08-16 | 2014-02-20 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus clavatus and pullulanase for saccharification |
US9745560B2 (en) | 2012-08-29 | 2017-08-29 | Lallemand Hungary Liquidity Management Llc | Expression of enzymes in yeast for lignocellulose derived oligomer CBP |
WO2014035458A1 (en) | 2012-08-29 | 2014-03-06 | Mascoma Corporation | Expression of enzymes in yeast for lignocellulose derived oligomer cbp |
CN104797708A (en) * | 2012-08-29 | 2015-07-22 | 拉勒曼德匈牙利流动性管理有限责任公司 | Expression of enzymes in yeast for lignocellulose derived oligomer CBP |
WO2014043288A1 (en) | 2012-09-12 | 2014-03-20 | Butamax Advanced Biofuels Llc | Processes and systems for the production of fermentation products |
WO2014059273A1 (en) | 2012-10-11 | 2014-04-17 | Butamax Advanced Biofuels Llc | Processes and systems for the production of fermentation products |
WO2014064331A1 (en) * | 2012-10-26 | 2014-05-01 | Roal Oy | Novel esterases in the treatment of cellulosic and lignocellulosic material |
WO2014092960A1 (en) | 2012-12-11 | 2014-06-19 | Danisco Us Inc. | Trichoderma reesei host cells expressing a glucoamylase from aspergillus fumigatus and methods of use thereof |
EP3321353A1 (en) | 2012-12-11 | 2018-05-16 | Danisco US Inc. | Yeast host cells epxressing a glucoamylase from aspergillus fumigatus and methods of use thereof |
US9765374B2 (en) | 2012-12-14 | 2017-09-19 | Danisco Us Inc | Method of using α-amylase from Aspergillus fumigatus and isoamylase for saccharification |
WO2014093125A1 (en) | 2012-12-14 | 2014-06-19 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus fumigatus and isoamylase for saccharification |
WO2014098939A1 (en) | 2012-12-20 | 2014-06-26 | E. I. Du Pont De Nemours And Company | Expression of xylose isomerase activity in yeast |
WO2014099415A1 (en) | 2012-12-20 | 2014-06-26 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus terreus and pullulanase for saccharification |
WO2014099525A1 (en) | 2012-12-21 | 2014-06-26 | Danisco Us Inc. | Paenibacillus curdlanolyticus amylase, and methods of use, thereof |
WO2014099523A1 (en) | 2012-12-21 | 2014-06-26 | Danisco Us Inc. | Alpha-amylase variants |
EP3354728A1 (en) | 2012-12-21 | 2018-08-01 | Danisco US Inc. | Alpha-amylase variants |
US8778639B1 (en) * | 2013-02-12 | 2014-07-15 | Novozymes Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US9080194B2 (en) | 2013-02-12 | 2015-07-14 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US8771993B1 (en) * | 2013-02-12 | 2014-07-08 | Novozymes A/S | Polypeptides having endoglucanse activity and polynucleotides encoding same |
EP3336183A1 (en) | 2013-03-11 | 2018-06-20 | Danisco US Inc. | Alpha-amylase conbinatorial variants |
US8906656B2 (en) | 2013-03-11 | 2014-12-09 | E I Du Pont De Nemours And Company | Cow rumen xylose isomerases active in yeast cells |
US9187743B2 (en) | 2013-03-11 | 2015-11-17 | E I Du Pont De Nemours And Company | Bacterial xylose isomerases active in yeast cells |
US8669076B1 (en) | 2013-03-11 | 2014-03-11 | E I Du Pont De Nemours And Company | Cow rumen xylose isomerases active in yeast cells |
US9371535B2 (en) | 2013-03-11 | 2016-06-21 | E I Du Pont De Nemours And Company | Bacterial xylose isomerases active in yeast cells |
WO2014164410A1 (en) | 2013-03-11 | 2014-10-09 | E. I. Du Pont De Nemours And Company | Bacterial xylose isomerases active in yeast cells |
WO2014164800A1 (en) | 2013-03-11 | 2014-10-09 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2014164777A1 (en) | 2013-03-11 | 2014-10-09 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
EP3978604A1 (en) | 2013-03-11 | 2022-04-06 | Danisco US Inc. | Alpha-amylase combinatorial variants |
WO2014151447A1 (en) | 2013-03-15 | 2014-09-25 | Butamax Advanced Biofuels Llc | Processes and systems for the production of fermentative alcohols |
US10612061B2 (en) | 2013-03-15 | 2020-04-07 | Lallemand Hungary Liquidity Management Llc | Expression of beta-glucosidases for hydrolysis of lignocellulose and associated oligomers |
US11168315B2 (en) | 2013-03-15 | 2021-11-09 | Lallemand Hungary Liquidity Management Llc | Expression of beta-glucosidases for hydrolysis of lignocellulose and associated oligomers |
WO2014151805A2 (en) | 2013-03-15 | 2014-09-25 | Mascoma Corporation | Expression of beta-glucosidases for hydrolysis of lignocellulose and associated oligomers |
WO2014200658A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from promicromonospora vindobonensis |
WO2014200657A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces xiamenensis |
WO2014200656A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces umbrinus |
WO2014204596A1 (en) | 2013-06-17 | 2014-12-24 | Danisco Us Inc. | Alpha-amylase from bacillaceae family member |
WO2014202621A1 (en) * | 2013-06-20 | 2014-12-24 | Dsm Ip Assets B.V. | Carbohydrate degrading polypeptide and uses thereof |
WO2015006843A3 (en) * | 2013-07-15 | 2015-04-02 | Centro Nacional De Pesquisa Em Energia E Materiais - Cnpem | Bifunctional enzyme used to degrade biomass and produce xylose in a single operation |
EP3033413B1 (en) | 2013-08-15 | 2020-06-24 | Lallemand Hungary Liquidity Management LLC | Methods for the improvement of product yield and production in a microorganism through glycerol recycling |
US11753656B2 (en) | 2013-08-15 | 2023-09-12 | Lallemand Hungary Liquidity Management Llc | Methods for the improvement of product yield and production in a microorganism through glycerol recycling |
WO2015023989A1 (en) * | 2013-08-15 | 2015-02-19 | Lallemand Hungary Liquidity Management Llc | Methods for the improvement of product yield and production in a microorganism through glycerol recycling |
WO2015031477A1 (en) | 2013-08-30 | 2015-03-05 | Novozymes A/S | Enzyme composition and uses thereof |
WO2015041940A3 (en) * | 2013-09-19 | 2015-07-23 | Shell Oil Company | Novel yeast strains |
WO2015050724A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
WO2015065978A1 (en) | 2013-10-28 | 2015-05-07 | Danisco Us Inc. | Trehalase in fermentations |
WO2015066669A1 (en) | 2013-11-04 | 2015-05-07 | Danisco Us Inc. | Proteases in corn processing |
WO2015066667A1 (en) | 2013-11-04 | 2015-05-07 | Danisco Us Inc. | Proteases in wheat processing |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015075392A1 (en) * | 2013-11-22 | 2015-05-28 | IFP Energies Nouvelles | Endoglucanase variants having improved activity, and uses of same |
CN105874066A (en) * | 2013-11-22 | 2016-08-17 | Ifp新能源公司 | Endoglucanase variants having improved activity, and uses of same |
US10000780B2 (en) | 2013-11-22 | 2018-06-19 | IFP Energies Nouvelles | Endoglucanase variants having improved activity, and uses of same |
US9920308B2 (en) | 2013-11-22 | 2018-03-20 | IFP Energies Nouvelles | Endoglucanase variants having improved activity, and uses of same |
WO2015075391A1 (en) * | 2013-11-22 | 2015-05-28 | IFP Energies Nouvelles | Endoglucanase variants having improved activity, and uses of same |
FR3013732A1 (en) * | 2013-11-22 | 2015-05-29 | IFP Energies Nouvelles | ENDOGLUCANASIC VARIANTS WITH IMPROVED ACTIVITY AND USES THEREOF |
FR3013731A1 (en) * | 2013-11-22 | 2015-05-29 | IFP Energies Nouvelles | ENDOGLUCANASIC VARIANTS WITH IMPROVED ACTIVITY AND USES THEREOF |
WO2015094809A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Chimeric fungal alpha-amylases comprising carbohydrate binding module and the use thereof |
WO2015094714A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Proteases in grain processing |
EP3165609A4 (en) * | 2014-06-12 | 2017-09-27 | Biocelere Agroindustrial Ltda. | Expression cartridge for the transformation of eukaryotic cells, method for transforming eukaryotic cells, genetically modified organism, method for producing biofuels and/or biochemicals, and thus produced biofuel and/or biochemical |
US10155953B2 (en) | 2014-06-12 | 2018-12-18 | Biocelere Agroindustrial Ltda. | Expression cartridge for the transformation of eukaryotic cells, method for transforming eukaryotic cells, genetically modified organism, method for producing biofuels and/or biochemicals, and thus produced biofuel and/or biochemical |
CN104293812B (en) * | 2014-10-09 | 2016-09-14 | 中国农业科学院生物技术研究所 | Heat-resistance neutral cellulase Cel6C and encoding gene thereof and application |
US10711259B2 (en) | 2014-12-19 | 2020-07-14 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
US11053490B2 (en) | 2014-12-19 | 2021-07-06 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
US11926852B2 (en) | 2014-12-19 | 2024-03-12 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
US11788079B2 (en) | 2014-12-19 | 2023-10-17 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
US10724023B2 (en) | 2015-02-06 | 2020-07-28 | Cargill, Incorporated | Microorganisms expressing modified glucoamylase enzymes |
US10364421B2 (en) | 2015-02-06 | 2019-07-30 | Cargill, Incorporated | Modified glucoamylase enzymes and yeast strains having enhanced bioproduct production |
WO2016160584A1 (en) * | 2015-03-27 | 2016-10-06 | Cargill, Incorporated | Glucoamylase-modified yeast strains and methods for bioproduct production |
US10344288B2 (en) | 2015-03-27 | 2019-07-09 | Cargill, Incorporated | Glucoamylase-modified yeast strains and methods for bioproduct production |
US20190376071A1 (en) * | 2015-03-27 | 2019-12-12 | Cargill, Incorporated | Glucoamylase-modified yeast strains and methods for bioproduct production |
US11332728B2 (en) | 2015-09-04 | 2022-05-17 | Lallemand Hungary Liquidity Management Llc | Yeast strains for the expression and secretion of heterologous proteins at high temperatures |
US20180265853A1 (en) * | 2015-09-04 | 2018-09-20 | Lallemand Hungary Liquidity Management Llc | Yeast strains for the expression and secretion of heterologous proteins at high temperatures |
WO2017037614A1 (en) | 2015-09-04 | 2017-03-09 | Lallemand Hungary Liquidity Management Llc | Yeast strains for the expression and secretion of heterologous proteins at high temperatures |
US10947568B2 (en) | 2015-11-06 | 2021-03-16 | Lallemand Hungary Liquidity Management Llc | Limiting yeast-produced trehalose in fermentation |
US11634734B2 (en) | 2015-11-06 | 2023-04-25 | Lallemand Hungary Liquidity Management Llc | Limiting yeast-produced trehalose in fermentation |
US10570421B2 (en) | 2015-11-06 | 2020-02-25 | Lallemand Hungary Liquidity Management Llc | Limiting yeast-produced trehalose in fermentation |
WO2017077504A1 (en) | 2015-11-06 | 2017-05-11 | Lallemand Hungary Liquidity Management Llc | Limiting yeast-produced trehalose in fermentation |
US11572576B2 (en) | 2015-11-06 | 2023-02-07 | Lallemand Hungary Liquidity Management Llc | Limiting yeast-produced trehalose in fermentation |
US11987649B2 (en) | 2015-11-26 | 2024-05-21 | Novozymes A/S | Wet milling process |
US11649298B2 (en) | 2015-11-26 | 2023-05-16 | Novozymes A/S | Wet milling process |
US10836837B2 (en) | 2015-11-26 | 2020-11-17 | Novozymes A/S | Wet milling process |
EP3901257A1 (en) | 2015-12-09 | 2021-10-27 | Danisco US Inc. | Alpha-amylase combinatorial variants |
US11920170B2 (en) | 2015-12-09 | 2024-03-05 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2017100720A1 (en) | 2015-12-09 | 2017-06-15 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2017173324A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017173190A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017176875A1 (en) | 2016-04-08 | 2017-10-12 | E I Du Pont De Nemours And Company | Arabinose isomerases for yeast |
WO2018002360A1 (en) | 2016-07-01 | 2018-01-04 | Lallemand Hungary Liquidity Management Llc | Alpha-amylases for combination with glucoamylases for improving saccharification |
US11421212B2 (en) | 2016-08-05 | 2022-08-23 | Cargill, Incorporated | Engineered yeast strains with signal sequence-modified glucoamylase polypeptides and enhanced ethanol production |
US11180786B2 (en) | 2016-11-25 | 2021-11-23 | Novozymes A/S | GH10 xylanase, GH62 arabinofuranosidase, milling process and other application |
CN110177879A (en) * | 2016-12-22 | 2019-08-27 | 拉勒曼德匈牙利流动性管理有限责任公司 | The sulphite tolerance of recombinant yeast host cell |
WO2018115513A1 (en) | 2016-12-22 | 2018-06-28 | Lallemand Hungary Liquidity Management Llc | Sulfite tolerance in recombinant yeast host cells |
JP7194112B2 (en) | 2017-03-13 | 2022-12-21 | ラレマンド ハンガリー リクィディティー マネジメント エルエルシー | Recombinant Yeast Host Cells Expressing Cell-associated Heterologous Proteins |
JP2020510442A (en) * | 2017-03-13 | 2020-04-09 | ラレマンド ハンガリー リクィディティー マネジメント エルエルシーLallemand Hungary Liquidity Management Llc | Recombinant yeast host cells expressing cell-associated heterologous proteins |
WO2018184004A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Alpha-amylase combinatorial variants |
WO2018215956A1 (en) | 2017-05-23 | 2018-11-29 | Lallemand Hungary Liquidity Management Llc. | Optimization of biomass-based fermentations |
WO2018222990A1 (en) | 2017-06-02 | 2018-12-06 | Novozymes A/S | Improved yeast for ethanol production |
WO2018226569A1 (en) | 2017-06-06 | 2018-12-13 | Danisco Us Inc | Use of betaine to stabilize and/or increase the activity of enzymes in stressful environments |
WO2019036721A2 (en) | 2017-08-18 | 2019-02-21 | Danisco Us Inc | Alpha-amylase variants |
WO2019099235A1 (en) | 2017-11-14 | 2019-05-23 | Danisco Us Inc | Alpha-amylase, composition and method |
WO2019148192A1 (en) | 2018-01-29 | 2019-08-01 | Novozymes A/S | Microorganisms with improved nitrogen utilization for ethanol production |
WO2019186371A1 (en) | 2018-03-26 | 2019-10-03 | Lallemand Hungary Liquidity Management Llc | Chimeric amylases comprising an heterologous starch binding domain |
WO2019231944A2 (en) | 2018-05-31 | 2019-12-05 | Novozymes A/S | Processes for enhancing yeast growth and productivity |
US11866751B2 (en) | 2018-07-25 | 2024-01-09 | Novozymes A/S | Yeast expressing a heterologous alpha-amylase for ethanol production |
WO2020023411A1 (en) | 2018-07-25 | 2020-01-30 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
WO2020058914A1 (en) | 2018-09-19 | 2020-03-26 | Danstar Ferment Ag | Expression of heterologous enzymes in yeast for reducing diacetyl and dextrin |
WO2020076697A1 (en) | 2018-10-08 | 2020-04-16 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
US11807889B2 (en) | 2018-10-08 | 2023-11-07 | Novozymes A/S | Yeast expressing a heterologous phospholipase for ethanol production |
WO2020089847A1 (en) | 2018-11-02 | 2020-05-07 | Lallemand Hungary Liquidity Management Llc | Process for preventing or limiting microbial contamination during continuous culture |
WO2020100069A1 (en) | 2018-11-13 | 2020-05-22 | Lallemand Hungary Liquidity Management Llc | Modulation of formate oxidation by recombinant yeast host cell during fermentation |
WO2020100072A1 (en) | 2018-11-13 | 2020-05-22 | Lallemand Hungary Liquidity Management Llc | Synergistic bacterial and yeast combinations |
WO2020100062A1 (en) | 2018-11-13 | 2020-05-22 | Lallemand Hungary Liquidity Management Llc | Combined expression of trehalose producing and trehalose degrading enzymes |
WO2020115716A1 (en) | 2018-12-07 | 2020-06-11 | Lallemand Hungary Liquidity Management Llc | Modulation of nadph generation by recombinant yeast host cell during fermentation |
CN110438019A (en) * | 2019-06-06 | 2019-11-12 | 浙江工业大学 | A kind of composite bacteria agent and its fermented garbage from kitchen prepare the application of organic liquid fertilizer |
WO2021021458A1 (en) | 2019-07-26 | 2021-02-04 | Novozymes A/S | Microorganisms with improved nitrogen transport for ethanol production |
WO2021025872A1 (en) | 2019-08-06 | 2021-02-11 | Novozymes A/S | Fusion proteins for improved enzyme expression |
WO2021119304A1 (en) | 2019-12-10 | 2021-06-17 | Novozymes A/S | Microorganism for improved pentose fermentation |
EP4081645A4 (en) * | 2019-12-23 | 2023-12-27 | CARGILL, Incorporated | Fermentation method and uses thereof |
US11999987B2 (en) | 2020-03-19 | 2024-06-04 | Lallemand Hungary Liquidity Management Llc | Bacterial cocultures expressing a bacteriocin system |
WO2021229429A2 (en) | 2020-05-11 | 2021-11-18 | Lallemand Hungary Liquidity Management Llc | Recombinant yeast host cell expressing an hydrolase |
WO2022049250A1 (en) | 2020-09-04 | 2022-03-10 | Novozymes A/S | Improved fermenting organism for ethanol production |
WO2022261003A1 (en) | 2021-06-07 | 2022-12-15 | Novozymes A/S | Engineered microorganism for improved ethanol fermentation |
WO2023028521A1 (en) * | 2021-08-24 | 2023-03-02 | Inscripta, Inc. | Genome-wide rationally-designed mutations leading to enhanced cellobiohydrolase i production in s. cerevisiae |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
WO2024064901A2 (en) | 2022-09-23 | 2024-03-28 | Novozymes A/S | Improved fermenting organism for ethanol production |
WO2024137704A2 (en) | 2022-12-19 | 2024-06-27 | Novozymes A/S | Processes for producing fermentation products using fiber-degrading enzymes with engineered yeast |
Also Published As
Publication number | Publication date |
---|---|
CA2801577A1 (en) | 2011-12-08 |
US20200095592A1 (en) | 2020-03-26 |
EP2576762A2 (en) | 2013-04-10 |
BR112012031362A2 (en) | 2015-10-13 |
US20130323822A1 (en) | 2013-12-05 |
US20230028975A1 (en) | 2023-01-26 |
WO2011153516A3 (en) | 2012-03-29 |
CN103124783A (en) | 2013-05-29 |
US20160068850A1 (en) | 2016-03-10 |
US9206444B2 (en) | 2015-12-08 |
US10385345B2 (en) | 2019-08-20 |
CA3152266A1 (en) | 2011-12-08 |
US20140308724A1 (en) | 2014-10-16 |
EP2576762A4 (en) | 2013-12-04 |
US11193130B2 (en) | 2021-12-07 |
US20170240906A1 (en) | 2017-08-24 |
EP3168300A1 (en) | 2017-05-17 |
US10294484B2 (en) | 2019-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11193130B2 (en) | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose | |
US20210388398A1 (en) | Yeast expressing cellulases for simultaneous saccharification and fermentation using cellulose | |
US10047380B2 (en) | Genetically modified strain of S. cerevisiae engineered to ferment xylose and arabinose | |
CA2881772C (en) | Expression of enzymes in yeast for lignocellulose derived oligomer cbp | |
CA3021166C (en) | Heterologous expression of fungal cellobiohydrolases in yeast | |
US11168315B2 (en) | Expression of beta-glucosidases for hydrolysis of lignocellulose and associated oligomers | |
WO2010005551A2 (en) | Heterologous expression of termite cellulases in yeast | |
WO2009139839A1 (en) | Construction of protrophic/celluloytic yeast strains expressing tethered and secreted cellulases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180035781.2 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2801577 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2011790526 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011790526 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11790526 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13701652 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012031362 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012031362 Country of ref document: BR Kind code of ref document: A2 Effective date: 20121203 |